ACAT2	100678	ACAT2 ?ACAT2 deficiency, 614055 (1)	
CHRNA1	100690	CHRNA1, ACHRD, CMS2A, SCCMS, FCCMS Myasthenic syndrome, slow-channel congenital, 601462 (3); Myasthenic syndrome, fast-channel congenital, 608930 (3); Multiple pterygium syndrome, lethal type, 253290 (3)	
CHRNB1	100710	CHRNB1, ACHRB, SCCMS, CMS2A, CMS1D Myasthenic syndrome, slow-channel congenital, 601462 (3); Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)	
CHRND	100720	CHRND, ACHRD, SCCMS, CMS2A, FCCMS Myasthenic syndrome, slow-channel congenital, 601462 (3); Myasthenic syndrome, fast-channel congenital, 608930 (3); Multiple pterygium syndrome, lethal type, 253290 (3)	
CHRNE	100725	CHRNE, SCCMS, CMS2A, FCCMS, CMS1E, CMS1D Myasthenic syndrome, slow-channel congenital, 601462 (3); Myasthenic syndrome, fast-channel congenital, 608930 (3); Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)	
CHRNG	100730	CHRNG, ACHRG Myasthenia gravis, neonatal transient (2); Escobar syndrome, 265000 (3); Multiple pterygium syndrome, lethal type, 253290 (3)	
ACHE	100740	ACHE, YT [Blood group, Yt system], 112100 (3)	
ASCL1	100790	ASCL1, ASH1 Central hypoventilation syndrome, congenital, 209880 (3); Haddad syndrome, 209880 (3)	
ACO2	100850	ACO2, ICRD Infantile cerebellar-retinal degeneration, 614559 (3)	
ACR	102480	ACR ?Male infertility due to acrosin deficiency (2)	
ACTC1	102540	ACTC1, CMD1R, CMH11, ASD5, LVNC4 Cardiomyopathy, dilated, 1R, 613424 (3); Cardiomyopathy, familial hypertrophic, 11, 612098 (3); Atrial septal defect 5, 612794 (3); Left ventricular noncompaction 4, 613424 (3)	
ACTG1	102560	ACTG1, DFNA20, DFNA26, BRWS2 Deafness, autosomal dominant 20/26, 604717 (3); Baraitser-Winter syndrome 2, 614583 (3)	
FLNC	102565	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4 Myopathy, myofibrillar, 5, 609524 (3); Myopathy, distal, 4, 614065 (3)	
ACTN2	102573	ACTN2, CMD1AA Cardiomyopathy, dilated, 1AA, 612158 (3)	
ACVR1	102576	ACVR1, ACVRLK2, ALK2, FOP Fibrodysplasia ossificans progressiva, 135100 (3)	
PML	102578	PML, MYL Leukemia, acute promyelocytic, PML/RARA type (3)	
STAT3	102582	STAT3, APRF, HIES Hyper-IgE recurrent infection syndrome, 147060 (3)	
ACTA1	102610	ACTA1, ASMA, NEM3, NEM1, CFTD1 Myopathy, nemaline, 3, 161800 (3); Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3); Myopathy, actin, congenital, with cores (3); Myopathy, congenital, with fiber-type disproportion 1, 255310 (3)	
ACTA2	102620	ACTA2, ACTSA, AAT6, MYMY5 Aortic aneurysm, familial thoracic 6, 611788 (3); Multisystemic smooth muscle dysfunction syndrome, 613834 (3); Moyamoya disease 5, 614042 (3)	
ACTB	102630	ACTB, BRWS1 Dystonia, juvenile-onset, 607371 (3); Baraitser-Winter syndrome 2, 243310 (3)	
ADD1	102680	ADD1 {Hypertension, essential, salt-sensitive}, 145500 (3)	
ADK	102750	ADK Hypermethioninemia due to adenosine kinase deficiency, 614300 (3)	
AMPD3	102772	AMPD3 [AMP deaminase deficiency, erythrocytic], 612874 (3)	
AK1	103000	AK1 Hemolytic anemia due to adenylate kinase deficiency, 612631 (3)	
AK2	103020	AK2 Reticular dysgenesis, 267500 (3)	
SLC25A4	103220	SLC25A4, ANT1, T1, PEO3, PEO2 Progressive external ophthalmoplegia with mitochondrial DNA deletions 3, 609283 (3); Cardiomyopathy, familial hypertrophic, 192600 (3)	
H19	103280	H19, D11S813E, ASM1, BWS, WT2 Beckwith-Wiedemann syndrome, 130650 (3); Silver-Russell syndrome, 180860 (3); Wilms tumor 2, 194071 (3)	
AGRN	103320	AGRN Myasthenia, limb-girdle, familial, 254300 (3)	
ADH1C	103730	ADH1C, ADH3 {Alcohol dependence, protection against}, 103780 (3); {Parkinson disease, susceptibility to}, 168600 (3)	
ALDOA	103850	ALDOA, GSD12 Glycogen storage disease XII, 611881 (3)	
A2M	103950	A2M , A2MD Alpha-2-macroglobulin deficiency, 614036 (1); {Alzheimer disease, susceptibility to}, 104300 (3)	
ZFHX3	104155	ZFHX3, ATBF1 {Prostate cancer, susceptibility to}, 176807 (3)	
NAGA	104170	NAGA Schindler disease, type I, 609241 (3); Kanzaki disease, 609242 (3); Schindler disease, type III, 609241 (3)	
PSEN1	104311	PSEN1, AD3 Alzheimer disease, type 3, 607822 (3); Alzheimer disease, type 3, with spastic paraparesis and unusual plaques, 607822 (3); Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 (3); Dementia, frontotemporal, 600274 (3); Pick disease, 172700 (3); Cardiomyopathy, dilated, 1U, 613694 (3); Acne inversa, familial, 3, 613737 (3)	
SLC3A1	104614	SLC3A1, ATR1, D2H, NBAT Cystinuria, 220100 (3)	
ACY1	104620	ACY1, ACY1D Aminoacylase 1 deficiency, 609924 (3)	
APP	104760	APP, AAA, CVAP, AD1 Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants, 605714 (3); Alzheimer disease 1, familial, 104300 (3)	
APCS	104770	APCS, SAP {?Amyloidosis, secondary, susceptibility to} (1)	
ALK	105590	ALK, NBLST3 {Neuroblastoma, susceptibility to, 3}, 613014 (3)	
ANG	105850	ANG, RNASE5, ALS9 Amyotrophic lateral sclerosis 9, 611895 (3)	
AGTR1	106165	AGTR1, AGTR1A, AT2R1 Hypertension, essential, 145500 (3); Renal tubular dysgenesis, 267430 (3)	
ANK2	106410	ANK2, LQT4 Long QT syndrome-4, 600919 (3); Cardiac arrhythmia, ankyrin-B-related, 600919 (3)	
CD19	107265	CD19, CVID3 Immunodeficiency, common variable, 3, 613493 (3)	
CD44	107269	CD44, MDU2, MDU3, MIC4, IN [Blood group, Indian system], 609027 (3)	
CD59	107271	CD59, MIC11 CD59 deficiency, 612300 (3)	
SERPINA3	107280	SERPINA3, AACT, ACT Alpha-1-antichymotrypsin deficiency (3); Cerebrovascular disease, occlusive (3)	
SERPINC1	107300	SERPINC1, AT3, AT3D, THPH7 Thrombophilia due to antithrombin III deficiency, 613118 (3)	
ALDH7A1	107323	ALDH7A1, ATQ1, EPD, PDE Epilepsy, pyridoxine-dependent, 266100 (3)	
SERPINA1	107400	SERPINA1, PI, AAT Emphysema due to AAT deficiency, 613490 (3); Emphysema-cirrhosis, due to AAT deficiency, 613490 (3); Hemorrhagic diathesis due to \'antithrombin\' Pittsburgh, 613490 (3); {Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (1)	
IFNGR1	107470	IFNGR1 Mycobacterial infection, atypical, familial disseminated, 209950 (3); BCG infection, generalized familial, 209950 (3); {H. pylori infection, susceptibility to}, 600263 (3); {Tuberculosis, susceptibility to}, 607948 (3); {Mycobacterium tuberculosis infection, protection against}, 600263 (3); {Hepatitis B virus infection, susceptibility to}, 610424 (3)	
TFAP2A	107580	TFAP2A, AP2TF, BOFS Branchiooculofacial syndrome, 113620 (3)	
APOA1	107680	APOA1 ApoA-I and apoC-III deficiency, combined (3); Hypoalphalipoproteinemia, 604091 (3); Corneal clouding, autosomal recessive (3); Amyloidosis, 3 or more types, 105200 (3)	
APOC3	107720	APOC3, HALP2 Hyperalphalipoproteinemia 2, 614028 (3)	
AQP1	107776	AQP1, CHIP28, CO [Blood group, Colton], 110450 (3); [Aquaporin-1 deficiency] (3)	
AQP2	107777	AQP2 Diabetes insipidus, nephrogenic, 125800 (3)	
CYP19A1	107910	CYP19A1, CYP19, ARO Aromatase deficiency, 613546 (3); Aromatase excess syndrome, 139300 (3)	
DDC	107930	DDC Aromatic L-amino acid decarboxylase deficiency, 608643 (3)	
ATP2A1	108730	ATP2A1, SERCA1 Brody myopathy, 601003 (3)	
ATP2B2	108733	ATP2B2, PMCA2 {Deafness, autosomal recessive 12, modifier of}, 601386 (3)	
ATP2A2	108740	ATP2A2, ATP2B, DAR Darier disease, 124200 (3); Acrokeratosis verruciformis, 101900 (3)	
NPPA	108780	NPPA, PND, ANP, ATFB6 Atrial fibrillation, familial, 6, 612201 (3)	
NPR2	108961	NPR2, ANPRB, AMDM Acromesomelic dysplasia, Maroteaux type, 602875 (3)	
NPR3	108962	NPR3, ANPRC ?Hypertension, salt-resistant (1)	
BSG	109480	BSG [Blood group, OK], 111380 (3)	
CD40	109535	CD40, TNFRSF5 Immunodeficiency with hyper-IgM, type 3, 606843 (3)	
BCL3	109560	BCL3 Leukemia/lymphoma, B-cell, 3 (2)	
BCL6	109565	BCL6 Lymphoma, B-cell (2)	
ADRB3	109691	ADRB3 {Obesity, susceptibility to}, 601665 (3)	
B2M	109700	B2M Hypoproteinemia, hypercatabolic, 241600 (3)	
BLVRA	109750	BLVRA Hyperbiliverdinemia, 614156 (3)	
HTR1A	109760	HTR1A, ADRB2RL1, PFMCD Periodic fever, menstrual cycle dependent, 614674 (3)	
RHD	111680	RHD [Rh-negative blood type] (3)	
CD79A	112205	CD79A, IGA Agammaglobulinemia 3, 613501 (3)	
MS4A1	112210	MS4A1, CD20, CVID5 Immunodeficiency, common variable, 5, 613495 (3)	
BMP2	112261	BMP2, BMP2A, BDA2 {HFE hemochromatosis, modifier of}, 235200 (3); Brachydactyly, type A2, 112600 (3)	
BMP4	112262	BMP4, BMP2B1, BMP2B, MCOPS6, OFC11 Microphthalmia, syndromic 6, 607932 (3); Orofacial cleft 11, 600625 (3)	
BDNF	113505	BDNF, BULN2, ANON2 {Memory impairment, susceptibility to} (3); Central hypoventilation syndrome, congenital, 209880 (3); {Obsessive-compulsive disorder, protection against}, 164230 (3); {Bulimia nervosa, age of onset of weight loss in}, 607499 (3); {Anorexia nervosa, susceptibility to}, 610269 (3)	
BCAT1	113520	BCAT1, BCT1 ?Hyperleucinemia-isoleucinemia or hypervalinemia (1)	
BCAT2	113530	BCAT2, BCT2 ?Hypervalinemia or hyperleucine-isoleucinemia (1)	
BRCA1	113705	BRCA1, PSCP, BROVCA1, PNCA4 {Breast-ovarian cancer, familial, 1}, 604370 (3); {Pancreatic cancer, susceptibility to, 4}, 614320 (3)	
-	113721	BCPR Breast cancer (1)	
UCP1	113730	UCP1 {Obesity, susceptibility to}, 601665 (3)	
DST	113810	DST, BPAG1, DMH, D6S1101, HSAN6 Neuropathy, hereditary sensory and autonomic, type VI, 614653 (3)	
COL17A1	113811	COL17A1, BPAG2 Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	
CDH15	114019	CDH15, CDH14, CDH3, MRD3 Mental retardation, autosomal dominant 3, 612580 (3)	
CDH3	114021	CDH3, CDHP, PCAD, HJMD Hypotrichosis, congenital, with juvenile macular dystrophy, 601553 (3); Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3)	
CALCR	114131	CALCR, CRT {Osteoporosis, postmenopausal, susceptibility}, 166710 (3)	
CACNA1C	114205	CACNA1C, CACNL1A1, CCHL1A1, TS Timothy syndrome, 601005 (3); Brugada syndrome 3, 611875 (3)	
CACNA1S	114208	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1 Hypokalemic periodic paralysis, type 1, 170400 (3); {Malignant hyperthermia susceptibility 5}, 601887 (3); {Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3)	
CAPN3	114240	CAPN3, CANP3 Muscular dystrophy, limb-girdle, type 2A, 253600 (3)	
CASQ2	114251	CASQ2 Ventricular tachycardia, catecholaminergic polymorphic, 2, 611938 (3)	
NUP214	114350	NUP214, D9S46E, CAN, CAIN Leukemia, acute myeloid, 601626 (3); Leukemia, T-cell acute lymphoblastic (3)	
CA4	114760	CA4, RP17 Retinitis pigmentosa 17, 600852 (3)	
CA8	114815	CA8, CALS, CARP, CAMRQ3 Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3, 613227 (3)	
CEL	114840	CEL, BSSL, CELL, MODY8 Maturity-onset diabetes of the young, type VIII, 609812 (3)	
CAT	115500	CAT Acatalasemia, 614097 (3)	
TYRP1	115501	TYRP1, CAS2, GP75, SHEP11 Albinism, oculocutaneous, type III, 203290 (3); Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair), 612271 (3)	
CTNNB1	116806	CTNNB1 Colorectal cancer (3); Hepatoblastoma (3); Pilomatricoma, 132600 (3); Ovarian cancer, 167000 (3); Hepatocellular carcinoma, 114550 (3)	
CTSD	116840	CTSD, CPSD, CLN10 Ceroid lipofuscinosis, neuronal, 10, 610127 (3)	
CEBPA	116897	CEBPA, CEBP Leukemia, acute myeloid, 601626 (3)	
CNBP	116955	ZNF9, CNBP1, DM2, PROMM Myotonic dystrophy 2, 602668 (3)	
CP	117700	CP [Hypoceruloplasminemia, hereditary], 604290 (3); Cerebellar ataxia, 604290 (3); Hemosiderosis, systemic, due to aceruloplasminemia, 604290 (3)	
HSPD1	118190	HSPD1, SPG13, HSP60, HLD4 Spastic paraplegia 13, autosomal dominant, 605280 (3); Leukodystrophy, hypomyelinating, 4, 612233 (3)	
CHN1	118423	CHN1, CHN, ARHGAP2, RHOGAP2, DURS2 Duane retraction syndrome 2, 604356 (3)	
CLCN1	118425	CLCN1 Myotonia congenita, recessive, 255700 (3); Myotonia congenita, dominant, 160800 (3); Myotonia levior, recessive (3)	
CETP	118470	CETP, HDLCQ10 Hyperalphalipoproteinemia, 143470 (3); [High density lipoprotein cholesterol level QTL 10], 143470 (3)	
CYP11A1	118485	CYP11A, P450SCC Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, 613743 (3)	
CHAT	118490	CHAT, CMS1A2 Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)	
CHRM3	118494	CHRM3, EGBRS Eagle-Barrett syndrome, 100100 (3)	
CHRNA2	118502	CHRNA2 Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)	
CHRNA3	118503	CHRNA3, LNCR2, PAOD2 {Lung cancer susceptibility 2}, 612052 (3)	
CHRNA4	118504	CHRNA4, ENFL1 Epilepsy, nocturnal frontal lobe, 1, 600513 (3); {Nicotine addiction, susceptibility to}, 188890 (3)	
CHRNA5	118505	CHRNA5, LNCR2 {Lung cancer susceptibility 2}, 612052 (3); {Nicotine dependence, susceptibility to}, 612052 (3)	
CHRNB2	118507	CHRNB2, EFNL3 Epilepsy, nocturnal frontal lobe, 3, 605375 (3)	
CHRNA7	118511	CHRNA7 Schizophrenia, neurophysiologic defect in (2)	
VCAN	118661	VCAN, CSPG2, WGN, WGN1, ERVR Wagner syndrome 1, 143200 (3)	
COL4A3	120070	COL4A3 Alport syndrome, autosomal recessive, 203780 (3); Hematuria, benign familial, 141200 (3); Alport syndrome, autosomal dominant, 104200 (3)	
COL4A2	120090	COL4A2, POREN2, ICH Porencephaly 2, 614483 (3); {Stroke, hemorrhagic}, 614519 (3)	
COL10A1	120110	COL10A1 Metaphyseal chondrodysplasia, Schmid type, 156500 (3)	
COL7A1	120120	COL7A1 Epidermolysis bullosa dystrophica, AD, 131750 (3); Epidermolysis bullosa dystrophica, AR, 226600 (3); Epidermolysis bullosa, pretibial, 131850 (3); EBD, Bart type, 132000 (3); EBD, localisata variant (3); Transient bullous of the newborn, 131705 (3); Epidermolysis bullosa pruriginosa, 604129 (3); Toenail dystrophy, isolated, 607523 (3); EBD inversa, 226600 (3)	
COL4A1	120130	COL4A1, POREN1, HANAC Porencephaly 1, 175780 (3); Brain small vessel disease with hemorrhage, 607595 (3); Angiopathy, hereditary, with nephropathy, aneurysms, and muscle, 611773 (3); Brain small vessel disease with Axenfeld-Rieger anomaly, 607595 (3)	
COL4A4	120131	COL4A4 Alport syndrome, autosomal recessive, 203780 (3); Hematuria, familial benign (3)	
COL1A2	120160	COL1A2 Ehlers-Danlos syndrome, type VIIB, 130060 (3); Osteogenesis imperfecta, type IV, 166220 (3); Osteogenesis imperfecta, type III, 259420 (3); Osteogenesis imperfecta, type II, 166210 (3); {Osteoporosis, postmenopausal}, 166710 (3); Ehlers-Danlos syndrome, cardiac valvular form, 225320 (3)	
COL3A1	120180	COL3A1 Ehlers-Danlos syndrome, type IV, 130050 (3); Ehlers-Danlos syndrome, type III, 130020 (3)	
COL5A2	120190	COL5A2 Ehlers-Danlos syndrome, type I, 130000 (3)	
COL9A1	120210	COL9A1, EDM6, STL4 Epiphyseal dysplasia, multiple, 6, 614135 (3); Stickler syndrome, type IV, 614134 (3)	
COL5A1	120215	COL5A1 Ehlers-Danlos syndrome, type II, 130010 (3); Ehlers-Danlos syndrome, type I, 130000 (3)	
COL6A1	120220	COL6A1, OPLL Bethlem myopathy, 158810 (3); Ullrich congenital muscular dystrophy, 254090 (3); {Ossification of the posterior longitudinal spinal ligaments}, 602475 (2)	
COL6A2	120240	COL6A2 Bethlem myopathy, 158810 (3); Ullrich congenital muscular dystrophy, 254090 (3); Myosclerosis, congenital, 255600 (3)	
COL6A3	120250	COL6A3 Bethlem myopathy, 158810 (3); Ullrich congenital muscular dystrophy, 254090 (3)	
COL8A2	120252	COL8A2, FECD1, PPCD2 Corneal dystrophy, Fuchs endothelial, 1, 136800 (3); Corneal dystrophy polymorphous posterior, 2, 609140 (3)	
COL9A2	120260	COL9A2, EDM2, STL5 Epiphyseal dysplasia, multiple, 2, 600204 (3); {Intervertebral disc disease, susceptibility to}, 603932 (3); Stickler syndrome, type V, 614284 (3)	
COL9A3	120270	COL9A3, EDM3, IDD Epiphyseal dysplasia, multiple, 3, 600969 (3); Epiphyseal dysplasia, multiple, with myopathy (3); {Intervertebral disc disease, susceptibility to}, 603932 (3)	
COL11A1	120280	COL11A1, STL2 Stickler syndrome, type II, 604841 (3); Marshall syndrome, 154780 (3); {Lumbar disc herniation, susceptibility to}, 603932 (3); Fibrochondrogenesis, 228520 (3)	
COL11A2	120290	COL11A2, STL3, DFNA13, DFNB53, FBCG2 Stickler syndrome, type III, 184840 (3); Otospondylomegaepiphyseal dysplasia, 215150 (3); Weissenbacher-Zweymuller syndrome, 277610 (3); Deafness, autosomal dominant 13, 601868 (3); Deafness, autosomal recessive 53, 609706 (3); Fibrochondrogenesis 2, 614524 (3)	
COL18A1	120328	COL18A1, KNO1 Knobloch syndrome, type 1, 267750 (3)	
MMP1	120353	MMP1, CLG COPD, rate of decline of lung function in, 606963 (3); {Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}, 226600 (3)	
MMP2	120360	MMP2, CLG4A, MONA Torg-Winchester syndrome, 259600 (3)	
MMP9	120361	MMP9, CLG4B, MANDP2 Metaphyseal anadysplasia 2, 613073 (3)	
MLH1	120436	MLH1, COCA2, HNPCC2 Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3); Mismatch repair cancer syndrome, 276300 (3); Muir-Torre syndrome, 158320 (3)	
DCC	120470	DCC Colorectal cancer (3); Mirror movements, congenital, 157600 (3)	
MME	120520	MME, CD10, CALLA, NEP [Neutral endopeptidase deficiency] (1); Membranous glomerulonephritis, antenatal (1)	
C1QA	120550	C1QA C1q deficiency, 613652 (3)	
C1QB	120570	C1QB C1q deficiency, 613652 (3)	
C1QC	120575	C1QC, C1QG C1q deficiency, 613652 (3)	
C1S	120580	C1S C1s deficiency, 613783 (3)	
CR1	120620	CR1, C3BR CR1 deficiency (1); {?SLE susceptibility} (1); [Blood group, Knops system], 607486 (3); {Malaria, severe, resistance to}, 611162 (3)	
CR2	120650	CR2, C3DR, SLEB9 {Systemic lupus erythematosus, susceptibility to, 9}, 610927 (3)	
C3	120700	C3, ARMD9, AHUS5 C3 deficiency, 613779 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 5}, 612925 (3); {Macular degeneration, age-related, 9}, 611378 (3)	
C4A	120810	C4A, C4S, C4AD C4a deficiency, 614380 (3); [Blood group, Rodgers], 614374 (3); ?Systemic lupus erythematosus, susceptibility to or protection against}, 152700 (2)	
C4B	120820	C4B, C4F, C4BD C4B deficiency, 614379 (3)	
C5	120900	C5 C5 deficiency, 609536 (3)	
CD46	120920	MCP, CD46, AHUS2 {Hemolytic uremic syndrome, atypical, susceptibility to, 2}, 612922 (3)	
C9	120940	C9 C9 deficiency, 613825 (3); C9 deficiency with dermatomyositis, 613825 (3)	
C8A	120950	C8A C8 deficiency, type I, 613790 (3)	
C8B	120960	C8B C8 deficiency, type II, 613789 (3)	
ITGAM	120980	ITGAM, CR3A, CD11B, MAC1A, SLEB6 {Systemic lupus erythematous, association with susceptibility to, 6}, 609939 (3)	
GJB2	121011	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID Deafness, autosomal recessive 1A, 220290 (3); Deafness, autosomal dominant 3A, 601544 (3); Vohwinkel syndrome, 124500 (3); Keratoderma, palmoplantar, with deafness, 148350 (3); Keratitis-ichthyosis-deafness syndrome, 148210 (3); Hystrix-like ichthyosis with deafness, 602540 (3); Bart-Pumphrey syndrome, 149200 (3)	
GJA5	121013	GJA5, CX40, ATFB11 Atrial fibrillation, familial, 11, 614049 (3)	
GJA1	121014	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1 Oculodentodigital dysplasia, 164200 (3); Syndactyly, type III, 186100 (3); Hypoplastic left heart syndrome 1, 241550 (3); Atrioventricular septal defect 3, 600309 (3); Oculodentodigital dysplasia, autosomal recessive, 257850 (3); Hallermann-Streiff syndrome, 234100 (3)	
GJA3	121015	GJA3, CX46, CZP3, CAE3 Cataract, zonular pulverulent-3, 601885 (3)	
CBFB	121360	CBFB, PEBP2B Myeloid leukemia, acute, M4/M4Eo subtype, somatic, 601626 (1)	
SERPINA6	122500	CBG, SERPINA6 Corticosteroid-binding globulin deficiency, 611489 (3)	
MSX2	123101	MSX2, CRS2, HOX8 Craniosynostosis, type 2, 604757 (3); Parietal foramina 1, 168500 (3); Parietal foramina with cleidocranial dysplasia, 168550 (3)	
CRYAB	123590	CRYAB, CRYA2, CTPP2 Myopathy, myofibrillar, alpha-B crystallin-related, 608810 (3); Cataract, posterior polar 2, 613763 (3); Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related, 613869 (3)	
CRYBA1	123610	CRYBA1, CRYB1 Cataract, congenital zonular, with sutural opacities, 600881 (3)	
CRYBB3	123630	CRYBB3, CRYB3, CATCN2 Cataract, congenital nuclear, 2, 609741 (3)	
CRYBA4	123631	CRYBA4, MCOPCT4 Cataract, lamellar 2, 610425 (3); Microphthalmia with cataract 4, 610426 (3)	
CRYM	123740	CRYM, DFNA40 Deafness, autosomal dominant 40 (3)	
CREB1	123810	CREB1 Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)	
CNGA1	123825	CNGA1, CNCG1, RP49 Retinitis pigmentosa 49, 613756 (3)	
CDK4	123829	CDK4, CMM3 {Melanoma, cutaneous malignant, 3}, 609048 (3)	
PPIB	123841	PPIB, CYPB, OI9 Osteogenesis imperfecta, type IX, 259440 (3)	
IL10RB	123889	CRFB4, IBD25 {Hepatitis B virus, susceptibility to}, 610424 (3); Inflammatory bowel disease 25, early onset, autosomal recessive, 612567 (3)	
CYP2B6	123930	CYP2B6, CYP2B, EFVM Efavirenz, poor metabolism of, 614546 (3); {Efavirenz central nervous system toxicity, susceptibility to}, 614546 (3)	
KRT4	123940	KRT4, CYK4 White sponge nevus, 193900 (3)	
CYCS	123970	CYCS, CYC, THC4 Thrombocytopenia 4, 612004 (3)	
POR	124015	POR Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, 201750 (3); Disordered steroidogenesis due to cytochrome P450 oxidoreductase, 613571 (3)	
CYP2C19	124020	CYP2C, CYP2C19 Mephenytoin poor metabolizer, 609535 (3); Opremazole poor metabolizer, 609535 (3); Proguanil poor metabolizer, 609535 (3); Clopidogrel, impaired responsiveness to, 609535 (3)	
CYP2D6	124030	CYP2D6, CPD6, P450DB1 {Debrisoquine sensitivity}, 608902 (3); {Codeine sensitivity}, 608902 (3)	
DAO	124050	DAO, DAMOX {Schizophrenia}, 181500 (2)	
CYP11B2	124080	CYP11B2 Hypoaldosteronism, congenital, due to CMO II deficiency, 610600 (3); Hypoaldosteronism, congenital, due to CMO I deficiency, 203400 (3); {Low renin hypertension, susceptibility to} (3); Aldosterone to renin ratio raised (3)	
COX6B1	124089	COX6B1 Cytochrome c oxidase deficiency, 220110 (3)	
IL10	124092	IL10, CSIF, GVHDS {HIV-1, susceptibility to}, 609423 (3); {Graft-versus-host disease, protection against}, 614395 (3); {Rheumatoid arthritis, progression of}, 180300 (3)	
CD55	125240	CD55, DAF, CROM [Blood group Cromer], 613793 (3)	
DCN	125255	DCN, CSCD Corneal dystrophy, congenital stromal, 610048 (3)	
DEK	125264	DEK, D6S231E Leukemia, acute nonlymphocytic (2)	
ALAD	125270	ALAD, ALADH, PBGS Porphyria, acute hepatic, 612740 (3); {Lead poisoning, susceptibility to}, 612740 (3)	
DSPP	125485	DSPP, DPP, DGI1, DFNA39, DTDP2 Dentinogenesis imperfecta, Shields type II, 125490 (3); Deafness, autosomal dominant 36, with dentinogenesis, 605594 (3); Dentinogenesis imperfecta, Shields type III, 125500 (3); Dentin dysplasia, type II, 125420 (3)	
DNASE1	125505	DNASE1, DNL1 {Systemic lupus erythematosus, susceptibility to}, 152700 (3)	
DSC2	125645	DSC2, DSC3, ARVD11 Arrhythmogenic right ventricular dysplasia 11, 610476 (3); Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair, 610476 (3)	
DSP	125647	DSP, KPPS2, PPKS2 Keratosis palmoplantaris striata II, 612908 (3); Dilated cardiomyopathy with woolly hair and keratoderma, 605676 (3); Arrhythmogenic right ventricular dysplasia 8, 607450 (3); Skin fragility-woolly hair syndrome, 607655 (3); Epidermolysis bullosa, lethal acantholytic, 609638 (3)	
DES	125660	DES, CMD1I, MFM1, SCPNK Myopathy, myofibrillar, desmin-related, cardioskeletal, 601419 (3); Cardiomyopathy, dilated, 1I, 604765 (3); Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)	
DSG1	125670	DSG1, PPKS1, SPPK1 Keratosis palmoplantaris striata I, 148700 (3)	
DSG2	125671	DSG2, ARVD10, ARVC10, CMD1BB Arrhythmogenic right ventricular dysplasia 10, 610193 (3); Cardiomyopathy, dilated, 1BB, 612877 (3)	
DHFR	126060	DHFR Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3)	
DHODH	126064	DHODH, URA1, POADS Miller syndrome, 263750 (3)	
CYP24A1	126065	CYP24A1, CYP24, HCAI Hypercalcemia, infantile, 143880 (3)	
PCBD1	126090	PCBD, DCOH Hyperphenylalaninemia, BH4-deficient, D, 264070 (3)	
ARNT	126110	ARNT Leukemia, acute myeloblastic (3)	
DPP6	126141	DPP6, VF2 Ventricular fibrillation, paroxysmal familial, 2, 612956 (3)	
HBEGF	126150	HBEGF, DTR, DTSF, HEGFL {Diphtheria, susceptibility to} (1)	
DDIT3	126337	DDIT3, GADD153, CHOP10 Myxoid liposarcoma, 613488 (1)	
ERCC2	126340	ERCC2, EM9, XPD, COFS2 Xeroderma pigmentosum, group D, 278730 (3); Trichothiodystrophy, 601675 (3); Cerebrooculofacioskeletal syndrome 2, 610756 (3)	
DNMT1	126375	DNMT1, MCMT, HSN1E Neuropathy, hereditary sensory, type IE, 614116 (3)	
ERCC1	126380	ERCC1, UV20, COFS4 Cerebrooculofacioskeletal syndrome 4, 610758 (3)	
LIG1	126391	LIG1 DNA ligase I deficiency (3)	
TOP1	126420	TOP1 DNA topoisomerase I, camptothecin-resistant (3)	
TOP2A	126430	TOP2A, TOP2 DNA topoisomerase II, resistance to inhibition of, by amsacrine (3)	
DRD2	126450	DRD2 Dystonia, myoclonic, 159900 (3)	
DRD3	126451	DRD3, ETM1, FET1 {Schizophrenia, susceptibility to}, 181500 (3); {Essential tremor, susceptibility to}, 190300 (3)	
DRD4	126452	DRD4 Autonomic nervous system dysfunction (3); [Novelty seeking personality], 601696 (1); {Attention deficit-hyperactivity disorder}, 143465 (3)	
SLC6A3	126455	SLC6A3, DAT1 {Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2); {Nicotine dependence, protection against}, 188890 (3); {Major affective disorder}, 125480 (3); Parkinsonism-dystonia, infantile, 613135 (3)	
SLC26A3	126650	SLC26A3, DRA, CLD ?Colon cancer (1); Chloride diarrhea, congenital, Finnish type, 214700 (3)	
DAG1	128239	DAG1, DAG, MDDGC7 Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7, 613818 (3)	
EGR2	129010	EGR2, KROX20 Neuropathy, congenital hypomyelinating, 1, 605253 (3); Charcot-Marie-Tooth disease, type 1D, 607678 (3); Dejerine-Sottas disease, 145900 (3)	
NT5E	129190	NT5E, NT5 Calcification of joints and arteries, 211800 (3)	
ELANE	130130	ELANE, ELA2, SCN1 Neutropenia, cyclic, 162800 (3); Neutropenia, severe congenital 1, autosomal dominant, 202700 (3)	
ELN	130160	ELN Supravalvar aortic stenosis, 185500 (3); Cutis laxa, AD, 123700 (3)	
ETFB	130410	ETFB, MADD Glutaric acidemia IIB, 231680 (3)	
EPB41	130500	EPB41, EL1 Elliptocytosis-1, 611804 (3)	
RPS14	130620	RPS14, EMTB Macrocytic anemia, refractory, due to 5q deletion, somatic, 153550 (3)	
ENG	131195	ENG, END, HHT1, ORW Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3)	
SELE	131210	SELE, ELAM1 [Blood pressure regulation QTL], 145500 (2)	
TYMP	131222	TYMP, ECGF1, MNGIE, PDECGF, MEDPS1, MTDPS1 Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)	
ANXA5	131230	ANXA5, ENX2, RPRGL3 {Pregnancy loss, recurrent, susceptibility to, 3}, 614391 (3)	
EDN3	131242	EDN3, WS4B, HSCR4 Waardenburg syndrome, type 4B, 613265 (3); Central hypoventilation syndrome, congenital, 209880 (3); {Hirschsprung disease, susceptibility to, 4}, 613712 (3)	
EDNRA	131243	EDNRA Migraine, resistance to, 157300 (3)	
EDNRB	131244	EDNRB, HSCR2, ABCDS, WS4A {Hirschsprung disease, susceptibility to, 2}, 600155 (3); ABCD syndrome, 600501 (3); Waardenburg syndrome, type 4A, 277580 (3)	
EN2	131310	EN2, AUTS10 {Autism susceptibility 10}, 611016 (3)	
GATA3	131320	GATA3, HDR, HDRS Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)	
PDYN	131340	PDYN, SCA23 Spinocerebellar ataxia 23, 610245 (3)	
ENO3	131370	ENO3, GSD13 Glycogen storage disease XIII, 612932 (3)	
EPX	131399	EPX Eosinophil peroxidase deficiency, 261500 (3)	
EGF	131530	EGF, URG, HOMG4 Hypomagnesemia 4, renal, 611718 (3)	
EGFR	131550	EGFR Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3); Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3); {Nonsmall cell lung cancer, susceptibility to}, 211980 (3)	
EPHX2	132811	EPHX2 {Hypercholesterolemia, familial, due to LDLR defect, modifier of}, 143890 (3)	
STOM	133090	EPB72 ?Stomatocytosis I, 185000 (1)	
EPO	133170	EPO, MVCD2 {Microvascular complications of diabetes 2}, 612623 (3)	
EPOR	133171	EPOR [Erythrocytosis, familial, 1], 133100 (3)	
EWSR1	133450	EWSR1, EWS Ewing sarcoma, 612219 (3); Neuroepithelioma, 612219 (3)	
ERCC3	133510	ERCC3, XPB Xeroderma pigmentosum, group B, 610651 (3); Trichothiodystrophy, 601675 (3)	
ERCC4	133520	ERCC4, XPF Xeroderma pigmentosum, group F, 278760 (3); XFE progeroid syndrome, 610965 (3)	
ERCC5	133530	ERCC5, XPG, COFS3 Xeroderma pigmentosum, group G, 278780 (3); Cerebrooculofacioskeletal syndrome 3 (3)	
SLC1A1	133550	SLC1A1, EAAC1 ?Dicarboxylicaminoaciduria, 222730 (1)	
CFD	134350	CFD, ADN Complement factor D deficiency, 613912 (3)	
CFH	134370	HF1, CFH, HUS, ARMD4, AHUS1 {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3); Complement factor H deficiency, 609814 (3); {Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3)	
CFHR1	134371	CFHR1, FHR1, HFL1, CFHL1 {Macular degeneration, age-related, reduced risk of}, 603075 (3); {Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)	
F13A1	134570	F13A1, F13A Factor XIIIA deficiency, 613225 (3); {Myocardial infarction, protection against}, 608446 (3); {Venous thrombosis, protection against}, 188050 (3)	
F13B	134580	F13B Factor XIIIB deficiency, 613235 (3)	
FAS	134637	TNFRSF6, APT1, FAS, CD95, ALPS1A {Autoimmune lymphoproliferative syndrome}, 601859 (3); Squamous cell carcinoma, burn scar-related, somatic (3); Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)	
FASLG	134638	TNFSF6, APT1LG1, FASL, ALPS1B Autoimmune lymphoproliferative syndrome, type IB, 601859 (3); {Lung cancer, susceptibility to}, 212980 (3)	
FTL	134790	FTL, NBIA3 Hyperferritinemia-cataract syndrome, 600886 (3); Neurodegeneration with brain iron accumulation 3, 606159 (3)	
FBN1	134797	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD Marfan syndrome, 154700 (3); Shprintzen-Goldberg syndrome, 182212 (3); Ectopia lentis, familial, 129600 (3); MASS syndrome, 604308 (3); Weill-Marchesani syndrome 2, dominant, 608328 (3); Aortic aneurysm, ascending, and dissection (3); Stiff skin syndrome, 184900 (3); Acromicric dysplasia, 102370 (3); Geleophysic dysplasia 2, 614185 (3)	
FGB	134830	FGB Dysfibrinogenemia, beta type (3); Afibrinogenemia, congenital, 202400 (3); Thrombophilia, dysfibrinogenemic (3)	
FGG	134850	FGG Dysfibrinogenemia, gamma type (3); Hypofibrinogenemia, gamma type (3); Thrombophilia, dysfibrinogenemic (3)	
FGFR3	134934	FGFR3, ACH Achondroplasia, 100800 (3); Hypochondroplasia, 146000 (3); Thanatophoric dysplasia, type I, 187600 (3); Crouzon syndrome with acanthosis nigricans, 612247 (3); Muenke syndrome, 602849 (3); Bladder cancer, somatic, 109800 (3); Colorectal cancer, somatic, 114500 (3); Cervical cancer, somatic, 603956 (3); LADD syndrome, 149730 (3); CATSHL syndrome, 610474 (3); Nevus, keratinocytic, nonepidermolytic, 162900 (3); Thanatophoric dysplasia, type II, 187601 (3); Spermatocytic seminoma, somatic, 273300 (3)	
FGFR4	134935	FGFR4 {Cancer progression/metastasis} (3)	
FN1	135600	FN1, FN, LETS, FNZ, GFND2 Glomerulopathy with fibronectin deposits 2, 601894 (3); Plasma fibronectin deficiency, 614101 (1)	
FBLN1	135820	FBLN1 Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses, 608180 (3)	
FLG	135940	FLG, ATOD2 Ichthyosis vulgaris, 146700 (3); {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	
FMO3	136132	FMO3, TMAU Trimethylaminuria, 602079 (3)	
FGFR1	136350	FGFR1, FLT2, KAL2, OGD Pfeiffer syndrome, 101600 (3); Jackson-Weiss syndrome, 123150 (3); Kallmann syndrome 2, 147950 (3); Hypogonadotropic hypogonadism, 146110 (3); Osteoglophonic dysplasia, 166250 (3); Trigonocephaly 1, 190440 (3)	
FLT3	136351	FLT3 Leukemia, acute myeloid, reduced survival in (3); Leukemia, acute myeloid, 601626 (3); Leukemia, acute lymphoblastic (3)	
FLT4	136352	FLT4, VEGFR3, PCL, LMPH1A Lymphedema, hereditary I, 153100 (3); Hemangioma, capillary infantile, somatic, 602089 (3)	
FOLR1	136430	FOLR1 Neurodegeneration due to cerebral folate transport deficiency, 613068 (3)	
FSHR	136435	FSHR, ODG1 Ovarian dysgenesis 1, 233300 (3); Ovarian response to FSH stimulation, 276400 (3); Ovarian hyperstimulation syndrome, 608115 (3)	
KDSR	136440	FVT1 Lymphoma/leukemia, B-cell, variant (1)	
FSHB	136530	FSHB Follicle-stimulating hormone deficiency, isolated, 229070 (3)	
FOXO1	136533	FOXO1A, FKHR Rhabdomyosarcoma, alveolar, 268220 (3)	
FUT6	136836	FUT6 Fucosyltransferase 6 deficiency, 613852 (3)	
FH	136850	FH, HLRCC, MCUL1 Fumarase deficiency, 606812 (3); Leiomyomatosis and renal cell cancer, 150800 (3)	
B4GALT1	137060	B4GALT1, GGTB2, GT1, GTB, CDG2D Congenital disorder of glycosylation, type IId, 607091 (3)	
FUS	137070	FUS, TLS, ALS6 Amyotrophic lateral sclerosis 6, autosomal recessive, with or without frontotemporal dementia, 608030 (3)	
GABRA2	137140	GABRA2 {Alcohol dependence, susceptibility to}, 103780 (3)	
ABAT	137150	ABAT, GABAT GABA-transaminase deficiency, 613163 (3)	
GABRA1	137160	GABRA1, EJM5, ECA4 {Epilepsy, juvenile myoclonic, susceptibility to, 5}, 611136 (3); {Epilepsy, childhood absence, susceptibility to, 4}, 611136 (3)	
GABRD	137163	GABRD, GEFSP5, EIG10, EJM7 {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3); {Epilepsy, idiopathic generalized, 10}, 613060 (3); {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3)	
GABRG2	137164	GABRG2, GEFSP3, CAE2, ECA2 Epilepsy, generalized, with febrile seizures plus, type 3, 611277 (3); {Epilepsy, childhood absence, susceptibility to, 2}, 607681 (3); Febrile seizures, familial, 8, 611277 (3); Dravet syndrome, 607208 (3)	
GGCX	137167	GGCX Vitamin K-dependent coagulation defect, 277450 (3); Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency, 610842 (3)	
GGT2	137181	GGT2 [Gamma-glutamyltransferase, familial high serum] (2)	
TACSTD2	137290	TACSTD2, TROP2, M1S1 Corneal dystrophy, gelatinous drop-like, 204870 (3)	
GATA2	137295	GATA2, DCML, MONOMAC Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency, 614172 (3); Emberger syndrome, 614038 (3); {Myelodysplastic syndrome, susceptibility to}, 614286 (3); {Leukemia, acute myeloid, susceptibility to}, 601626 (3)	
GSN	137350	GSN Amyloidosis, Finnish type, 105120 (3)	
GFAP	137780	GFAP Alexander disease, 203450 (3)	
MPV17	137960	MPV17, MTDPS6 Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810 (3)	
GCG	138030	GCG [?Hyperproglucagonemia] (1)	
GCGR	138033	GCGR {Diabetes mellitus, noninsulin-dependent}, 125853 (3)	
GCK	138079	GCK, HHF3 MODY, type II, 125851 (3); Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3); Diabetes mellitus, gestational, 125851 (3); Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3); Diabetes mellitus, permanent neonatal, 606176 (3)	
H6PD	138090	H6PD, GDH, G6PDH, CORTRD1 Cortisone reductase deficiency 1, 604931 (3)	
GLUD1	138130	GLUD1 Hyperinsulinism-hyperammonemia syndrome, 606762 (3)	
SLC2A1	138140	SLC2A1, GLUT1, DYT18, PED, ,GLUT1DS GLUT1 deficiency syndrome 1, 606777 (3); GLUT1 deficiency syndrome 2, 612126 (3)	
SLC2A2	138160	SLC2A2, GLUT2 {Diabetes mellitus, noninsulin-dependent} (3); Fanconi-Bickel syndrome, 227810 (3)	
GOT1	138180	GOT1, ASTQTL1 Aspartate aminotransferase, serum level of, QTL1, 614419 (3)	
SLC2A4	138190	SLC2A4, GLUT4 {Diabetes mellitus, noninsulin-dependent}, 125853 (3)	
GRIK2	138244	GRIK2, GLUR6, MRT6 Mental retardation, autosomal recessive, 6, 611092 (3)	
GRIN1	138249	GRIN1, NMDAR1, MRD8 Mental retardation, autosomal dominant 8, 614254 (3)	
ALDH18A1	138250	ALDH18A1, PYCS, GSAS, ARCL3A Cutis laxa, autosomal recessive, type IIIA, 219150 (3)	
GRIN2B	138252	GRIN2B, NMDAR2B, MRD6 Mental retardation, autosomal dominant 6, 613970 (3)	
GRIN2A	138253	GRIN2A, NMDAR2A, EPND Epilepsy with neurodevelopmental defects, 613971 (3)	
GLUL	138290	GLUL, GLNS Glutamine deficiency, congenital, 610015 (3)	
GFPT1	138292	GFPT1, GFAT1, GFPT1L, MSLG Myasthenia, limb-girdle, with tubular aggregates, 610542 (3)	
GPX1	138320	GPX1, GPXD Hemolytic anemia due to glutathione peroxidase deficiency, 614164 (1)	
GPD1	138420	GPD1, HTGTI Hypertriglyceridemia, transient infantile, 614480 (3)	
GPD2	138430	GPD2 {Diabetes, type 2, susceptibility to}, 125853 (3)	
GLRA1	138491	GLRA1, STHE, HKPX1 Hyperekplexia, hereditary 1, autosomal dominant or recessive, 149400 (3)	
GLRB	138492	GLRB, HKPX2 Hyperekplexia 2, autosomal recessive, 614619 (3)	
GYS1	138570	GYS1, GYS Glycogen storage disease 0, muscle, 611556 (3)	
GYS2	138571	GYS2 Glycogen storage disease, type 0, 240600 (3)	
GP1BB	138720	GP1BB, BS, BDPLT1 Bernard-Soulier syndrome, type B, 231200 (3); Giant platelet disorder, isolated, 231200 (3)	
HAGH	138760	HAGH, GLO2 [Glyoxalase II deficiency], 614033 (1)	
GNRHR	138850	GNRHR, LHRHR Hypogonadotropic hypogonadism (3); Fertile eunuch syndrome, 228300 (3)	
GRN	138945	GRN Frontotemporal lobar degeneration with ubiquitin-positive inclusions, 607485 (3)	
CSF3R	138971	CSF3R, GCSFR Neutrophilia, hereditary, 162830 (3)	
CSF2RB	138981	CSF2RB, SMDP5 Surfactant metabolism dysfunction, pulmonary, 5, 614370 (3)	
GNB3	139130	GNB3 {Hypertension, essential, susceptibility to}, 145500 (3)	
RASA1	139150	RASA1, GAP, CMAVM, PKWS Parkes Weber slndrome, 608355 (3); Capillary malformation-arteriovenous malformation, 608354 (3); Basal cell carcinoma, somatic, 605462 (3)	
GHRH	139190	GHRH, GHRF ?Isolated growth hormone deficiency due to defect in GHRF (1); Gigantism due to GHRF hypersecretion (1)	
GHRHR	139191	GHRHR, GHRFR, IGHD1B Growth hormone deficiency, isolated, type IB, 612781 (3)	
GH1	139250	GH1, GHN, IGHD1B Growth hormone deficiency, isolated, type IA, 262400 (3); Growth hormone deficiency, isolated, type IB, 612781 (3); Growth hormone deficiency, isolated, type II, 173100 (3); Kowarski syndrome, 262650 (3)	
GNAT1	139330	GNAT1, CSNBAD3 Night blindness, congenital stationary, autosomal dominant 3, 610444 (3)	
GNAT2	139340	GNAT2, ACHM4 Achromatopsia-4, 613856 (3)	
KRT1	139350	KRT1, EPPK, NEPPK, EHK Epidermolytic hyperkeratosis, 113800 (3); Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3); Ichthyosis histrix, Curth-Macklin type, 146590 (3); Palmoplantar keratoderma, nonepidermolytic, 600962 (3); Palmoplantar keratoderma, epidermolytic, 144200 (3); Keratosis palmoplantaris striata III, 607654 (3)	
GNAI2	139360	GNAI2, GNAI2B, GIP Pituitary ACTH-secreting adenoma (3); Ventricular tachycardia, idiopathic, 192605 (3)	
GNAI3	139370	GNAI3, ARCND1 Auriculocondylar syndrome 1, 603483 (3)	
HP	140100	HP [Anhaptoglobinemia], 614081 (3); [Hypohaptoglobinemia], 614081 (3)	
HMOX1	141250	HMOX1 Heme oxygenase-1 deficiency, 614034 (3); {Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)	
HBA2	141850	HBA2, HBH Thalassemia, alpha-, 604131 (3); Heinz body anemia, 140700 (3); Erythrocytosis (3); Hypochromic microcytic anemia (3); Hemoglobin H disease, nondeletional, 613978 (3)	
HBD	142000	HBD Thalassemia, delta- (3); Thalassemia due to Hb Lepore (3)	
HBG1	142200	HBG1 Fetal hemoglobin quantitative trait locus 1, 141749 (3)	
HBG2	142250	HBG2, TNCY Fetal hemoglobin quantitative trait locus 1, 141749 (3); Cyanosis, transient neonatal, 613977 (3)	
SERPIND1	142360	HCF2, HC2, SERPIND1, THPH10 Thrombophilia due to heparin cofactor II deficiency, 612356 (3)	
HGF	142409	HGF, DFNB39 Deafness, autosomal recessive 39, 608265 (3)	
HNF1A	142410	HNF1A, TCF1, MODY3, IDDM20 MODY, type III, 600496 (3); {Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3); {Diabetes mellitus, insulin-dependent}, 222100 (3); Hepatic adenoma, somatic, 142330 (3); Renal cell carcinoma, 144700 (3); Diabetes mellitus, insulin-dependent, 20, 612520 (3)	
NRG1	142445	NRG1, HGL, HRGA, ARIA {?Schizophrenia, susceptibility to}, 603013 (1)	
HSPG2	142461	HSPG2, PLC, SJS, SJA, SJS1 Schwartz-Jampel syndrome, type 1, 255800 (3); Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3)	
HK1	142600	HK1 Hemolytic anemia due to hexokinase deficiency, 235700 (3)	
HRG	142640	HRG, THPH11 Thrombophilia due to HRG deficiency, 613116 (3); Thrombophilia due to elevated HRG, 613116 (1)	
HARS	142810	HARS, USH3B Usher syndrome type 3B, 614504 (3)	
HLA-C	142840	HLA-C, PSORS1 {Psoriasis susceptibility 1}, 177900 (3); {HIV-1 viremia, susceptibility to}, 609423 (3)	
HLA-DRB1	142857	HLA-DRB1, SS1 {Pemphigoid, susceptibility to} (2); {Sarcoidosis, susceptibility l, 1}, 181000 (3); {Multiple sclerosis, susceptibility to}, 126200 (3); {Rheumatoid arthritis, susceptibility to}, 180300 (3)	
HLA-DPB1	142858	HLA-DPB1 {Beryllium disease, chronic, susceptibility to} (3)	
HLA-G	142871	HLA-G {Asthma, susceptibility to}, 600807 (2)	
HOXA1	142955	HOXA1, HOX1F, BSAS Bosley-Salih-Alorainy syndrome, 601536 (3); Athabaskan brainstem dysgenesis syndrome, 601536 (3)	
HOXA11	142958	HOXA11, HOX1I Radioulnar synostosis with amegakaryocytic thrombocytopenia, 605432 (3)	
HOXA13	142959	HOXA13, HOX1J Hand-foot-uterus syndrome, 140000 (3); Guttmacher syndrome, 176305 (3)	
MSX1	142983	MSX1, HOX7, HYD1, OFC5, STHAG1 Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3); Witkop syndrome, 189500 (3); Orofacial cleft 5, 608874 (3)	
HOXD10	142984	HOXD10, HOX4D Vertical talus, congenital, 192950 (3); Charcot-Marie-Tooth disease, foot deformity of, 192950 (3)	
HOXD13	142989	HOXD13, HOX4I, SPD, BDSD Synpolydactyly, type II, 186000 (3); Brachydactyly, type E, 113300 (3); Brachydactyly, type D, 113200 (3); Synpolydactyly with foot anomalies, 186000 (3); Syndactyly, type V, 186300 (3); Brachydactyly-syndactyly syndrome, 610713 (3); VACTERL association, 192350 (3)	
HMX1	142992	HMX1, H6 Oculoauricular syndrome, 612109 (3)	
VSX2	142993	CHX10, HOX10, MCOP2, MCOPCB3 Microphthalmia with coloboma 3, 610092 (3); Microphthalmia, isolated 2, 610093 (3)	
MNX1	142994	MNX1, HLXB9, HOXHB9, SCRA1 Currarino syndrome, 176450 (3)	
HADHB	143450	HADHB Trifunctional protein deficiency, 609015 (3)	
ACSM3	145505	ACSM3, SAH {?Hypertension, essential} (1)	
IL7R	146661	IL7R, IL7RA, CD127 Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type, 608971 (3)	
IMPDH1	146690	IMPDH1, RP10, LCA11 Retinitis pigmentosa 10, 180105 (3); Leber congenital amaurosis 11, 613837 (3)	
INSL3	146738	INSL3 Cryptorchidism, idiopathic, 219050 (3)	
FCGR3A	146740	FCGR3A, CD16, IGFR3 Neutropenia, alloimmune neonatal (3); {Viral infections, recurrent} (3)	
FCGR1A	146760	FCGR1A, IGFR1, CD64 [IgG receptor I, phagocytic, familial deficiency of] (3)	
IGLL1	146770	IGLL1, IGO, IGL5, VPREB2, AGM2 Agammaglobulinemia 2, 613500 (3)	
FCGR2A	146790	FCGR2A, IGFR2, CD32 {Lupus nephritis, susceptibility to} (3)	
HLA-DQA1	146880	HLA-DQA1, CELIAC1 {Celiac disease, susceptibility to}, 212750 (3)	
ADAR	146920	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1 Dyschromatosis symmetrica hereditaria, 127400 (3)	
CXCR1	146929	CXCR1, IL8RA {AIDS, slow progression to}, 609423 (3)	
IL10RA	146933	IL10RA, IL10R, IBD28 Inflammatory bowel disease 28, early onset, autosomal recessive, 613148 (3)	
IGHM	147020	IGHM, MU, AGM1 Agammaglobulinemia 1, 601495 (3)	
IGHG2	147110	IGHG2 IgG2 deficiency, selective (3)	
MS4A2	147138	MS4A2, FCER1B {Atopy, susceptibility to}, 147050 (3)	
TCF3	147141	TCF3, E2A Leukemia, acute lymphoblastic (1)	
IGKC	147200	IGKC, IGKCD [Kappa light chain deficiency], 614102 (3)	
CD79B	147245	CD79B, IGB, B29, AGM6 Agammaglobulinemia 6, 612692 (3)	
ITPR1	147265	ITPR1, SCA15, SCA16 Spinocerebellar ataxia 15, 606658 (3)	
ITPR3	147267	ITPR3 {Diabetes, type 1, susceptibility to}, 222100 (2)	
IGF2R	147280	IGF2R, MPRI Hepatocellular carcinoma (3)	
IGF1R	147370	IGF1R Insulin-like growth factor I, resistance to, 270450 (3)	
IGF1	147440	IGF1 Growth retardation with deafness and mental retardation due to IGF1 deficiency, 608747 (3)	
SOD1	147450	SOD1, ALS1 Amyotrophic lateral sclerosis, due to SOD1 deficiency, 105400 (3)	
SOD2	147460	SOD2, MNSOD, MVCD6 {Microvascular complications of diabetes 6}, 612634 (3)	
ITPA	147520	ITPA [Inosine triphosphatase deficiency], 613850 (3)	
ITGA6	147556	ITGA6 Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3)	
ITGB4	147557	ITGB4 Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3); Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3); Epidermolysis bullosa of hands and feet, 131800 (3)	
IFNGR2	147569	IFNGR2, IFNGT1, IFGR2 {Mycobacterial infection, atypical, familial disseminated}, 209950 (3)	
IFNG	147570	IFNG, IFG, IFI {TSC2 angiomyolipomas, renal, modifier of}, 613254 (3); {Aplastic anemia}, 609135 (3); {Tuberculosis, protection against}, 607948 (3); {AIDS, rapid progression to}, 609423 (3);{Hepatitis C virus, response to therapy of}, 609532 (3)	
IRF1	147575	IRF1, MAR Myelodysplastic syndrome, preleukemic (3); Myelogenous leukemia, acute (3); Gastric cancer, somatic, 137215 (3); Nonsmall cell lung cancer, somatic, 211980 (3)	
IL6	147620	IL6, IFNB2, BSF2, HSF, HGF {Rheumatoid arthritis, systemic juvenile}, 604302 (3); {Kaposi sarcoma, susceptibility to}, 148000 (3); {Diabetes, susceptibility to}, 222100, 125853 (3); {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}, 108010 (3); {Crohn disease-associated growth failure}, 266600 (3)	
IDH2	147650	IDH2, IDPM, D2HGA2 D-2-hydrosyglutaric aciduria 2, 613657 (3)	
IFNA1	147660	IFNA1, IFNA@ Interferon, alpha, deficiency (1)	
INSR	147670	INSR, HHF5 Leprechaunism, 246200 (3); Rabson-Mendenhall syndrome, 262190 (3); Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3); Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3)	
IL1RN	147679	IL1RN, MVCD4, DIRA {Gastric cancer risk after H. pylori infection}, 137215 (3); {Microvascular complications of diabetes 4}, 612628 (3); Interleukin 1 receptor antagonist deficiency, 612852 (3)	
IL2	147680	IL2 Severe combined immunodeficiency due to IL2 deficiency (1)	
IL13	147683	IL13, ALRH, BHR1 {Asthma, susceptibility to}, 600807 (3); {Allergic rhinitis, susceptibility to}, 607154 (3)	
IL1B	147720	IL1B {Gastric cancer risk after H. pylori infection}, 137215 (3)	
IL2RA	147730	IL2RA, IL2R, IDDM10 Interleukin-2 receptor, alpha chain, deficiency of, 606367 (3); {Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 601942 (3)	
IL4R	147781	IL4R, IL4RA {Atopy, susceptibility to}, 147050 (3); {AIDS, slow progression to}, 609423 (3)	
JAK2	147796	JAK2, THCYT3 Polycythemia vera, 263300 (3); Thrombocythemia 3, 614521 (3); Myelofibrosis, idiopathic, 254450 (3); {Budd-Chiari syndrome}, 600880 (3); Leukemia, acute myelogenous, 601626 (3); Myeloproliferative disorder with erythrocytosis (3)	
ICAM1	147840	ICAM1 {Malaria, cerebral, susceptibility to}, 611162 (3)	
KRT5	148040	KRT5, DDD Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3); Epidermolysis bullosa simplex, Koebner type, 131900 (3); Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3); Epidermolysis bullosa simplex with mottled pigmentation, 131960 (3); Dowling-Degos disease, 179850 (3); Epidermolysis bullosa simplex with migratory circinate erythema, 609352 (3)	
KRT6A	148041	KRT6A Pachyonychia congenita, Jadassohn-Lewandowsky type, 167200 (3)	
KRT6B	148042	KRT6B, PC2 Pachyonychia congenita, Jackson-Lawler type, 167210 (3)	
KRT3	148043	KRT3 Meesmann corneal dystrophy, 122100 (3)	
KRT8	148060	KRT8 Cirrhosis, cryptogenic (3); {Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3)	
KRT13	148065	KRT13 White sponge nevus, 193900 (3)	
KRT14	148066	KRT14 Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3); Epidermolysis bullosa simplex, Koebner type, 131900 (3); Epidermolysis bullosa simplex, recessive, 601001 (3); Naegeli-Franceschetti-Jadassohn syndrome, 161000 (3); Dermatopathia pigmentosa reticularis, 125595 (3); Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3)	
KRT16	148067	KRT16, FNEPPK Pachyonychia congenita, Jadassohn-Lewandowsky type, 167200 (3); Palmoplantar keratoderma, nonepidermolytic, 600962 (3); Palmoplantar verrucous nevus, unilateral, 144200 (3); Palmoplantar keratoderma, nonepidermolytic, focal, 613000 (3)	
KRT17	148069	KRT17, PC2, PCHC1 Pachyonychia congenita, Jackson-Lawler type, 167210 (3); Steatocystoma multiplex, 184500 (3)	
KRT18	148070	KRT18 Cirrhosis, cryptogenic (3); {Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3)	
KRT10	148080	KRT10, EHK, BCIE, BIE Epidermolytic hyperkeratosis, 113800 (3); Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3); Ichthyosis with confetti, 609165 (3)	
KIF11	148760	KIF11, KNSL1, MCLMR Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation, 152950 (3)	
LDHA	150000	LDHA, LDH1, GSD11 Glycogen storage disease XI, 612933 (3)	
LDHB	150100	LDHB, LDHBD Lactate dehydrogenase-B deficiency, 614128 (3)	
CSH1	150200	CSH1, CSA, PL [Placental lactogen deficiency] (1)	
LAMB1	150240	LAMB1 ?Cutis laxa, marfanoid neonatal type, 614100 (1)	
LAMC2	150292	LAMC2, LAMNB2, LAMB2T Epidermolysis bullosa, junctional, Herlitz type, 226700 (3); Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	
LAMB3	150310	LAMB3 Epidermolysis bullosa, junctional, Herlitz type, 226700 (3); Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	
LAMB2	150325	LAMB2, LAMS, NPHS5 Nephrotic syndrome, type 5, with or without ocular abnormalities, 614199 (3); Pierson syndrome, 609049 (3)	
LMNA	150330	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3); Cardiomyopathy, dilated, 1A, 115200 (3); Lipodystrophy, familial partial, 2, 151660 (3); Emery-Dreifuss muscular dystrophy 3, AR, 181350 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3); Muscular dystrophy, congenital, 613205 (3); Muscular dystrophy, limb-girdle, type 1B, 159001 (3); Mandibuloacral dysplasia, 248370 (3); Hutchinson-Gilford progeria, 176670 (3); Restrictive dermopathy, lethal, 275210 (3); Heart-hand syndrome, Slovenian type, 610140 (3); Malouf syndrome, 212112 (3)	
LMNB1	150340	LMNB1 Leukodystrophy, adult-onset, autosomal dominant, 169500 (3)	
LMNB2	150341	LMNB2, LMN2 {Lipodystrophy, partial, acquired, susceptibility to}, 608709 (3)	
RPSA	150370	LAMR1, LAMBR ?Arrhythmogenic right ventricular dysplasia 5, 604400 (1)	
LGALS2	150571	LGALS2 {Myocardial infarction, susceptibility to}, 608446 (3)	
RUNX1	151385	RUNX1, CBFA2, AML1 Leukemia, acute myeloid, 601626 (3); Platelet disorder, familial, with associated myeloid malignancy, 601399 (3)	
BCR	151410	BCR, CML, PHL, ALL Leukemia, chronic myeloid, 608232 (3); Leukemia, acute lymphocytic, 613065 (3)	
LYL1	151440	LYL1 Leukemia, T-cell acute lymphoblastoid (2)	
LIFR	151443	LIFR, STWS, SWS, SJS2 Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3)	
-	151450	LAG5 Neutropenia, neonatal alloimmune (1)	
PTPRC	151460	PTPRC, CD45, LCA {Hepatitic C virus, susceptibility to}, 609532 (3); Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)	
LIPC	151670	LIPC, HL, LIPH, HDLCQ12 [High density lipoprotein cholesterol level QTL 12], 612797 (3); {Diabetes mellitus, noninsulin-dependent}, 125853 (3); Hepatic lipase deficiency, 614025 (3)	
ALOX5	152390	ALOX5 {Atherosclerosis, susceptibility to} (3); {Asthma, diminished response to antileukotriene treatment in}, 600807 (3)	
-	152424	LCRB Thalassemia, Hispanic gamma-delta-beta, 613985 (3)	
KCNH2	152427	KCNH2, LQT2, HERG, SQT1 Long QT syndrome-2, 613688 (3); {Long QT syndrome-2, acquired, susceptibility to}, 613688 (3); Short QT syndrome-1, 609620 (3)	
LOR	152445	LOR Vohwinkel syndrome with ichthyosis, 604117 (3)	
GNRH1	152760	GNRH1, LNRH ?Hypogonadotropic hypogonadism due to GNRH deficiency, 227200 (1)	
LHCGR	152790	LHCGR, LHR, LCGR Precocious puberty, male, 176410 (3); Leydig cell hypoplasia with pseudohermaphroditism, 238320 (3); Leydig cell hypoplasia with hypergonadotropic hypogonadism, 238320 (3); Luteinizing hormone resistance, female, 238320 (3); Leydig cell adenoma, somatic, with precocious puberty, 176410 (3)	
LCK	153390	LCK SCID due to LCK deficiency (1)	
LTA	153440	LTA, TNFB {Myocardial infarction, susceptibility to}, 608446 (3); {Psoriatic arthritis, susceptibility to}, 607507 (3); {Leprosy, susceptibility to, 4}, 610988 (3)	
LYZ	153450	LYZ Amyloidosis, renal, 105200 (3)	
PLOD1	153454	PLOD, PLOD1 Ehlers-Danlos syndrome, type VI, 225400 (3); Nevo syndrome, 601451 (3)	
LOXL1	153456	LOXL1, LOXL {Exfoliation syndrome, susceptibility to}, 177650 (3)	
MIF	153620	MIF {Rheumatoid arthritis, systemic juvenile, susceptibility to}, 604302 (3)	
MSR1	153622	MSR1, SCARA1, SRA Prostate cancer, hereditary, 176807 (3); Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	
MAK	154235	MAK, RP62 REtinitis pigmentosa 62, 614181 (3)	
ME2	154270	ME2, ODS1 {Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3); {Opioid dependence, susceptibility to}, 610064 (3)	
MBL2	154545	MBL2, MBL, MBP1, MBL2D {Chronic infections, due to MBL deficiency}, 614372 (3)	
MPI	154550	MPI, PMI1, CDG1B Congenital disorder of glycosylation, type Ib, 602579 (3)	
MGP	154870	MGP, NTI Keutel syndrome, 245150 (3); {Natural teeth remaining intact} (2)	
MAX	154950	MAX {Pheochromocytoma, susceptibility to}, 171300 (3)	
MC3R	155540	MC3R, BMIQ9 {Obesity, severe, susceptibility to, BMIQ9}, 602025 (3); {Mycobacterium tuberculosis, protection against}, 607948 (3)	
MC4R	155541	MC4R Obesity, autosomal dominant, 601665 (3)	
MC1R	155555	MC1R, SHEP2, CMM5 [Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3); [Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3); [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3); {UV-induced skin damage}, 266300 (3); {Oculocutaneous albinism, type II, modifier of}, 203200 (3); {Melanoma, cutaneous malignant, 5}, 613099 (3)	
ACAN	155760	ACAN, AGC1, CSPG1, MSK16, SEDK Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3); Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3); Osteochondritis dissecans, short stature, and early-onset osteoarthritis, 165800 (3)	
MN1	156100	MN1, MGCR Meningioma, 607174 (3)	
LAMA2	156225	LAMA2, LAMM Muscular dystrophy, congenital merosin-deficient, 607855 (3); Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)	
NME1	156490	NME1, NM23 Neuroblastoma, 256700 (3)	
MTAP	156540	MTAP, DMSMFH Diaphyseal medullary stenosis with malignant fibrous histiocytoma, 112250 (3)	
MTR	156570	MTR Methylcobalamin deficiency, cblG type, 250940 (3); {Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)	
MITF	156845	MITF, WS2A, CMM8 Waardenburg syndrome, type 2A, 193510 (3); Waardenburg syndrome/ocular albinism, digenic, 103470 (3); Tietz albinism-deafness syndrome, 103500 (3); {Melanoma, cutaneous malignant, susceptibility to, 8}, 614456 (3)	
MAPT	157140	MAPT, MTBT1, DDPAC, MSTD Dementia, frontotemporal, with or without parkinsonism, 600274 (3); Pick disease, 172700 (3); Supranuclear palsy, progressive, 601104 (3); Supranuclear palsy, progressive atypical, 260540 (3); {Parkinson disease, susceptibility to}, 168600 (3); Tauopathy and respiratory failure (3)	
MSMB	157145	MSMB, HPC13 {Prostate cancer, hereditary, 13}, 611928 (3)	
MTTP	157147	MTP Abetalipoproteinemia, 200100 (3); {Metabolic syndrome, protection against}, 605552 (3)	
NDUFS1	157655	NDUFS1 Mitochondrial complex I deficiency, 252010 (3)	
RMRP	157660	RMRP, RMRPR, CHH Cartilage-hair hypoplasia, 250250 (3); Metaphyseal dysplasia without hypotrichosis, 250460 (3); Anauxetic dysplasia, 607095 (3)	
MUC7	158375	MUC7 {Asthma, protection against}, 600807 (3)	
SLC20A2	158378	SLC20A2, MLVAR, GLVR2, IBGC3 Basal ganglia cancification, idiopathic, 3, 614540 (3)	
MCC	159350	MCC Colorectal cancer (3)	
MPZ	159440	MPZ, CMT1B, CMTDI3, CHM, DSS Charcot-Marie-Tooth disease, type 1B, 118200 (3); Dejerine-Sottas disease, 145900 (3); Neuropathy, congenital hypomyelinating, 605253 (3); Charcot-Marie-Tooth disease, type 2J, 607736 (3); Roussy-Levy syndrome, 180800 (3); Charcot-Marie-Tooth disease, type 2I, 607677 (3); Charcot-Marie-Tooth disease, dominant intermediate 3, 607791 (3)	
MOG	159465	MOG, NRCLP7 Narcolepsy 7, 614250 (3)	
MPL	159530	MPL, TPOR, MPLV, THCYT2 Thrombocytopenia, congenital amegakaryocytic, 604498 (3); Thrombocythemia 2, 601977 (3); Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)	
MYF6	159991	MYF6, CNM3 Myopathy, centronuclear, 3, 614408 (3)	
MYH6	160710	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3 Cardiomyopathy, familial hypertrophic, 14, 613251 (3); Atrial septal defect 3, 614089 (3); Cardiomyopathy, dilated, 1EE, 613252 (3); {Sick sinus syndrome 3}, 614090 (3)	
MYH3	160720	MYH3 Arthrogryposis, distal, type 2A, 193700 (3); Arthrogryposis, distal, type 2B, 601680 (3)	
MYH2	160740	MYH2 Inclusion body myopathy-3, 605637 (3)	
MYH8	160741	MYH8 Carney complex variant, 608837 (3); Trismus-pseudocamptodactyly syndrome, 158300 (3)	
MYH11	160745	MYH11, AAT4, FAA4 Aortic aneurysm, familial thoracic 4, 132900 (3)	
MYH7	160760	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD Cardiomyopathy, familial hypertrophic, 1, 192600 (3); Cardiomyopathy, dilated, 1S, 613426 (3); Myopathy, myosin storage, 608358 (3); Laing distal myopathy, 160500 (3); Scapuloperoneal syndrome, myopathic type, 181430 (3); Left ventricular noncompaction 5, 613426 (3)	
MYH9	160775	MYH9, MHA, FTNS, DFNA17, BDPLT6 May-Hegglin anomaly, 155100 (3); Fechtner syndrome, 153640 (3); Sebastian syndrome, 605249 (3); Deafness, autosomal dominant 17, 603622 (3); Epstein syndrome, 153650 (3); Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3)	
MYO5A	160777	MYO5A, MYH12, GS1 Griscelli syndrome, type 1, 214450 (3)	
MYL2	160781	MYL2, CMH10 Cardiomyopathy, familial hypertrophic, 10, 608758 (3)	
MYL3	160790	MYL3, CMH8 Cardiomyopathy, familial hypertrophic, 8, 608751 (3)	
MYBPC1	160794	MYBPC1 Arthrogryposis, distal, type 1B, 614335 (3)	
NQO2	160998	NQO2, NMOR2 {?Breast cancer susceptibility}, 114480 (1)	
NDUFV1	161015	NDUFV1, UQOR1 Mitochondrial complex I deficiency, 252010 (3)	
IL12B	161561	IL12B, NKSF2 BCG and salmonella infection, disseminated, 209950 (1); {Asthma, susceptibility to}, 600807 (3)	
NEB	161650	NEB, NEM2 Nemaline myopathy 2, autosomal recessive, 256030 (3)	
NGF	162030	NGFB, HSAN5 Neuropathy, hereditary sensory and autonomic, type V, 608654 (3)	
PCSK1	162150	PCSK1, NEC1, PC1, PC3, BMIQ12 Obesity with impaired prohormone processing, 600955 (3); {Obesity, susceptibility to, BMIQ12}, 612362 (3)	
NEFH	162230	NEFH {Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)	
NEFL	162280	NEFL, CMT2E, CMT1F Charcot-Marie-Tooth disease, type 2E, 607684 (3); Charcot-Marie-Tooth disease, type 1F, 607734 (3)	
TAC3	162330	TAC3, NKNB Hypogonadotropic hypogonadism, 146110 (3)	
TACR3	162332	TACR3, NK3R Hypogonadotropic hypogonadism, 146110 (3)	
CXCR4	162643	CXCR4, D2S201E, NPY3R, WHIM WHIM syndrome, 193670 (3); Myelokathexis, isolated (3)	
NTF4	162662	NTF4 , NTF5, NT5, NT4, GLC1O Glaucoma 1, open angle, 1O, 613100 (3)	
NOS2	163730	NOS2A, NOS2 {Hypertension, susceptibility to}, 145500 (2); {Malaria, resistance to}, 611162 (3)	
SNCA	163890	SNCA, NACP, PARK1, PARK4 Parkinson disease 4, 605543 (3); Dementia, Lewy body, 127750 (3); Parkinson disease 1, 168601 (3)	
SLC6A2	163970	SLC6A2, NAT1, NET1 Orthostatic intolerance, 604715 (3)	
NFKBIA	164008	NFKBIA, IKBA Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency, 612132 (3)	
NUMA1	164009	NUMA1 Leukemia, acute promyelocytic, NUMA/RARA type (3)	
MATR3	164015	MATR3, MPD2 Myopathy, distal 2, 606070 (3)	
NPM1	164040	NPM1 Leukemia, acute promyelocytic, NPM/RARA type (3); Leukemia, acute myeloid, 601626 (3)	
PNP	164050	PNP, NP Immunodeficiency due to purine nucleoside phosphorylase deficiency, 613179 (3)	
OAS1	164350	OAS1, OIAS {Viral infection, susceptibility to} (3); {Diabetes mellitus, type 1, susceptibility to}, 222100 (3)	
ABL2	164690	ABL2, ABLL, ARG Leukemia, acute myeloid, with eosinophilia (1)	
AKT1	164730	AKT1 Breast cancer, somatic, 114480 (3); Colorectal cancer, somatic, 114500 (3); Ovarian cancer, somatic, 167000 (3); {Schizophrenia, susceptibility to}, 181500 (2); Proteus syndrome, somatic, 176920 (3)	
AKT2	164731	AKT2, HIHGHH Diabetes mellitus, type II, 125853 (3); Hypoinsulinemic hypoglycemia with hemihypertrophy, 240900 (3)	
BRAF	164757	BRAF, NS7 Melanoma, malignant, somatic (3); Colorectal cancer, somatic (3); Adenocarcinoma of lung, somatic, 211980 (3); Nonsmall cell lung cancer, somatic (3); Cardiofaciocutaneous syndrome, 115150 (3); Noonan syndrome 7, 613706 (3); LEOPARD syndrome 3, 613707 (3)	
RAF1	164760	RAF1, CRAF, NS5 Noonan syndrome 5, 611553 (3); LEOPARD syndrome 2, 611554 (3)	
CSF1R	164770	CSF1R, FMS, HDLS Leukoencephalopathy, diffuse hereditary, with spheroids, 221820 (3)	
MDM2	164785	MDM2, ACTFS {Accelerated tumor formation, susceptibility to}, 614401 (3)	
NRAS	164790	NRAS, ALPS4, NS6 Colorectal cancer, 114500 (3); Thyroid carcinoma, follicular, 188470 (3); Autoimmune lymphoproliferative syndrome type IV, 614470 (3); Noonan syndrome 6, 613224 (3)	
MYCN	164840	MYCN, NMYC, ODED, MODED Feingold syndrome, 164280 (3)	
MET	164860	MET, AUTS9 Renal cell carcinoma, papillary, familial and somatic, 605074 (3); Hepatocellular carcinoma, childhood type, 114550 (3); {Autism suseptibility 9}, 611015 (3)	
ERBB2	164870	ERBB2, NGL, NEU, HER2 Adenocarcinoma of lung, somatic, 211980 (3); Glioblastoma, somatic, 137800 (3); Gastric cancer, somatic, 137215 (3); Ovarian cancer, somatic, (3)	
FOXG1	164874	FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1 Rett syndrome, congenital variant, 613454 (3)	
KIT	164920	KIT, PBT Piebaldism (3); Mast cell leukemia (3); Mastocytosis with associated hematologic disorder (3); Germ cell tumors, 273300 (3); Gastrointestinal stromal tumor, somatic, 606764 (3); Leukemia, acute myeloid, 601626 (3)	
FGF3	164950	FGF3, INT2 Deafness, congenital with inner ear agenesis, microtia, and microdontia, 610706 (3)	
-	164953	LPSA, D19S381E Liposarcoma (1)	
WNT5A	164975	WNT5A Robinow syndrome, autosomal dominant, 180700 (3)	
MECOM	165215	EVI1 3q21q26 syndrome (1)	
GLI2	165230	GLI2, HPE9 Holoprosencephaly-9, 610829 (3)	
GLI3	165240	GLI3, PAPA, PAPB Greig cephalopolysyndactyly syndrome, 175700 (3); Pallister-Hall syndrome, 146510 (3); Polydactyly, preaxial, type IV, 174700 (3); Polydactyly, postaxial, types A1 and B, 174200 (3); {Hypothalamic hamartomas, somatic}, 241800 (3)	
LCO	165320	LCO ?Hepatocellular carcinoma (1)	
WNT3	165330	WNT3, INT4 Tetra-amelia, autosomal recessive, 273395 (3)	
CBL	165360	CBL, CBL2, NSLL Noonan syndrome-like disorder with or without juvenile meylomonocytic leukemia, 613563 (3)	
ODC1	165640	ODC1 {Colonic adenoma recurrence, reduced risk of}, 114500 (3)	
PAX2	167409	PAX2 Optic nerve coloboma with renal disease, 120330 (3); Renal hypoplasia, isolated (3)	
PAX7	167410	PAX7, RMS2 Rhabdomyosarcoma 2, alveolar, 268220 (3)	
PAX4	167413	PAX4, MODY9, KPD Maturity-onset diabetes of the young, type IX, 612225 (3); Diabetes mellitus, type 2, 125853 (3); Diabetes mellitus, ketosis-prone, 612227 (3)	
PAX5	167414	PAX5, BSAP Lymphoplasmacytoid lymphoma (1)	
PAX8	167415	PAX8 Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)	
PAX9	167416	PAX9, STHAG3 Tooth agenesis, selective, 3, 604625 (3)	
PRRX1	167420	PRRX1, PMX1, PHOX1, AGOTC Agnathia-otocephaly complex, 202650 (3)	
SPINK1	167790	SPINK1, PSTI, PCTT, TATI, TCP Pancreatitis, hereditary, 167800 (3); {Fibrocalculous pancreatic diabetes, susceptibility to}, 608189 (3); Tropical calcific pancreatitis, 608189 (3)	
ELAVL4	168360	ELAVL4, HUD, PNEM Neuropathy, paraneoplastic sensory (1)	
PTH	168450	PTH Hypoparathyroidism, autosomal dominant, 146200 (3); Hypoparathyroidism, autosomal recessive, 146200 (3)	
CCND1	168461	CCND1, PRAD1, BCL1 {Colorectal cancer, susceptibility to}, 114500 (3); {von Hippel-Lindau disease, modification of}, 193300 (3)	
PTH1R	168468	PTHR1, PTHR, PFE Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3); Chondrodysplasia, Blomstrand type, 215045 (3); Eiken syndrome, 600002 (3); Failure of tooth eruption, primary, 125350 (3)	
TAP1	170260	TAP1, ABCB2, TAP1, RING4, PSF1 Bare lymphocyte syndrome, type I, 604571 (3)	
TAP2	170261	TAP2, ABCB3, PSF2, RING11 Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3); Wegener-like granulomatosis (3)	
PRF1	170280	PRF1, HPLH2, FLH2 Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3); Lymphoma, non-Hodgkin, 605027 (3)	
PLIN1	170290	PLIN1, PLIN, FPLD4 Lipodystrophy, familial partial, type 4, 613877 (3)	
PRPH	170710	PRPH {Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)	
ABCB1	171050	ABCB1, PGY1, MDR1, IBD13, CLCs {Colchicine resistance}, 120080 (3); {Inflammatory bowel disease 13}, 612244 (3)	
ABCB4	171060	ABCB4, PGY3, MDR3 Cholestasis, progressive familial intrahepatic 3, 602347 (3); Cholestasis, familial intrahepatic, of pregnancy, 147480 (3); Gallbladder disease 1, 600803 (3)	
PNMT	171190	PNMT, PENT ?Hypertension, essential, 145500 (1)	
ACP5	171640	ACP5, SPENCDI Spondyloenchondrodysplasia with immune dysregulation, 607944 (3)	
ACP2	171650	ACP2 ?Lysosomal acid phosphatase deficiency, 200950 (1)	
ALPL	171760	ALPL, HOPS, TNSALP Hypophosphatasia, infantile, 241500 (3); Hypophosphatasia, childhood, 241510 (3); Odontohypophosphatasia, 146300 (3); Hypophosphatasia, adult, 146300 (3)	
PIK3CA	171834	PIK3CA Ovarian cancer, somatic, 167000 (3); Breast cancer, somatic, 114480 (3); Colorectal cancer, somatic, 114500 (3); Gastric cancer, somatic, 137215 (3); Hepatocellular carcinoma, somatic, 114550 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, 162900 (3)	
PFKL	171860	PFKL Hemolytic anemia due to phosphofructokinase deficiency (1)	
PGM1	171900	PGM1, GSD14 Glycogen storage disease XIV, 612934 (3)	
GPI	172400	GPI Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency, 613470 (3)	
PLN	172405	PLN, PLB, CMD1P, CMH18 Cardiomyopathy, dilated, 1P, 609909 (3); Cardiomyopathy, familial hypertrophic, 18, 613874 (3)	
PLA2G2A	172411	PLA2G2A, PLA2B, PLA2L, MOM1 {Colorectal cancer}, 114500 (3)	
ENO1	172430	ENO1, PPH, MPB1 Enolase deficiency (1)	
MTHFD1	172460	MTHFD, MTHFC {Spina bifida, folate-sensitive, susceptibility to}, 601634 (3); {Abruptio placentae, susceptibility to} (3)	
PHKG2	172471	PHKG2, GSD9C Glycogen storage disease IXc, 613027 (3); Cirrhosis due to liver phosphorylase kinase deficiency (3)	
PSPH	172480	PSP, PSPHD Phosphoserine phosphatase deficiency, 614023 (3)	
PHKB	172490	PHKB Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3)	
SERPINF1	172860	SERPINF1, PEDF, OI6 Osteogenesis imperfecta, type VI, 613982 (3)	
POU1F1	173110	POU1F1, PIT1, CPHD1 Pituitary hormone deficiency, combined, 1, 613038 (3)	
SERPINB6	173321	SERPINB6, PI6, PTI, SPI3, DFNB91 Deafness, autosomal recessive 91, 613453 (3)	
JUP	173325	JUP, DP3, PDGB, ARVD12 Naxos disease, 601214 (3); Arrhythmogenic right ventricular dysplasia 12, 611528 (3)	
ENPP1	173335	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2 Ossification of posterior longitudinal ligament of spine, 602475 (3); {Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3); {Obesity, susceptibility to}, 601665 (3); Arterial calcification, generalized, of infancy, 1, 208000 (3); Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3)	
PLG	173350	PLG Plasminogen Tochigi disease (3); Thrombophilia, dysplasminogenemic (1); Plasminogen deficiency, types I and II (1); Conjunctivitis, ligneous, 217090 (3)	
SERPINE1	173360	PAI1, PLANH1, SERPINE1 Plasminogen activator inhibitor-1 deficiency, 613329 (3); {Transcription of plasminogen activator inhibitor, modulator of} (3)	
PLAT	173370	PLAT, TPA Thrombophilia, familial, due to decreased release of PLAT, 612348 (1); Hyperfibrinolysis, familial, due to increased release of PLAT, 612348 (1)	
PDGFRB	173410	PDGFRB, PDGFR Myeloproliferative disorder with eosinophilia, 131440 (3); Myelomonocytic leukemia, chronic (3)	
PDGFRA	173490	PDGFRA Gastrointestinal stromal tumor, somatic, 606764 (3); Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)	
CD36	173510	CD36, CHDS7, BDPLT10 [Macrothrombocytopenia] (1); Platelet glycoprotein IV deficiency, 608404 (3); {Malaria, cerebral, susceptibility to}, 611162 (3); {Malaria, cerebral, reduced risk of}, 611162 (3); {Coronary heart disease, susceptibility to, 7}, 610938 (3)	
GP9	173515	GP9 Bernard-Soulier syndrome, type C, 231200 (3)	
PARP1	173870	PARP1, ADPRT, PPOL, PARP ?Xeroderma pigmentosum (1)	
PKD2	173910	PKD2 Polycystic kidney disease 2, 613095 (3)	
POLG	174763	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS Progressive external ophthalmoplegia, autosomal recessive, 258450 (3); Progressive external ophthalmoplegia, autosomal dominant, 157640 (3); Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3); Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3); Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)	
KCNA1	176260	KCNA1, AEMK, EA1 Episodic ataxia/myokymia syndrome, 160120 (3)	
KCNE1	176261	KCNE1, JLNS, LQT5, JLNS2 Jervell and Lange-Nielsen syndrome 2, 612347 (3); Long QT syndrome-5, 613695 (3)	
KCNC3	176264	KCNC3, SCA13 Spinocerebellar ataxia 13, 605259 (3)	
KCNA5	176267	KCNA5, ATFB7 Atrial fibrillation, familial, 7, 612240 (3)	
TTR	176300	TTR, PALB Amyloidosis, hereditary, transthyretin-related, 105210 (3); [Dystransthyretinemic hyperthyroxinemia], 145680 (3); Carpal tunnel syndrome, familial, 115430 (3)	
PBX1	176310	PBX1 Leukemia, acute pre-B-cell (2)	
PRNP	176640	PRNP, PRIP, KURU, CJD Creutzfeldt-Jakob disease, 123400 (3); Gerstmann-Straussler disease, 137440 (3); Insomnia, fatal familial, 600072 (3); Prion disease with protracted course, 606688 (3); Huntington disease-like 1, 603218 (3); {Kuru, susceptibility to}, 245300 (3)	
PHB	176705	PHB {Breast cancer, susceptibility to}, 114480 (3)	
ZBTB16	176797	ZBTB16, ZNF145, PLZF Leukemia, acute promyelocytic, PL2F/RARA type (3); Skeletal defects, genital hypoplasia, and mental retardation, 612447 (3)	
PSAP	176801	PSAP, SAP1 Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3); Gaucher disease, atypical, 610539 (3); Combined SAP deficiency, 611721 (3); Krabbe disease, atypical, 611722 (3)	
PTGER2	176804	PTGER2 {Asthma, aspirin-induced, susceptibility to}, 208550 (3)	
POMC	176830	POMC Obesity, adrenal insufficiency, and red hair due to POMC deficiency, 609734 (3); {Obesity, early-onset, susceptibility to}, 601665 (3)	
MAP2K1	176872	MAP2K1, PRKMK1, MKK1, MEK1 Cardiofaciocutaneous syndrome, 115150 (3)	
PTPN11	176876	PTPN11, PTP2C, SHP2, NS1 Noonan syndrome 1, 163950 (3); LEOPARD syndrome 1, 151100 (3); Leukemia, juvenile myelomonocytic, 607785 (3); Metachondromatosis, 156250 (3)	
PROS1	176880	PROS1, THPH5, THPH6 Thrombophilia due to protein S deficiency, autosomal dominant, 612336 (3); Thrombophilia due to protein S deficiency, autosomal recessive, 614514 (3)	
PTPN1	176885	PTPN1, PTP1B {Insulin resistance, susceptibility to}, 125853 (3)	
PTPRZ1	176891	PTPRZ1, PTP18 {H. pylori infection, susceptibility to}, 600263 (1)	
PROZ	176895	PROZ, PZ [Protein Z deficiency], 614024 (1)	
F2	176930	F2, THPH1, RPRGL2 Hypoprothrombinemia, 613679 (3); Dysprothrombinemia, 613679 (3); Thrombophilia due to thrombin defect, 188050 (3); {Stroke, ischemic, susceptibility to}, 601367 (3); {Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3)	
TYK2	176941	TYK2 Tyrosine kinase 2 deficiency, 611521 (3)	
FGFR2	176943	FGFR2, BEK, CFD1, JWS, TK14, BBDS Crouzon syndrome, 123500 (3); Jackson-Weiss syndrome, 123150 (3); Beare-Stevenson cutis gyrata syndrome, 123790 (3); Pfeiffer syndrome, 101600 (3); Apert syndrome, 101200 (3); Saethre-Chotzen syndrome, 101400 (3); Craniosynostosis, nonspecific (3); Gastric cancer, somatic, 137215 (3); Craniofacial-skeletal-dermatologic dysplasia (3); Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3); Scaphocephaly and Axenfeld-Rieger anomaly (3); LADD syndrome, 149730 (3); Scaphocephaly, maxillary retrusion, and mental retardation, 609579 (3); Bent bone dysplasia syndrome, 614592 (3)	
EPHA2	176946	EPHA2, ECK, ARCC2, CTPP1, CTPA, ARCC2 Cataract, posterior polar, 1, 116600 (3); Cataract, age-related cortical, 2, 613020 (3)	
PRKCA	176960	PRKCA, PKCA Pituitary tumor, invasive (3)	
PRKCG	176980	PRKCG, PKCC, PKCG, SCA14 Spinocerebellar ataxia 14, 605361 (3)	
PSMB8	177046	PSMB8, LMP7, RING10, JMP, NKJO, ALDD Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)	
PRKCSH	177060	PRKCSH, G19P1, PCLD Polycystic liver disease, 174050 (3)	
EPB42	177070	EPB42, SPH5 Spherocytosis, hereditary, type 5, 612690 (3)	
MAF	177075	MAF, CCA4 Cataract, pulverulent or cerulean, with or without microcornea, 610202 (3)	
SFTPC	178620	SFTPC, SFTP2, SMDP2 Surfactant metabolism dysfunction, pulmonary, 2, 610913 (3)	
SFTPA1	178630	SFTPA1, SFTP1 {Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)	
SFTPB	178640	SFTPB, SFTB3, SMDP1 Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3)	
SFTPA2	178642	SFTPA2, SPA2, COLEC5 Pulmonary fibrosis, idiopathic, 178500 (3)	
PYCR1	179035	PYCR1, PRO3, ARCL2B, ARCL3B Cutis laxa, autosomal recessive, type IIB, 612940 (3); Cutis laxa, autosomal recessive, type IIIB, 614438 (3)	
PDHB	179060	PDHB, PDHBD Pyruvate dehydrogenase E1-beta deficiency, 614111 (3)	
UBE2B	179095	UBE2B, RAD6B ?Male infertility (1)	
RDX	179410	RDX, DFNB24 Deafness, autosomal recessive 24, 611022 (3)	
RAP1GDS1	179502	RAP1GDS1 Lymphocytic leukemia, acute T-cell (3)	
PRPH2	179605	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2 Retinitis pigmentosa 7, 608133 (3); Retinitis punctata albescens, 136880 (3); Macular dystrophy, patterned, 169150 (3); Macular dystrophy, vitelliform, 608161 (3); Foveomacular dystrophy, adult-onset, with choroidal neovascularization, 608161 (3); Macular dystrophy (3); Retinitis pigmentosa, digenic, 608133 (3); Choriodal dystrophy, central areolar 2, 613105 (3)	
RAG1	179615	RAG1 Severe combined immunodeficiency, B cell-negative, 601457 (3); Omenn syndrome, 603554 (3); Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity, 609889 (3); Combined cellular and humoral immune defects with granulomas, 233650 (3)	
RAG2	179616	RAG2 Severe combined immunodeficiency, B cell-negative, 601457 (3); Omenn syndrome, 603554 (3); Combined cellular and humoral immune defects with granulomas, 233650 (3)	
RAD51	179617	RAD51A, RECA, MRMV2 {Breast cancer, susceptibility to}, 114480 (3); Mirror movements 2, 614508 (3)	
PRCC	179755	PRCC, RCCP1 Renal cell carcinoma, papillary, 605074 (3)	
REN	179820	REN, HNFJ2 [Hyperproreninemia] (3); Renal tubular dysgenesis, 267430 (3); Hyperuricemic nephropathy, familial juvenile 2, 613092 (3)	
RD3	180040	RD3, LCA12, C1orf36 Leber congenital amaurosis 12, 610612 (3)	
RPE65	180069	RPE65, RP20, LCA2 Leber congenital amaurosis 2, 204100 (3); Retinitis pigmentosa 20, 613794 (3)	
PDE6A	180071	PDE6A, PDEA, RP43 Retinitis pigmentosa 43, 613810 (3)	
PDE6B	180072	PDE6B, PDEB, RP40, CSNBAD2 Night blindness, congenital stationary, autosomal dominant 2, 163500 (3); Retinitis pigmentosa-40, 613801 (3)	
PDE6G	180073	PDE6G, PDEG, RP57 Retinitis pigmentosa 57, 613582 (3)	
RLBP1	180090	RLBP1 Fundus albipunctatus, 136880 (3); Retinitis punctata albescens, 136880 (3); Newfoundland rod-cone dystrophy, 607476 (3); Bothnia retinal dystrophy, 607475 (3)	
RARA	180240	RARA Leukemia, acute promyelocytic, 612376 (1)	
RHAG	180297	RHAG, RH50A Anemia, hemolytic, Rh-null, regulator type, 268150 (3); Rh-mod syndrome (3)	
RHO	180380	RHO, RP4, OPN2, CSNBAD1 Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3); Night blindness, congenital stationery, autosomal dominant 1, 610445 (3); Retinitis punctata albescens, 136880 (3)	
GRK1	180381	GRK1, RHOK, RK Oguchi disease-2, 613411 (3)	
LMO2	180385	LMO2, RBTNL1, RHOM2, TTG2 Leukemia, acute T-cell (2)	
RPIA	180430	RPIA, RPI Ribose 5-phosphate isomerase deficiency, 608611 (3)	
RNASEL	180435	RNASEL, RNS4, PRCA1, HPC1 Prostate cancer 1, 601518 (3)	
RPL35A	180468	RPL35A, DBA5 Diamond-Blackfan anemia 5, 612528 (3)	
RPS17	180472	RPS17, RPS17L1, RPS17L2, DBA4 Diamond-Blackfan anemia 4, 612527 (3)	
ROM1	180721	ROM1, ROSP1, RP7 Retinitis pigmentosa 7, digenic (3)	
RYR1	180901	RYR1, MHS, CCO {Malignant hyperthermia susceptibility 1}, 145600 (3); Central core disease, 117000 (3); Minicore myopathy with external ophthalmoplegia, 255320 (3); Neuromuscular disease, congenital, with uniform type 1 fiber, 117000 (3)	
RYR2	180902	RYR2, VTSIP, ARVD2, ARVC2 Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772 (3); Arrhythmogenic right ventricular dysplasia 2, 600996 (3)	
AHCY	180960	AHCY, SAHH Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, 613752 (3)	
SAG	181031	SAG, RP47 Oguchi disease-1, 258100 (3); Retinitis pigmentosa 47, 613758 (3)	
STIL	181590	STIL, SIL, MCPH7 Microcephaly, primary autosomal recessive, 7, 612703 (3)	
SPR	182125	SPR Dystonia, dopa-responsive, due to sepiapterin reductase deficiency, 612716 (3)	
HTR2A	182135	HTR2A {Schizophrenia, susceptibility to}, 181500 (3); {Obsessive-compulsive disorder, susceptibility to}, 164230 (3); {Seasonal affective disorder, susceptibility to}, 608516 (3); {Alcohol dependence, susceptibility to}, 103780 (3); {Anorexia nervosa, susceptibility to}, 606788 (3); {Major depressive disorder, response to citalopram therapy in}, 608516 (3)	
SLC6A4	182138	SLC6A4, HTT, OCD1 {Anxiety-related personality traits}, 607834 (3); {Obsessive-compulsive disorder}, 164230 (3)	
SNRPN	182279	SNRPN Prader-Willi syndrome, 176270 (3)	
CCL3	182283	CCL3, SCYA3, MIP1A {HIV infection, resistance to}, 609423 (2)	
SLC34A1	182309	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2 Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3); Fanconi renotubular syndrome 2, 613388 (3)	
ATP1B1	182330	ATP1B1 [Blood pressure regulation QTL], 145500 (2)	
ATP1A2	182340	ATP1A2, FHM2, MHP2 Migraine, familial hemiplegic, 2, 602481 (3); Alternating hemiplegia of childhood, 104290 (3); Migraine, familial basilar, 602481 (3)	
ATP1A3	182350	ATP1A3, DYT12, RDP Dystonia-12, 128235 (3)	
SLC5A1	182380	SLC5A1, SGLT1 Glucose/galactose malabsorption, 606824 (3)	
SLC5A2	182381	SLC5A2, SGLT2 Renal glucosuria, 233100 (3)	
SCN1A	182389	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3 Epilepsy, generalized, with febrile seizures plus, type 2, 604403 (3); Dravet syndrome, 607208 (3); Migraine, familial hemiplegic, 3, 609634 (3); Febrile seizures, familial, 3A, 604403 (3)	
SCN2A	182390	SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS Seizures, benign familial infantile, 3, 607745 (3); Epileptic encephalopathy, early infantile, 11, 613721 (3)	
SSTR5	182455	SSTR5 Somatostatin analog, resistance to, 102200 (3)	
SORD	182500	SORD, SORD1 ?Cataract, congenital (2)	
SOS1	182530	SOS1, GINGF, GF1, HGF, NS4 Fibromatosis, gingival, 135300 (3); Noonan syndrome 4, 610733 (3)	
SPTAN1	182810	SPTAN1, NEAS, EIEE5 Epileptic encephalopathy, early infantile, 5, 613477 (3)	
SPTA1	182860	SPTA1, EL2, SPH3, HS3, HPP Elliptocytosis-2, 130600 (3); Pyropoikilocytosis, 266140 (3); Spherocytosis, type 3, 270970 (3)	
SOX2	184429	SOX2, MCOPS3 Microphthalmia, syndromic 3, 206900 (3); Optic nerve hypoplasia and abnormalities of the central nervous system, 206900 (3)	
CSTA	184600	CSTA, STFA, STF1, AREI Exfoliative ichthyosis, autosomal recessive, ichthyosis bullosa of Siemens-like, 607936 (3)	
KITLG	184745	KITLG, MGF, SF, SCF, SHEP7 [Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3); Hyperpigmentation, familial progressive, 2, 145250 (3)	
SCP2	184755	SCP2 Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3)	
MMP3	185250	MMP3, STMY1, CHDS6 {Coronary heart disease, susceptibility to, 6}, 614466 (3)	
SDHB	185470	SDHB, SDH2, SDHIP, PGL4 Paragangliomas 4, 115310 (3); Pheochromocytoma, 171300 (3); Paraganglioma and gastric stromal sarcoma, 606864 (3); Cowden-like syndrome, 612359 (3); Gastrointestinal stromal tumor, 606764 (3)	
SOD3	185490	SOD3 [Superoxide dismutase, elevated extracellular] (3)	
EPCAM	185535	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8 Diarrhea 5, with tufting enteropathy, congenital, 613217 (3); Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)	
SURF1	185620	SURF1 Leigh syndrome, due to COX deficiency, 256000 (3)	
SDC3	186357	SDC3, SYND3, SDCN {Obesity, association with}, 601665 (3)	
CD247	186780	CD247, CD3Z, TCRZ Immunodeficiency due to defect in CD3-zeta, 610163 (3)	
CD3D	186790	CD3D, T3D Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)	
CD81	186845	CD81, TAPA1, CVID6 Immunodeficiency, common variable, 6, 613496 (3)	
TAL2	186855	TAL2 Leukemia-2, T-cell acute lymphoblastic (3)	
TCL4	186860	TCL4 Leukemia/lymphoma, T-cell (2)	
TRA@	186880	TCRA Leukemia/lymphoma, T-cell (3)	
CD8A	186910	CD8A CD8 deficiency, familial, 608957 (3)	
LMO1	186921	LMO1, RBTN1, RHOM1 Leukemia, T-cell acute lymphoblastic (2)	
CD4	186940	CD4 OKT4 epitope deficiency, 613949 (3)	
TCL1A	186960	TCL1A, TCL1 Leukemia/lymphoma, T-cell (2)	
ITK	186973	ITK, EMT Lymphoproliferative syndrome, EBV-associated, autosomal, 1, 613011 (3)	
CCL5	187011	CCL5, SCYA5, D17S136E, TCP228 {HIV-1 disease, delayed progression of} (3); {HIV-1 disease, rapid progression of} (3)	
TAL1	187040	TAL1, TCL5, SCL Leukemia-1, T-cell acute lymphocytic (3)	
TPMT	187680	TPMT 6-mercaptopurine sensitivity, 610460 (3)	
THBD	188040	THBD, THRM, AHUS6, THPH12 Thrombophilia due to thrombomodulin defect, 614486 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)	
THBS2	188061	THBS2 {Lumbar disc herniation, susceptibility to}, 603932 (3)	
TBXA2R	188070	TBXA2R, BDPLT13 {Bleeding disorder, platelet-type, 13, susceptibility to}, 614009 (3)	
TK2	188250	TK2, MTDPS2 Mitochondrial DNA depletion syndrome 2 (myopathic type), 609560 (3)	
TMPO	188380	TMPO, LAP2, CMD1T Cardiomyopathy, dilated, 1T, 613740 (3)	
TG	188450	TG, AITD3, TDH3 Thyroid dyshormonogenesis 3, 274700 (3); {Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)	
TSHB	188540	TSHB, CHNG4 Hypothryoidism, congenital, nongoitrous 4, 275100 (3)	
TIMP3	188826	TIMP3, SFD Sorsby fundus dystrophy, 136900 (3)	
PRKAR1A	188830	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1 Carney complex, type 1, 160980 (3); Myxoma, intracardiac, 255960 (3); Thyroid carcinoma, papillary, somatic, 188550 (3); Pigmented nodular adrenocortical disease, primary, 1, 610489 (3); Adrenocortical tumor, somatic, (3); Acrodysostosis 1, with or without hormone resistance, 101800 (3)	
TTN	188840	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC Cardiomyopathy, familial hypertrophic, 9, 613765 (3); Cardiomyopathy, dilated, 1G, 604145 (3); Tibial muscular dystrophy, tardive, 600334 (3); Muscular dystrophy, limb-girdle, type 2J, 608807 (3); Myopathy, proximal, with early respiratory muscle involvement, 603689 (3); Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)	
HNF1B	189907	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11 Renal cysts and diabetes syndrome, 137920 (3); Diabetes mellitus, noninsulin-dependent, 125853 (3); {Renal cell carcinoma}, 144700 (3)	
ZEB1	189909	ZEB1, TCF8, NIL2A, PPCD3, FECD6 Corneal dystrophy, posterior polymorphous, 3, 609141 (3); Corneal dystrophy, Fuchs endothelial, 6, 613270 (3)	
TEAD1	189967	TEAD1, TCF13, REF1 Sveinsson choreoretinal atrophy, 108985 (3)	
ABL1	189980	ABL1 Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)	
MYB	189990	MYB {T-cell acute lymphoblastic leukemia} (3)	
TF	190000	TF, TFQTL1 Atransferrinemia, 209300 (3)	
HRAS	190020	HRAS {Bladder cancer, somatic}, 109800 (3); Costello syndrome, 218040 (3); {Thyroid carcinoma, follicular, somatic}, 188470 (3)	
PDGFB	190040	PDGFB, SIS Meningioma, SIS-related (3); Dermatofibrosarcoma protuberans (3); Giant-cell fibroblastoma (3)	
KRAS	190070	KRAS, KRAS2, RASK2, NS Lung cancer, 211980 (3); Bladder cancer, 109800 (3); Breast cancer, somatic, 114480 (3); Pancreatic carcinoma, somatic, 260350 (3); Gastric cancer, 137215 (3); Leukemia, acute myelogenous (3); Noonan syndrome 3, 609942 (3); Cardiofaciocutaneous syndrome, 115150 (3)	
MYC	190080	MYC Burkitt lymphoma, 113970 (3)	
SRC	190090	SRC, ASV, SRC1 Colon cancer, advanced (3)	
THRA	190120	THRA, ERBA1, THRA1, CHNG6 Hypothyroidism, congenital, nongoitrous, 6, 614450 (3)	
ERBB3	190151	ERBB3, LCCS2 Lethal congenital contractural syndrome 2, 607598 (3)	
THRB	190160	THRB, ERBA2, THR1, PRTH Thyroid hormone resistance, 188570 (3); Thyroid hormone resistance, autosomal recessive, 274300 (3); Thyroid hormone resistance, selective pituitary, 145650 (3)	
TGFB1	190180	TGFB1, DPD1, CED Camurati-Engelmann disease, 131300 (3); {Cystic fibrosis lung disease, modifier of}, 219700 (3)	
TGFBR1	190181	TGFBR1, ALK5, AAT5, LDS2A, LDS1A, MSSE Loeys-Dietz syndrome, type 1A, 609192 (3); Loeys-Dietz syndrome, type 2A, 608967 (3); {Multiple self-healing squamous epithelioma, susceptiblity to}, 132800 (3)	
TGFBR2	190182	TGFBR2, HNPCC6, AAT3, MFS2, LDS1B, LDS2B Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3); Esophageal cancer, somatic, 133239 (3); Loeys-Dietz syndrome, type 1B, 610168 (3); Loeys-Dietz syndrome, type 2B, 610380 (3)	
TGM1	190195	TGM1, ICR2, LI1 Ichthyosis, lamellar, autosomal recessive, 242300 (3); Ichthyosiform erythroderma, congenital, 242100 (3); Self-healing collodion baby, 242300 (3)	
NOTCH1	190198	NOTCH1, TAN1 Aortic valve disease, 109730 (3); Leukemia, T-cell acute lymphoblastic (2)	
TGFB3	190230	TGFB3 Arrhythmogenic right ventricular dysplasia 1, 107970 (3)	
TPM2	190990	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4 Arthrogryposis multiplex congenita, distal, type 1, 108120 (3); Nemaline myopathy, 609285 (3); Arthrogryposis, distal, type 2B, 601680 (3)	
TPM1	191010	TPM1, CMH3, CMD1Y Cardiomyopathy, familial hypertrophic, 3, 115196 (3); Cardiomyopathy, dilated, 1Y, 611878 (3)	
TPM3	191030	TPM3, NEM1, CFTD Nemaline myopathy 1, autosomal dominant, 609284 (3); Myopathy, congenital, with fiber-type disproportion, 255310 (3); CAP myopathy, 609284 (3)	
TNNC1	191040	TNNC1, CMD1Z, CMH13 Cardiomyopathy, dilated, 1Z, 611879 (3); Cardiomyopathy, familial hypertrophic, 13, 613243 (3)	
TNNT1	191041	TNNT1, ANM Nemaline myopathy, Amish type, 605355 (3)	
TNNI2	191043	TNNI2, AMCD2B, DA2B, FSSV Arthrogryposis multiplex congenita, distal, type 2B, 601680 (3)	
TNNI3	191044	TNNI3, CMH7, CMD2A, RCM1, CMD1FF Cardiomyopathy, familial hypertrophic, 7, 613690 (3); Cardiomyopathy, familial restrictive, 115210 (3); Cardiomyopathy, dilated, 2A, 611880 (3); Cardiomyopathy, dilated, 1FF, 613286 (3)	
TNNT2	191045	TNNT2, CMH2, CMD1D, RCM3, LVNC6 Cardiomyopathy, familial hypertrophic, 2, 115195 (3); Cardiomyopathy, dilated, 1D, 601494 (3); Cardiomyopathy, familial restrictive, 3, 612422 (3); Left ventricular noncompaction 6, 601494 (3)	
TSC2	191092	TSC2, LAM Tuberous sclerosis-2, 191100 (3); Lymphangioleiomyomatosis, somatic, 606690 (3)	
TNF	191160	TNF, TNFA {Malaria, cerebral, susceptibility to}, 611162 (3); {Septic shock, susceptibility to} (3); {Asthma, susceptibility to}, 600807 (3); {Dementia, vascular, susceptibility to} (3); {Migraine without aura, susceptibility to}, 157300 (3)	
TP53	191170	TP53, P53, LFS1 Colorectal cancer, 114500 (3); Li-Fraumeni syndrome, 151623 (3); Hepatocellular carcinoma, 114550 (3); Osteosarcoma, 259500 (3); Choroid plexus papilloma, 260500 (3); Nasopharyngeal carcinoma, 607107 (3); Pancreatic cancer, 260350 (3); Adrenal cortical carcinoma, 202300 (3); Breast cancer, 114480 (3); Li-Fraumeni-like syndrome, 151623 (3)	
TNFRSF1A	191190	TNFRSF1A, TNFR1, TNFAR, FPF Periodic fever, familial, 142680 (3)	
MAP3K8	191195	MAP3K8, COT, EST, TPL2 Lung cancer, somatic, 211980 (3)	
TH	191290	TH, TYH Segawa syndrome, recessive, 605407 (3)	
BLK	191305	BLK, MODY11 Maturity-onset diabetes of the young, type 11, 613375 (3)	
KDR	191306	KDR Hemangioma, capillary infantile, somatic, 602089 (3); {Hemangioma, capillary infantile, susceptibility to}, 602089 (3)	
DDR2	191311	DDR2, NTRKR3, TKT Spondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3)	
NTRK1	191315	NTRK1, TRKA, MTC Insensitivity to pain, congenital, with anhidrosis, 256800 (3); Medullary thyroid carcinoma, familial, 155240 (3)	
UQCRB	191330	UQCRB, UQBP, QPC Mitochondrial complex III deficiency, 124000 (3)	
UBB	191339	UBB Cleft palate, isolated, 119540 (2)	
UCHL1	191342	UCHL1, PARK5 {Parkinson disease 5, susceptibility to}, 613643 (3)	
DPAGT1	191350	DPAGT2, DGPT, CDG1J Congenital disorder of glycosylation, type Ij, 608093 (3)	
USF1	191523	USF1, HYPLIP1 {Hyperlipidemia, familial combined, susceptibility to}, 602491 (3)	
UNG	191525	UNG, DGU, HIGM5 Immunodeficiency with hyper IgM, type 5, 608106 (3)	
UGT1A1	191740	UGT1A1, UGT1, GNT1, BILIQTL1 Crigler-Najjar syndrome, type I, 218800 (3); [Gilbert syndrome], 143500 (3); Crigler-Najjar syndrome, type II, 606785 (3); Hyperbilirubinemia, familial transcient neonatal, 237900 (3); [Bilirubin, serum level of, QTL1], 601816 (3)	
PLAU	191840	PLAU, URK, QPD, BDPLT5 {Alzheimer disease, late-onset, susceptibility to}, 104300 (3); Quebec platelet disorder, 601709 (3)	
UMOD	191845	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2 Hyperuricemic nephropathy, familial juvenile 1, 162000 (3); Medullary cystic kidney disease 2, 603860 (3); Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 (3)	
SCGB1A1	192020	SCGB1A1, UGB, CC10, CCSP, SCGB1A1 {Asthma, susceptibility to}, 600807 (3)	
CDH1	192090	CDH1, UVO, LCAM, ECAD Endometrial carcinoma, somatic, 608089 (3); Ovarian carcinoma, somatic, 167000 (3); {Breast cancer, lobular}, 114480 (3); Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3); {Prostate cancer, susceptibility to}, 176807 (3)	
ATP6V1B1	192132	ATP6B1, VPP3 Renal tubular acidosis with deafness, 267300 (3)	
AVP	192340	AVP, AVRP, VP Diabetes insipidus, neurohypophyseal, 125700 (3)	
ITGA2	192974	ITGA2, CD49B, BR, BDPLT9 ?Glycoprotein Ia deficiency, 614200 (1)	
VLDLR	192977	VLDLR, CARMQ1 Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1, 224050 (3)	
VIL1	193040	VIL1 Cholestasis, progressive canalicular (1)	
VCL	193065	VCL, CMD1W, CMH15 Cardiomyopathy, dilated, 1W, 611407 (3); Cardiomyopathy, familial hypertrophic, 15, 613255 (3)	
XBP1	194355	XBP1, XBP2 {Major affective disorder-7, susceptibility to}, 612371 (3)	
ACACA	200350	ACACA, ACAC, ACC1, ACACAD Acetyl-CoA carboxylase deficiency, 613933 (1)	
BBS1	209901	BBS1 Bardet-Biedl syndrome 1, 209900 (3)	
CFI	217030	CFI, FI, AHUS3 Complement factor I deficiency, 610984 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 3}, 612923 (3)	
C6	217050	C6 C6 deficiency, 612446 (3); Combined C6/C7 deficiency (3)	
C7	217070	C7 C7 deficiency, 610102 (3)	
KLKB1	229000	KLKB1, KLK3 Fletcher factor deficiency, 612423 (3)	
ETFDH	231675	ETFDH, MADD Glutaric acidemia IIC, 231680 (3)	
PCCA	232000	PCCA Propionicacidemia, 606054 (3)	
PCCB	232050	PCCB Propionicacidemia, 606054 (3)	
GLDC	238300	GLDC, HYGN1, GCSP, GCE, NKH Glycine encephalopathy, 605899 (3)	
AMT	238310	AMT, NKH, GCE Glycine encephalopathy, 605899 (3)	
GCSH	238330	GCSH, NKH Glycine encephalopathy, 605899 (3)	
DLD	238331	DLD, LAD, PHE3 Maple syrup urine disease, type III, 248600 (3); Leigh syndrome, 256000 (3)	
INVS	243305	INVS, INV, NPHP2, NPH2 Nephronophthisis 2, infantile, 602088 (3)	
LTC4S	246530	LTC4S Leukotriene C4 synthase deficiency, 614037 (1)	
PNLIP	246600	PNLIP, PNLIPD Pancreatic lipase deficiency, 614338 (1)	
DBT	248610	DBT, BCATE2 Maple syrup urine disease, type II, 248600 (3)	
BCKDHB	248611	BCKDHB, E1B Maple syrup urine disease, type Ib, 248600 (3)	
MVK	251170	MVK, MVLK Mevalonic aciduria, 610377 (3); Hyper-IgD syndrome, 260920 (3)	
IDUA	252800	IDUA, IDA Mucopolysaccharidosis Ih, 607014 (3); Mucopolysaccharidosis Is, 607016 (3); Mucopolysaccharidosis Ih/s, 607015 (3)	
F11	264900	F11 Factor XI deficiency, autosomal recessive, 612416 (3); Factor XI deficiency, autosomal dominant, 612416 (3)	
TBXAS1	274180	TBXAS1, GHOSAL, CYP5, BDPLT14 Ghosal hematodiaphyseal syndrome, 231095 (3); ?Thromboxane synthase deficiency, 614158 (1)	
TREH	275360	TREH Trehalase deficiency, 612119 (1)	
PRSS1	276000	PRSS1, TRY1 Pancreatitis, hereditary, 167800 (3); Trypsinogen deficiency, 614044 (1)	
MYO7A	276903	MYO7A, USH1B, DFNB2, DFNA11 Usher syndrome, type 1B, 276900 (3); Deafness, autosomal recessive 2, 600060 (3); Deafness, autosomal dominant 11, 601317 (3)	
MECP2	300005	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16 Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic 13, 300055 (3); Rett syndrome, preserved speech variant, 312750 (3); Encephalopathy, neonatal severe, 300673 (3); {Autism susceptibility, X-linked 3}, 300496 (3); Angelman syndrome, 105830 (3); Mental retardation, X-linked syndromic, Lubs type, 300260 (3)	
CLCN5	300008	CLCN5, CLCK2, NPHL2, DENTS, NPHL1 Dent disease, 300009 (3); Nephrolithiasis, type I, 310468 (3); Hypophosphatemic rickets, 300554 (3); Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)	
ATP7A	300011	ATP7A, MNK, MK, OHS, SMAX3 Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3); Spinal muscular atrophy, distal, X-linked 3, 300489 (3)	
NAA10	300013	NAA10, ARD1A, ARD1, TE2, NATD N-terminal acetyltransferase deficiency, 300855 (3)	
FLNA	300017	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1 Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome, type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3); Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, 300244 (3)	
ATRX	300032	ATRX, XH2, XNP, SHS, SFM1, MRXHF1 Alpha-thalassemia/mental retardation syndrome, 301040 (3); Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3); Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)	
AGTR2	300034	AGTR2, MRX88 Mental retardation, X-linked 88, 300852 (3)	
EFNB1	300035	EFNB1, EPLG2, CFNS, CFND Craniofrontonasal dysplasia, 304110 (3)	
SLC6A8	300036	SLC6A8, CRTR Creatine deficiency syndrome, X-linked, 300352 (3)	
GPC3	300037	GPC3, SDYS, SGBS1 Simpson-Golabi-Behmel syndrome, type 1, 312870 (3); Wilms tumor, somatic, 194070 (3)	
POU3F4	300039	POU3F4, DFN3, DFNX2 Deafness, X-linked 2, 304400 (3)	
SMC1A	300040	DXS423E, SMC1, CDLS2 Cornelia de Lange syndrome 2, 300590 (3)	
HCCS	300056	HCCS, MCOPS7 Microphthalmia, syndromic 7, 309801 (3)	
RPS6KA3	300075	RPS6KA3, RSK2, MRX19 Coffin-Lowry syndrome, 303600 (3); Mental retardation, X-linked 19, 300844 (3)	
NDUFA1	300078	NDUFA1, MWFE Mitochondrial complex I deficiency, 252010 (3)	
XIAP	300079	XIAP, BIRC4, API3, XLP2 Lymphoproliferative syndrome, X-linked, 2, 300635 (3)	
RBM10	300080	RBM10, DXS8237E, KIAA0122, TARPS TARP syndrome, 311900 (3)	
SLC16A2	300095	SLC16A2, DXS128, XPCT Allan-Herndon-Dudley syndrome, 300523 (3)	
TSPAN7	300096	TSPAN7, TM4SF2, MXS1, A15, MRX58 Mental retardation, X-linked 58, 300210 (3)	
GDI1	300104	GDI1, RABGD1A, MRX41, MRX48 Mental retardation, X-linked 41, 300849 (3)	
SMS	300105	SMS, SRS, MRSR Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)	
DIAPH2	300108	DIAPH2, DIA, POF2 Premature ovarian failure, 300511 (3)	
CACNA1F	300110	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2 Night blindness, congenital stationary, X-linked, type 2A, 300071 (3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)	
MAMLD1	300120	MAMLD1, CXorf6, F18, HYSP2 Hypospadias 2, X-linked, 300758 (3)	
DCX	300121	DCX, DBCN, LISX Lissencephaly, X-linked, 300067 (3); Subcortical laminal heteropia, X-linked, 300067 (3)	
DKC1	300126	DKC1, DKCX Dyskeratosis congenita, X-linked, 305000 (3); Hoyeraal-Hreidarsson syndrome, 300240 (3)	
OPHN1	300127	OPHN1, MRX60 Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance, 300486 (3)	
KDM6A	300128	KDM6A, UTX, KABUK2 Kabuki syndrome 2, 300867 (3)	
ABCB7	300135	ABCB7, ABC7, ASAT Anemia, sideroblastic, with ataxia, 301310 (3)	
IGBP1	300139	IGBP1 Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia, 300472 (3)	
PAK3	300142	PAK3, MRX30, MRX47 Mental retardation, X-linked 30/47, 300558 (3)	
ACSL4	300157	ACSL4, FACL4, ACS4, MRX63 Mental retardation, X-linked 63, 300387 (3)	
FHL1	300163	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B Scapuloperoneal myopathy, X-linked dominant, 300695 (3); Myopathy, X-linked, with postural muscle atrophy, 300696 (3); Myopathy, reducing body, X-linked, severe early-onset, 300717 (3); Myopathy, reducing body, X-linked, childhood-onset, 300718 (3); Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)	
AIFM1	300169	AIFM1, PDCD8, AIF, COXPD6 Combined oxidative phosphorylation deficiency 6, 300816 (3)	
OFD1	300170	OFD1, CXorf5, SGBS2, JBTS10 Oral-facial-digital syndrome 1, 311200 (3); Simpson-Golabi-Behmel syndrome, type 2, 300209 (3); Joubert syndrome 10, 300804 (3)	
CASK	300172	CASK, MICPCH, FGS4, CMG, MRXSNA Mental retardation and microcephaly with pontine and cerebellar hypoplasia, 300749 (3); FG syndrome 4, 300422 (3); Mental retardation, with or without nystagmus, 300422 (3)	
ARSE	300180	ARSE, CDPX1, CDPXR Chondrodysplasia punctata, X-linked recessive, 302950 (3)	
MED12	300188	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1 Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)	
DLG3	300189	DLG3, NEDLG, SAP102, MRX90 Mental retardation, X-linked 90, 300850 (3)	
SSX2	300192	SSX2 Sarcoma, synovial (3)	
TRAPPC2	300202	TRAPPC2, SEDL, SEDT Spondyloepiphyseal dysplasia tarda, 313400 (3)	
CDKL5	300203	CDKL5, STK9, ISSX, EIEE2 Epileptic encephalopathy, early infantile, 2, 300672 (3); Angelman syndrome-like, 105830 (3)	
EBP	300205	EBP, CDPX2, CPXD, CPX Chondrodysplasia punctata, X-linked dominant, 302960 (3)	
IL1RAPL1	300206	IL1RAPL1, IL1R8, MRX21, MRX34 Mental retardation, X-linked 21/34, 300143 (3)	
SMPX	300226	SMPX, DFNX4 Deafness, X-linked 4, 300066 (3)	
SLC9A6	300231	SLC9A6, NHE6 Mental retardation, X-linked syndromic, Christianson type, 300243 (3)	
BMP15	300247	BMP15, GDF9B, ODG2, POF4 Ovarian dysgenesis 2, 300510 (3); Premature ovarian failure 4, 300510 (3)	
IKBKG	300248	IKBKG, NEMO, FIP3, IP2, IPD2, AMCBX1 Incontinentia pigmenti, type II, 308300 (3); Ectodermal dysplasia, hypohidrotic, with immune deficiency, 300291 (3); Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3); Immunodeficiency, isolated, 300584 (3); {Atypical mycobacteriosis, familial}, 300636 (3); Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)	
HSD17B10	300256	HSD17B10, HADH2, ERAB, MRXS10, MRX17, MRX31, DUPXp11.22 17-beta-hydroxysteroid dehydrogenase X deficiency, 300438 (3); Mental retardation, X-linked syndromic 10, 300220 (3); Mental retardation, X-linked 17/31, microduplication, 300705 (3)	
UBQLN2	300264	UBQLN2, PLIC2, CHAP1, ALS15 Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia, 300857 (3)	
ZIC3	300265	ZIC3, HTX1, HTX, VACTERLX Heterotaxy, visceral, 1, X-linked 306955 (3); Congenital heart defects, nonsyndromic, 1, X-linked, 306955 (3); VACTERL association, X-linked, 314390 (3)	
ARHGEF6	300267	ARHGEF6, MRX46, COOL2 Mental retardation, X-linked 46, 300436 (3)	
NSDHL	300275	NSDHL CHILD syndrome, 308050 (3); CK syndrome, 300831 (3)	
NYX	300278	NYX, CSNB1A, NBM1 Night blindness, congenital stationary, type 1A, 310500 (3)	
FOXP3	300292	FOXP3, IPEX, AIID, XPID, PIDX Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked, 304790 (3); {Diabetes mellitus, type I, susceptibility to}, 222100 (3)	
MBTPS2	300294	MBTPS2, S2P, IFAP, KFSDX IFAP syndrome with or without BRESHECK syndrome, 308205 (3); Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)	
UPF3B	300298	UPF3B, RENT3B, MRXS14 Mental retardation, X-linked, syndromic 14, 300676 (3)	
BTK	300300	BTK, AGMX1, IMD1, XLA, AT Agammaglobulinemia, X-linked 1, 300755 (3); Agammaglobulinemia and isolated hormone deficiency, 307200 (3)	
CUL4B	300304	CUL4B, MRXSC, MRXHF2, SFM2, MRXS15 Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3)	
TBX22	300307	TBX22, CPX Cleft palate with ankyloglossia, 303400 (3)	
SSX4	300326	SSX4 Sarcoma, synovial (1)	
NLGN3	300336	NLGN3, ASPGX1, AUTSX1 {Autism susceptibility, X-linked 1}, 300425 (3); {Asperger syndrome susceptibility, X-linked 1}, 300494 (3)	
CHRDL1	300350	CHRDL1, VOPT, MGC1 Megalocornea 1, X-linked 309300 (3)	
TIMM8A	300356	TIMM8A, DFN1, DDP, MTS, DDP1 Deafness, X-linked 1, progressive (3); Mohr-Tranebjaerg syndrome, 304700 (3); Jensen syndrome, 311150 (3)	
ABCD1	300371	ABCD1, ALD, AMN Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)	
DMD	300377	DMD, BMD, CMD3B Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy, 300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)	
ARX	300382	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32 Epileptic encephalopathy, early infantile, 1, 308350 (3); Lissencephaly, X-linked 2, 300215 (3); Mental retardation, X-linked 29 and others, 300419 (3); Proud syndrome, 300004 (3); Partington syndrome, 309510 (3); Hydranencephaly with abnormal genitalia, 300215 (3)	
CFP	300383	PFC, PFD Properdin deficiency, X-linked, 312060 (3)	
EMD	300384	EMD, EDMD, STA Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3)	
CD40LG	300386	TNFSF5, CD40LG, HIGM1, IGM Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)	
CHM	300390	CHM, TCD Choroideremia, 303100 (3)	
AMELX	300391	AMELX, AMG, AIH1, AMGX, AI1E Amelogenesis imperfecta, hypoplastic/hypomaturation type 1E, 301200 (3)	
WAS	300392	WAS, IMD2, THC1, SCNX Wiskott-Aldrich syndrome, 301000 (3); Thrombocytopenia, X-linked, 313900 (3); Neutropenia, severe congenital, X-linked, 300299 (3); Thrombocytopenia, X-linked, intermittent, 313900 (3)	
TAZ	300394	TAZ, EFE2, BTHS, CMD3A, LVNCX Barth syndrome, 302060 (3); Cardiomyopathy, dilated, 3A, 300069 (3); Left ventricular noncompaction, X-linked, 300183 (3)	
PLP1	300401	PLP1, PMD, HLD1 Pelizaeus-Merzbacher disease, 312080 (3); Spastic paraplegia-2, 312920 (3)	
RAB40AL	300405	RAB40AL, RLGP Mental retardation, profound (2)	
PHF6	300414	PHF6, BFLS Borjeson-Forssman-Lehmann syndrome, 301900 (3)	
MTM1	300415	MTM1, MTMX Myotubular myopathy, X-linked, 310400 (3)	
NLGN4X	300427	NLGN4, KIAA1260, AUTSX2, ASPGX2 {Autism susceptibility, X-linked 2}, 300495 (3); {Asperger syndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)	
ARHGEF9	300429	ARHGEF9, PEM2, KIAA0424, EIEE8 Epileptic encephalopathy, early infantile, 8, 300607 (3)	
SLC6A14	300444	SLC6A14, OBX, BMIQ11 {Obesity, susceptibility to, BMIQ11}, 300306 (3)	
EDA	300451	ED1, EDA, HED, STHAGX1 Ectodermal dysplasia, anhidrotic, X-linked, 305100 (3); Tooth agenesis, selective, X-linked 1, 313500 (3)	
NHS	300457	NHS, CXN Nance-Horan syndrome, 302350 (3); Cataract, congenital, X-linked, 302200 (3)	
PCDH19	300460	PCDH19, KIAA1313, EFMR, EIEE9 Epileptic encephalopathy, early infantile, 9, 300088 (3)	
OTC	300461	OTC Ornithine transcarbamylase deficiency, 311250 (3)	
PQBP1	300463	PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8 Renpenning syndrome, 309500 (3)	
NR0B1	300473	DAX1, AHC, AHX, NROB1, SRXY2 Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism, 300200 (3); 46XY sex reversal 2, dosage-sensitive, 300018 (3)	
GK	300474	GK Glycerol kinase deficiency, 307030 (3)	
CYBB	300481	CYBB, CGD, AMCBX2 Chronic granulomatous disease, X-linked, 306400 (3); Atypical mycobacteriosis, familial, X-linked 2, 300645 (3)	
BCOR	300485	BCOR, KIAA1575, MCOPS2, MAA2, ANOP2 Microphthalmia, syndromic 2, 300166 (3)	
SH2D1A	300490	SH2D1A, LYP, IMD5, XLP, XLPD Lymphoproliferative syndrome, X-linked, 308240 (3)	
FTSJ1	300499	FTSJ1, JM23, SPB1, MRX44, MRX9 Mental retardation, X-linked 9, 309549 (3)	
PDHA1	300502	PDHA1, PHE1A Pyruvate dehydrogenase E1-alpha deficiency, 312170 (3); Leigh syndrome, X-linked, 308930 (3)	
FANCB	300515	FAAP95, FAAP90, FLJ34064, FANCB Fanconi anemia, complementation group B, 300514 (3)	
IQSEC2	300522	IQSEC2, KIAA0522, MRX1 Mental retardation, X-linked 1, 309530 (3)	
KIAA2022	300524	KIAA2022 ?Mental retardation, nonsyndromic, X-linked (2)	
OCRL	300535	OCRL, LOCR, OCRL1, NPHL2 Lowe syndrome, 309000 (3); Dent disease 2, 300555 (3)	
AVPR2	300538	AVPR2, DIR, DI1, ADHR Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndrome of inappropriate antidiuresis, 300539 (3)	
FGD1	300546	FGD1, FGDY, AAS, MRXS16 Aarskog-Scott syndrome, 305400 (3); Mental retardation, X-linked syndromic 16, 305400 (3)	
PHEX	300550	PHEX, HYP, HPDR1, LXHR Hypophosphatemic rickets, X-linked dominant, 307800 (3)	
MID1	300552	MID1, OGS1, BBBG1, FXY, OSX Opitz GBBB syndrome, type I, 300000 (3)	
BRWD3	300553	BRWD3, MRX93 Mental retardation, X-linked 93, 300659 (3)	
ATP6AP2	300556	ATP6AP2, ATP6M8-9, XMRE, MRXE Mental retardation, X-linked, with epilepsy, 300423 (3)	
PHF8	300560	PHF8, ZNF422, KIAA1111, MRXSSD Mental retardation syndrome, X-linked, Siderius type, 300263 (3)	
ZNF674	300573	ZNF674, MRX92 Mental retardation, X-linked 92, 300851 (3)	
ZDHHC15	300576	ZDHHC15, MRX91 Mental retardation, X-linked 91, 300577 (3)	
SHROOM4	300579	SHROOM4, KIAA1202, SDSX Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)	
POF1B	300603	FLJ22792, POF1B, POF2B Premature ovarian failure 2B, 300604 (3)	
C1GALT1C1	300611	C1GALT1C1, COSMC, C1GALT2 Tn syndrome, 300622 (3)	
FRMD7	300628	FRMD7, NYS1, XIPAN Nystagmus 1, congenital, X-linked, 310700 (3); Nystagmus, infantile periodic alternating, X-linked, 310700 (3)	
AP1S2	300629	AP1S2, MRX59, MRXSF, MRXS21 Mental retardation, X-linked syndromic, Fried type, 300630 (3)	
SRPX2	300642	SRPX2, SRPUL, RESDX Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643 (3)	
GLA	300644	GLA Fabry disease, 301500 (3); Fabry disease, cardiac variant, 301500 (3)	
ZDHHC9	300646	ZDHHC9, DHHC9, MRXSZ Mental retardation, X-linked syndromic, Raymond type, 300799 (3)	
FAM123B	300647	FAM123B, WTX, FLJ39827, OSCS Osteopathia striata with cranial sclerosis, 300373 (3)	
PORCN	300651	PORCN, PORC, DHOF, FODH Focal dermal hypoplasia, 305600 (3)	
NDP	300658	NDP, ND Norrie disease, 310600 (3); Exudative vitreoretinopathy, X-linked, 305390 (3)	
HUWE1	300697	HUWE1, UREB1, KIAA0312, LASU1 Mental retardation, X-linked syndromic, Turner type, 300706 (3)	
FAM58A	300708	FAM58A, STAR STAR syndrome, 300707 (3)	
MAGT1	300715	MAGT1, IAP, XMEN Mental retardation, X-linked 95, 300716 (3); Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, 300853 (3)	
F9	300746	F9, HEMB, THPH8 Hemophilia B, 306900 (3); {Warfarin sensitivity}, 122700 (3); Thrombophilia, X-linked, due to factor IX defect, 300807 (3); {Deep venous thrombosis, protection against}, 300807 (3)	
STS	300747	STS, ARSC1, ARSC, SSDD, XLI Ichthyosis, X-linked, 308100 (3)	
RP2	300757	RP2 Retinitis pigmentosa 2, 312600 (3)	
RAB39B	300774	RAB39B, MRX72 Mental retardation, X-linked 72, 300271 (3)	
PHKA2	300798	PHKA2, PHK, XLG, PHK, PYKL, GSD9A Glycogen storage disease, type IXa1, 306000 (3); Glycogen storage disease, type IXa2, 306000 (3)	
AFF2	300806	AFF2, FMR2, FRAXE, MRX2 Mental retardation, X-linked, FRAXE type, 309548 (3)	
GPR143	300808	GPR143, OA1, NYS6 Ocular albinism, type I, Nettleship-Falls type, 300500 (3); Nystagmus 6, congenital, X-linked, 300814 (3)	
OPN1MW	300821	OPN1MW, GCP, CBD, CBBM Colorblindness, deutan, 303800 (3); Blue cone monochromacy, 303700 (3)	
OPN1LW	300822	OPN1LW, RCP, CBP, CBBM Colorblindness, protan, 303900 (3); Blue cone monochromacy, 303700 (3)	
IDS	300823	IDS, MPS2, SIDS Mucopolysaccharidosis II, 309900 (3)	
KAL1	300836	KAL1, KMS, ADMLX Kallmann syndrome, 308700 (3)	
RS1	300839	RS1, XLRS1 Retinoschisis, 312700 (3)	
F8	300841	F8, F8C, HEMA Hemophilia A, 306700 (3)	
ALAS2	301300	ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1 Anemia, sideroblastic, X-linked, 300751 (3); Protoporphyria, erythropoietic, X-linked, 300752 (3)	
COL4A5	303630	COL4A5, ATS, ASLN Alport syndrome, 301050 (3)	
COL4A6	303631	COL4A6, DELXq22.3, CXDELq22.3 Leiomyomatosis, diffuse, with Alport syndrome, 308940 (4)	
GJB1	304040	GJB1, CX32, CMTX1 Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3)	
GATA1	305371	GATA1, GF1, ERYF1, NFE1, XLTT Dyserythropoietic anemia with thrombocytopenia, 300367 (3); Macrothrombocytopenia, 300367 (3); Leukemia, megakaryoblastic, with or without Down syndrome, 190685 (3); Leukemia, megakaryoblastic, of Down syndrome, 190685 (3); Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3); Anemia, X-linked, without thrombocytopenia, 300835 (3)	
GRIA3	305915	GRIA3, GLUR3, MRX94 Mental retardation, X-linked 94, 300699 (3)	
CSF2RA	306250	CSF2RA, SMDP4 Surfactant metabolism dysfunction, pulmonary, 4, 300770 (3)	
HPRT1	308000	HPRT1, HPRT Lesch-Nyhan syndrome, 300322 (3); HPRT-related gout, 300323 (3)	
IL2RG	308380	IL2RG, SCIDX1, SCIDX, IMD4 Severe combined immunodeficiency, X-linked, 300400 (3); Combined immunodeficiency, X-linked, moderate, 312863 (3)	
L1CAM	308840	L1CAM, CAML1, HSAS1 Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome, 303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)	
LAMP2	309060	LAMP2, LAMPB, LGP110 Danon disease, 300257 (3)	
FMR1	309550	FMR1, FRAXA, POF1 Fragile X syndrome, 300624 (3); Fragile X tremor/ataxia syndrome, 300623 (3); Premature ovarian failure 1, 311360 (3)	
PIGA	311770	PIGA, MCAHS2 Paroxysmal nocturnal hemoglobinuria, somatic, 300818 (3); Multiple congenital anomalies-hypotonia-seizures syndrome 2, 300868 (3)	
PGK1	311800	PGK1, PGKA Phosphoglycerate kinase 1 deficiency, 300653 (3)	
PRPS1	311850	PRPS1, CMTX5, DFNX1, DFN2 Gout, PRPS-related, 300661 (3); Phosphoribosylpyrophosphate synthetase superactivity, 300661 (3); Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 (3); Arts syndrome, 301835 (3); Deafness, X-linked 1, 304500 (3)	
PHKA1	311870	PHKA1 Muscle glycogenosis, 300559 (3)	
POLA1	312040	POLA1 ?N syndrome, 310465 (1)	
RPL10	312173	RPL10, DXS648, QM, AUTSX5 {Autism, susceptibility to, X-linked 5}, 300847 (3)	
UBE2A	312180	UBE2A, RAD6A, MRXSN, MRXS30 Mental retardation, X-linked syndromic, Nascimento-type, 300860 (3)	
RPGR	312610	RPGR, RP3, CRD, RP15, COD1, CORDX1 Retinitis pigmentosa 3, 300029 (3); Cone-rod dystrophy-1, 304020 (3); Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3); Macular degeneration, X-linked atrophic, 300834 (3)	
SHOX	312865	SHOX, GCFX, SS, PHOG Short stature, idiopathic familial, 300582 (3); Leri-Weill dyschondrosteosis, 127300 (3); Langer mesomelic dysplasia, 249700 (3)	
SAT1	313020	SAT1, SSAT, KFSD, KFSDX Keratosis follicularis spinulosa decalvans, 308800 (3)	
SOX3	313430	SOX3, MRGH Mental retardation, X-linked, with isolated growth hormone deficiency, 300123 (3); Panhypopituitarism, X-linked, 312000 (3)	
SYN1	313440	SYN1 Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3)	
SYP	313475	SYP, MRXSYP Mental retardation, X-linked 96, 300802 (3)	
TAF1	313650	TAF1, TAF2A, CCG1, BA2R, DYT3 Dystonia-Parkinsonism, X-linked, 314250 (3)	
AR	313700	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1 Androgen insensitivity, 300068 (3); Spinal and bulbar muscular atrophy of Kennedy, 313200 (3); Androgen insensitivity, partial, with or without breast cancer, 312300 (3); {Prostate cancer, susceptibility to}, 176807 (3); Hypospadias 1, X-linked, 300633 (3)	
TFE3	314310	TFE3, RCCX1 Renal cell carcinoma, papillary, 1, 300854 (3)	
UBA1	314370	UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1 Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)	
XIST	314670	XIC, XCE, XIST, SXI1 X-inactivation, familial skewed, 300087 (3)	
KDM5C	314690	KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534 (3)	
XK	314850	XK, MCLDS McLeod syndrome with or without chronic granulomatous disease, 300842 (3)	
ZNF711	314990	ZNF711, ZNF6, CMPX1, MRX97 Mental retardation, X-linked 97, 300803 (3)	
ZNF41	314995	ZNF41, MRX89 Mental retardation, X-linked 89, 300848 (3)	
ZNF81	314998	ZNF81, MRX45 Mental retardation, X-linked 45, 300498 (3)	
DAZ1	400003	DAZ ?Sertoli-cell-only syndrome (1)	
USP9Y	400005	USP9Y, DFFRY, SPGFY2 Spermatogenic failure, Y-linked, 2, 415000 (3)	
SHOX	400020	SHOXY Short stature, idiopathic familial, 300582 (3); Leri-Weill dyschondrosteosis, 127300 (3); Langer mesomelic dysplasia, 249700 (3)	
SRY	480000	SRY, TDF, TDY, SRXX1, SRXY1 46XY sex reversal 1, 400044 (3); 46XX sex reversal 1, 400045 (3)	
CACNB2	600003	CACNB2 Brugada syndrome 4, 611876 (3)	
CIITA	600005	MHC2TA, C2TA Bare lymphocyte syndrome, type II, complementation group A, 209920 (3); {Rheumatoid arthritis, susceptibility to}, 180300 (3)	
NNMT	600008	NNMT Homocysteine plasma level (2)	
SMARCA2	600014	SMARCA2, SNF2L2, NCBRS Nicolaides-Baraitser syndrome, 601358 (3)	
CNTN1	600016	CNTN1 Myopathy, congenital, Compton-North, 612540 (3)	
MXI1	600020	MXI1 Neurofibrosarcoma (3); {Prostate cancer, susceptibility to}, 176807 (3)	
LBR	600024	LBR, PHA Pelger-Huet anomaly, 169400 (3); HEM skeletal dysplasia, 215140 (3); Reynolds syndrome, 613471 (3)	
DLX5	600028	DLX5, SHFM1D Split-hand/foot malformation 1 with sensorineural hearing loss, 220600 (3)	
CHIT1	600031	CHIT, CHITD [Chitotriosidase deficiency], 614122 (3)	
EMX2	600035	EMX2 Schizencephaly, 269160 (3)	
OTX2	600037	OTX2, MCOPS5, CPHD6 Microphthalmia, syndromic 5, 610125 (3); Pituitary hormone deficiency, combined, 6, 613986 (3); Retinal dystrophy, early-onset, and pituitary dysfunction, 610125 (3)	
BAX	600040	BAX Colorectal cancer (3); T-cell acute lymphoblastic leukemia (3)	
THPO	600044	THPO, MGDF, MPLLG, TPO, THCYT1 Thrombocythemia 1, 187950 (3)	
DDB1	600045	DDB1 Xeroderma pigmentosum, group E, subtype 2 (1)	
-	600049	MDS1 Myelodysplasia syndrome-1 (3)	
CNGA3	600053	CNGA3, CNG3, ACHM2 Achromatopsia-2, 216900 (3)	
ITGB2	600065	ITGB2, CD18, LCAMB, LAD Leukocyte adhesion deficiency, 116920 (3)	
LRP2	600073	LRP2, DBS Donnai-Barrow syndrome, 222448 (3)	
CD24	600074	CD24 {Multiple sclerosis, susceptibility to}, 126200 (3)	
TBP	600075	TBP, SCA17, HDL4 Spinocerebellar ataxia 17, 607136 (3); {Parkinson disease, susceptibility to}, 168600 (3)	
PTPN12	600079	PTPN12, PTPG1 Colon cancer (3)	
RRAS2	600098	RRAS2, TC21 Ovarian carcinoma (3)	
MMP13	600108	MMP13, CLG3, MANDP1 Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3); Metaphyseal anadysplasia 1, 602111 (3)	
SLC1A3	600111	SLC1A3, EAAT1, EA6 Episodic ataxia, type 6, 612656 (3)	
DYNC1H1	600112	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3); Mental retardation, autosomal dominant 13, 614563 (3); Spinal muscular atrophy, lower extremity, autosomal dominant, 158600 (3)	
SGCA	600119	SGCA, ADL, DAG2, LGMD2D, DMDA2 Muscular dystrophy, limb-girdle, type 2D, 608099 (3); Adhalinopathy, primary (1)	
PDE4D	600129	PDE4D, DPDE3, STRK1, ACRDYS2 {Stroke, susceptibility to, 1}, 606799 (3); Acrodysostosis 2, with or without hormone resistance, 614613 (3)	
CREBBP	600140	CREBBP, CBP, RSTS Rubinstein-Taybi syndrome, 180849 (3)	
KCNMA1	600150	KCNMA1, SLO Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)	
CDKN2A	600160	CDKN2A, MTS1, P16, MLM, CMM2 {Melanoma, cutaneous malignant, 2}, 155601 (3); Melanoma and neural system tumor syndrome, 155755 (3); Pancreatic cancer/melanoma syndrome, 606719 (3); Orolaryngeal cancer, multiple, (3)	
SCN5A	600163	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2 Long QT syndrome-3, 603830 (3); Brugada syndrome 1, 601144 (3); Heart block, progressive, type IA, 113900 (3); Heart block, nonprogressive, 113900 (3); Ventricular fibrillation, familial, 1, 603829 (3); Sick sinus syndrome 1, 608567 (3); Cardiomyopathy, dilated, 1E, 601154 (3); {Sudden infant death syndrome, susceptibility to}, 272120 (3); Atrial fibrillation, familial, 10, 614022 (3)	
AQP3	600170	AQP3 [Blood group GIL], 607457 (3)	
JAK3	600173	JAK3, JAKL SCID, autosomal recessive, T-negative/B-positive type, 600802 (3)	
GUCY2D	600179	GUCY2D, GUC2D, LCA1, CORD6, RCD2 Leber congenital amaurosis 1, 204000 (3); Cone-rod dystrophy 6, 601777(3)	
CRAT	600184	CRAT, CAT1 ?Carnitine acetyltransferase deficiency (1)	
BRCA2	600185	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2 {Breast-ovarian cancer, familial, 2}, 612555 (3); Fanconi anemia, complementation group D1, 605724 (3); Prostate cancer, 176807 (3); {Breast cancer, male, susceptibility to}, 114480 (3); Wilms tumor, 194070 (3); {Medulloblastoma}, 155255 (3); {Glioblastoma 3}, 613029 (3); {Pre-B-cell acute lymphoblastic leukemia}, (3); Pancreatic cancer, 613347 (3)	
SS18	600192	SS18, SSXT, SYT Sarcoma, synovial (1)	
KRT2	600194	KRT2, KRT2A, KRT2E Ichthyosis bullosa of Siemens, 146800 (3)	
ASIP	600201	ASIP, AGTIL, SHEP9 [Skin/hair/eye pigmentation 9, dark/light hair], 611742 (3); [Skin/hair/eye pigmentation 9, brown/nonbrown eyes], 611742 (3)	
RUNX2	600211	RUNX2, CBFA1, PEBP2A1, AML3 Cleidocranial dysplasia, 119600 (3); Dental anomalies, isolated (3)	
PLCG2	600220	PLCG2, FCAS3 Familial cold autoinflammatory syndrome 3, 614468 (3)	
TEK	600221	TEK, TIE2, VMCM Venous malformations, multiple cutaneous and mucosal, 600195 (3)	
GCH1	600225	GCH1, DYT5, HPABH4B Dystonia, DOPA-responsive, with or without hyperphenylalainemia, 128230 (3); Hyperpehnylalaninemia, BH4-deficient, B, 233910 (3)	
SCNN1A	600228	SCNN1A, BESC2 Pseudohypoaldosteronism, type I, 264350 (3); Bronchiectasis with or without elevated sweat chloride 2, 613021 (3)	
HMGCS2	600234	HMGCS2 HMG-CoA synthase-2 deficiency, 605911 (3)	
SCN1B	600235	SCN1B, GEFSP1 Generalized epilepsy with febrile seizures plus, type 1, 604233 (3); Brugada syndrome 5, 612838 (3); Cardiac conduction defect, nonspecific, 612838 (3)	
PDCD1	600244	PDCD1, SLEB2 {Systemic lupus erythematosus, susceptibility to, 2}, 605218 (3); {Multiple sclerosis, disease progression, modifier of}, 126200 (3)	
PMS2	600259	PMS2, PMSL2, HNPCC4 Mismatch repair cancer syndrome, 276300 (3); Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3)	
SLC11A1	600266	NRAMP1, NRAMP, SLC11A1 {Mycobacterium tuberculosis, susceptibility to infection by}, 607948 (3); {Buruli ulcer, susceptibility to}, 610446 (3)	
DSC3	600271	DSC3, DSC4 Hypotrichosis and recurrent skin vesicles, 613102 (3)	
NOTCH2	600275	NOTCH2, AGS2, HJCYS Alagille syndrome 2, 610205 (3); Hajdu-Cheney syndrome, 102500 (3)	
NOTCH3	600276	NOTCH3, CADASIL, CASIL Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)	
HNF4A	600281	HNF4A, TCF14, MODY1 MODY, type I, 125850 (3); {Diabetes mellitus, noninsulin-dependent}, 125853 (3)	
GARS	600287	GARS, SMAD1, CMT2D, HMN5 Charcot-Marie-Tooth disease, type 2D, 601472 (3); Neuropathy, distal hereditary motor, type V, 600794 (3)	
PCM1	600299	PCM1, PTC4 Thyroid carcinoma, papillary, 188550 (3)	
ACADSB	600301	ACADSB, SBCAD 2-methylbutyrylglycinuria, 610006 (3)	
COMP	600310	COMP, EDM1, MED, PSACH Pseudoachondroplasia, 177170 (3); Epiphyseal dysplasia, multiple 1, 132400 (3)	
RGR	600342	RGR, RP44 Retinitis pigmentosa 44, 613769 (3)	
SMN1	600354	SMN1, SMA1, SMA2, SMA3, SMA4 Spinal muscular atrophy-1, 253300 (3); Spinal muscular atrophy-2, 253550 (3); Spinal muscular atrophy-3, 253400 (3); Spinal muscular atrophy-4, 271150 (3)	
GMPS	600358	GMPS Leukemia, acute myelogenous, 601626 (3)	
KCNJ1	600359	KCNJ1, ROMK1 Bartter syndrome, type 2, 241200 (3)	
GUCA1A	600364	GUCA1A, GCAP, COD3, CORD14 Cone dystrophy-3, 602093 (3); Cone-rod dystrophy 14, 602093 (3)	
SLC25A3	600370	SLC25A3, PHC Micochondrial phosphate carrier deficiency, 610773 (3)	
BBS4	600374	BBS4 Bardet-Biedl syndrome 4, 209900 (3)	
PEX5	600414	PEX5, PXR1, PTS1R Adrenoleukodystrophy, neonatal, 202370 (3); Zellweger syndrome, 214100 (3)	
TTPA	600415	TTPA, TTP1, AVED Ataxia with isolated vitamin E deficiency, 277460 (3)	
ECE1	600423	ECE1 Hirschsprung disease, cardiac defects, and autonomic dysfunction, 613870 (3); {Hypertension, essential, susceptibility to}, 145500 (3)	
GCNT2	600429	GCNT2 [Blood group, Ii], 110800 (3); Adult i phenotype with congenital cataract, 110800 (3); Adult i phenotype without cataract, 110800 (3)	
AKR1C2	600450	AKR1C2, DDH2, DD2, HAKRD, SRXY8 Obesity, hyperphagia, and developmental delay (3); 46XY sex reversal 8, 614279 (3)	
AKR1C4	600451	AKR1C4, CHDR, CDR, HAKRA, DD4 {46XY sex reversal 8, modifier of}, 614279 (3)	
NTRK2	600456	NTRK2, TRKB Obesity, hyperphagia, and developmental delay, 613886 (3)	
SKIV2L	600478	SKIV2L, SKI2, SKI2W, THES2 Trichohepatoenteric syndrome 2, 614602 (3)	
FGF8	600483	FGF8, KAL6 Kallmann syndrome 6, 612702 (3)	
EIF4G1	600495	EIF4G1, EIF4G, PARK18 Parkinson disease 18, 614251 (3)	
IGHMBP2	600502	IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6 Neuronopathy, distal hereditary motor, type VI, 604320 (3)	
ABCC8	600509	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2 Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3); Hypoglycemia of infancy, leucine-sensitive, 240800 (3); Diabetes mellitus, transient neonatal 2, 610374 (3); Diabetes mellitus, noninsulin-dependent, 125853 (3); Diabetes mellitus, permanent neonatal, 606176 (3)	
RELN	600514	RELN, RL, LIS2 Lissencephaly 2 (Norman-Roberts type), 257320 (3)	
P2RY12	600515	P2RY12, P2Y12, BDPLT8 Bleeding disorder, platelet-type, 8, 609821 (3)	
MASP1	600521	MASP1, CRARF, 3MC1 3MC syndrome 1, 257920 (3)	
SLC11A2	600523	NRAMP2 Anemia, hypochromic microcytic, 206100 (3)	
DLX3	600525	DLX3, TDO, AI4 Trichodontoosseous syndrome, 190320 (3); Amelogenesis imperfecta, hypomaturation-hypoplastic type, with taurodontism, 104510 (3)	
CPT1A	600528	CPT1A CPT deficiency, hepatic, type IA, 255120 (3)	
AUH	600529	AUH 3-methylglutaconic aciduria, type I, 250950 (3)	
NDUFV2	600532	NDUFV2 Mitochondrial complex I deficiency, 252010 (3)	
ITGA7	600536	ITGA7 Muscular dystrophy, congenital, due to ITGA7 deficiency, 613204 (3)	
NR4A3	600542	CSMF Chondrosarcoma, extraskeletal myxoid, 612237 (3)	
STAT1	600555	STAT1, CANDF7 Mycobacterial infection, atypical, familial disseminated, 209950 (3); Mycobacterial and viral infections, susceptibility to, autosomal recessive, 613796 (3); Candidiasis, familial, 7, 614162 (3)	
ITIH4	600564	ITIH4, PK120, ITIHL1 {Hypercholesterolemia, susceptibility to}, 143890 (3)	
NRXN1	600565	NRXN1, PTHSL2, SCZD17 Pitt-Hopkins-like syndrome 2, 614325 (3); {Schizophrenia, susceptibility to, 17}, 614332 (3)	
CLCN2	600570	CLCN2, EGMA, ECA2, EGI11, EJM8 {Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3); {Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3); {Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3)	
GATA4	600576	GATA4, ASD2, VSD1 Atrial septal defect 2, 607941 (3); Ventricular septal defect 1, 614429 (3); Atrioventricular septal defect 4, 614430 (3)	
LHX3	600577	LHX3, CPHD3 Pituitary hormone deficiency, combined, 3, 221750 (3)	
PTPRO	600579	PTPRO, GLEPP1, NPHS6 Nephrotic syndrome, type 6, 614196 (3)	
NKX2-5	600584	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2 Atrial septal defect 7, with or without AV conduction defects, 108900 (3); Tetrology of Fallot, 187500 (3); Atrioventricular block, second-degree (3); Hypothyroidism, congenital nongoitrous, 5, 225250 (3); Ventricular septal defect 3, 614432 (3); Hypoplastic left heart syndrome 2, 614435 (3); Conotruncal heart malformations, variable, 217095 (3)	
KLF1	600599	KLF1, EKLF, INLU, HBFQTL6 Blood group--Lutheran inhibitor, 111150 (3); [Hereditary persistence of fetal hemoglobin], 613566 (3); Anemia, dyserythropoietic congenital, type IV, 613673 (3)	
STAR	600617	STAR Lipoid adrenal hyperplasia, 201710 (3)	
ETV6	600618	ETV6, TEL Leukemia, acute myeloid, somatic, 601626 (3)	
CD82	600623	CD82, SAR2, KAI1, ST6 {Prostate cancer, susceptibility to}, 176807 (2)	
OPCML	600632	OPCML {Ovarian cancer, somatic}, 167000 (3)	
NKX2-1	600635	NKX2-1, TITF1, NKX2A, TTF1 Goiter, familial, due to TTF-1 defect (1); Chorea, hereditary benign, 118700 (3); Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3)	
PVRL1	600644	HVEC, PVRL1, PVRR1, PRR1, ED4, OFC7, CLPED1 Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3); Orofacial cleft 7, 225060 (3)	
CPT2	600650	CPT2, IIAE4 Myopathy due to CPT II deficiency, 255110 (3); CPT deficiency, hepatic, type II, 600649 (3); CPT II deficiency, lethal neonatal, 608836 (3); {Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3)	
MEF2A	600660	MEF2A, ADCAD1 {Coronary artery disease, autosomal dominant, 1}, 608320 (3)	
MEF2C	600662	MEF2C, C5DELq14.3; DEL5q14.3 Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations, 613443 (3); Chromosome 5q14.3 deletion syndrome, 613443 (4)	
CHUK	600664	CHUK, IKBKA, NFKBIKA, IKKA, IKK1 Cocoon syndrome, 613630 (3)	
XRCC3	600675	XRCC3, CMM6 {Melanoma, cutaneous malignant, 6}, 613972 (3); {Breast cancer, susceptibility to}, 114480 (3)	
MSH6	600678	MSH6, GTBP, HNPCC5 Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3); Endometrial cancer, familial, 608089 (3); Mismatch repair cancer syndrome, 276300 (3)	
KCNJ2	600681	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9 Long QT syndrome-7, 170390 (3); Short QT syndrome-3, 609622 (3); Atrial fibrillation, familial, 9, 613980 (3)	
SLC16A1	600682	SLC16A1, MCT1, HHF7 Erythrocyte lactate transporter defect, 245340 (3); Hyperinsulinemic hypoglycemia, familial, 7, 610021 (3)	
TNNT3	600692	TNNT3, AMCD2B, DA2B, FSSV Arthyrgryposis, distal, type 2B, 601680 (3)	
HMGA2	600698	HMGA2, HMGIC, BABL Leiomyoma, uterine, somatic, 150699 (2)	
LPP	600700	LPP Lipoma (3); Leukemia, acute myeloid, 601626 (3)	
HMGA1	600701	HMGA1, HMGIY {Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	
SCN8A	600702	SCN8A, CIAT, EIEE13 Cognitive impairment with or without cerebellar ataxia, 614306 (3); Epileptic encephalopathy, early infantile, 13, 614558 (3)	
HSD11B1	600713	HSD11B1, HSD11, HSD11L, CORTRD2 Cortisone reductase deficiency 2, 614662 (3)	
PTPN22	600716	PTPN22, PEP, PTPN8, LYP {Diabetes, type 1, susceptibility to}, 222100 (3); {Rheumatoid arthritis, susceptibility to}, 180300 (3); {Systemic lupus erythematosus susceptibility to}, 152700 (3)	
PPT1	600722	PPT1, CLN1 Ceroid lipofuscinosis, neuronal, 1, 256730 (3)	
CNGB1	600724	CNGB1, CNCG3L, CNCG2, RP45 Retinitis pigmentosa 45, 613767 (3)	
SHH	600725	SHH, HPE3, HLP3, SMMCI, MCOPCB5 Holoprosencephaly-3, 142945 (3); Single median maxillary central incisor, 147250 (3); Microphthalmia with coloboma 5, 611638 (3); Schizencephaly, 269160 (3)	
IHH	600726	IHH, BDA1 Acrocapitofemoral dysplasia, 607778 (3); Brachydactyly, type A1, 112500 (3)	
PDX1	600733	IPF1, MODY4 Pancreatic agenesis, 260370 (3); MODY, type IV, 606392 (3); {Diabetes mellitus, type II, susceptibility to}, 125853 (3)	
KCNJ5	600734	KCNJ5, GIRK4, KATP1, LQT13 Long QT syndrome 13, 613485 (3); Hyperaldosteronism, familial, type III, 613677 (3)	
CEBPE	600749	CEBPE, CRP1 Specific granule deficiency, 245480 (3)	
SYN2	600755	SYN2 {Schizophrenia, susceptibility to}, 181500 (3)	
PSEN2	600759	PSEN2, AD4, STM2, CMD1V Alzheimer disease-4, 606889 (3); Cardiomyopathy, dilated, 1V, 613697 (3)	
SCNN1B	600760	SCNN1B, BESC1 Liddle syndrome, 177200 (3); Pseudohypoaldosteronism, type I, 264350 (3); Bronchiectasis with or without elevated sweat chloride 1, 211400 (3)	
SCNN1G	600761	SCNN1G, PHA1, BESC3 Liddle syndrome, 177200 (3); Pseudohypoaldosteronism, type I, 264350 (3); Bronchiectasis with or without elevated sweat chloride 3, 613071 (3)	
MUC5B	600770	MUC5B {Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)	
CDKN1B	600778	CDKN1B, KIP1, CDKN4, MEN4 Multiple endocrine neoplasia, type IV, 610755 (3)	
IRS2	600797	IRS2 {Diabetes mellitus, noninsulin-dependent}, 125853 (3)	
BMPR2	600799	BMPR2, PPH1 Pulmonary hypertension, familial primary, 178600 (3); Pulmonary venoocclusive disease, 265450 (3); Pulmonary hypertension, primary, fenfluramine-associated, 178600 (3)	
MTNR1B	600804	MTNR1B {Diabetes mellitus, type 2, susceptiblity to}, 125853 (3)	
LAMA3	600805	LAMA3, LOCS Epidermolysis bullosa, junctional, Herlitz type, 226700 (3); Epidermolysis bullosa, generalized atrophic benign, 226650 (3); Laryngoonychocutaneous syndrome, 245660 (3)	
PLCB4	600810	PLCB4, ARCND2 Auriculocondylar syndrome 2, 614669 (3)	
DDB2	600811	DDB2 Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3)	
MRE11A	600814	MRE11A, MRE11, ATLD Ataxia-telangiectasia-like disorder, 604391 (3)	
CSRP3	600824	CSRP3, CRP3, CLP, CMD1M, CMH12 Cardiomyopathy, dilated, 1M, 607482 (3); Cardiomyopathy, familial hypertrophic, 12, 612124 (3)	
PDE6C	600827	PDE6C, PDEA2, COD4 Cone dystrophy 4, 613093 (3)	
CXCL12	600835	CXCL12, SDF1 {AIDS, resistance to}, 609423 (3)	
GDNF	600837	GDNF, HSCR3 Central hypoventilation syndrome, 209880 (3); {Pheochromocytoma, modifier of}, 171300 (3); {Hirschsprung disease, susceptibility to, 3}, 613711 (3)	
FOXN1	600838	FOXN1, WHN T-cell immunodeficiency, congenital alopecia, and nail dystrophy, 601705 (3)	
SLC12A1	600839	SLC12A1, NKCC2 Bartter syndrome, type 1, 601678 (3)	
GCKR	600842	GCKR, GKRP, FGQTL5 [Fasting plasma glucose level QTL 5], 613463 (3)	
P2RX1	600845	P2RX1, P2X1 Bleeding disorder due to P2RX1 defect (3)	
DYRK1A	600855	DYRK1A, MNBH, MNB, MRD7 Mental retardation, autosomal dominant 7, 614104 (3)	
CDKN1C	600856	CDKN1C, KIP2, BWS Beckwith-Wiedemann syndrome, 130650 (3)	
SDHA	600857	SDHA, SDH1, SDHF, CMD1GG, PGL5 Leigh syndrome, 256000 (3); Mitochondrial respiratory chain complex II deficiency, 252011 (3); Cardiomyopathy, dilated, 1GG, 613642 (3); Paragangliomas 5, 614165 (3)	
GFI1	600871	GFI1, ZNF163, SCN2 Neutropenia, severe congenital 2, autosomal dominant, 613107 (3); Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3)	
MSH3	600887	MSH3 Endometrial carcinoma (3)	
HADHA	600890	HADHA, MTPA LCHAD deficiency, 609016 (3); Trifunctional protein deficiency, 609015 (3); HELLP syndrome, maternal, of pregnancy, 609016 (3); Fatty liver, acute, of pregnancy, 609016 (3)	
SGCB	600900	SGCB, LGMD2E Muscular dystrophy, limb-girdle, type 2E, 604286 (3)	
PPP1R3A	600917	PPP1R3A, PPP1R3 Insulin resistance, severe, digenic, 604367 (3)	
FGF9	600921	FGF9, SYNS3 Multiple synostoses syndrome 3, 612961 (3)	
MYLK	600922	MYLK, MLCK, AAT7 Aortic aneurysm, familial thoracic 7, 613780 (3)	
PPOX	600923	PPOX Porphyria variegata, 176200 (3)	
GFER	600924	GFER, ERV1, ALR Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay, 613076 (3)	
PTPRJ	600925	PTPRJ, DEP1 Colon cancer, somatic, 114500 (3)	
KCNJ8	600935	KCNJ8 ?Prinzmetal angina (1)	
HMMR	600936	HMMR {Breast cancer, susceptibility to}, 114480 (3)	
KCNJ11	600937	KCNJ11, BIR, PHHI, HHF2, TNDM3 Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3); Diabetes, permanent neonatal, 606176 (3); Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3); {Diabetes mellitus, type 2, susceptibility to}, 125853 (3); Diabetes mellitus, transient neonatal, 3, 610582 (3)	
IL11RA	600939	IL11RA, CRSDA Craniosynostosis and dental anomalies, 614188 (3)	
SERPINH1	600943	SERPINH2, PPROM, CBP2, CBP1, OI10 {Preterm premature rupture of the membranes, susceptibility to}, 610504 (3); Osteogenesis imperfecta, type X, 613848 (3)	
GHR	600946	GHR Laron dwarfism, 262500 (3); Short stature, 604271 (3); {Hypercholesterolemia, familial, modification of}, 143890 (3); Increased responsiveness to growth hormone (3)	
AANAT	600950	AANAT, SNAT, DSPS {Delayed sleep phase syndrome, susceptibility to}, 614163 (3)	
AMHR2	600956	AMHR2, AMHR Persistent Mullerian duct syndrome, type II, 261550 (3)	
AMH	600957	AMH, MIF Persistent Mullerian duct syndrome, type I, 261550 (3)	
MYBPC3	600958	MYBPC3, CMH4 Cardiomyopathy, familial hypertrophic, 4, 115197 (3); ?Cardiomyopathy, dilated, 115200 (3)	
SIX5	600963	SIX5, DMAHP, BOR2 Branchiootorenal syndrome 2, 610896 (3)	
SLC12A3	600968	SLC12A3, NCCT, TSC Gitelman syndrome, 263800 (3)	
MYO6	600970	MYO6, DFNA22, DFNB37 Deafness, autosomal dominant 22, 606346 (3); Deafness, autosomal recessive 37, 607821 (3); Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy, 606346 (3)	
DMP1	600980	DMP1, ARHR, ARHP Hypophosphatemic rickets, AR, 241520 (3)	
MAP3K1	600982	MAP3K1, MEKK1, MEKK, SRXY6 46XY sex reversal 6, 613762 (3)	
NR3C2	600983	NR3C2, MLR, MCR Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3); Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, 605115 (3)	
TNXB	600985	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDS3 Ehlers-Danlos syndrome, autosomal recessive, due to tenascin X deficiency, 606408 (3); Ehlers-Danlos syndrome, autosomal dominant, hypermobility type, 130020 (3)	
SMAD4	600993	MADH4, DPC4, SMAD4, JIP, MYHRS Pancreatic cancer (3); Polyposis, juvenile intestinal, 174900 (3); Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3); Myhre syndrome, 139210 (3)	
EPHB2	600997	EPHB2, EPHT3, DRT, ERK, PCBC, CAPB Prostate cancer, progression and metastasis of, 603688 (3)	
GNAQ	600998	GNAQ Bleeding diathesis due to GNAQ deficiency (1)	
GSS	601002	GSS, GSHS Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3); Glutathione synthetase deficiency, 266130 (3)	
CACNA1A	601011	CACNA1A, CACNL1A4, SCA6 Migraine, familial hemiplegic, 1, 141500 (3); Episodic ataxia, type 2, 108500 (3); Spinocerebellar ataxia 6, 183086 (3); Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia, 141500 (3)	
NPC2	601015	NPC2, HE1 Niemann-pick disease, type C2, 607625 (3)	
SNTA1	601017	SNT1, LQT12 Long QT syndrome 12, 612955 (3)	
NFKBIL1	601022	NFKBIL1 {Rheumatoid arthritis, susceptibility to}, 180300 (3)	
VCP	601023	VCP, IBMPFD, ALS14 Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3); Amyotrophic lateral sclerosis 14 with or without frontotemporal dementia, 613954 (3)	
SCARB1	601040	SCARB1, CD36L1, CLA1, HDLQTL6 [High density lipoprotien cholesterol level QTL6], 610762 (3)	
CAV1	601047	CAV1, BSCL3, CGL3 Lipodystrophy, congenital generalized, type 3, 612526 (3)	
AARS	601065	AARS, CMT2N Charcot-Marie-Tooth disease, axonal, type 2N, 613287 (2)	
FOXF1	601089	FOXF1, FKHL5, ACDMPV Alveolar capillary dysplasia with misalignment of pulmonary veins, 265380 (3)	
FOXC1	601090	FOXC1, FKHL7, FREAC3, IRID1, RIEG3 Iridogoniodysgenesis, type 1, 601631 (3); Rieger or Axenfeld anomalies, 602482 (3); Axenfeld-Rieger syndrome, type 3, 602482 (3); Iris hypoplasia and glaucoma, 601631 (3)	
FOXI1	601093	FOXI1, FKHL10, FREAC6 Enlarged vestibular aqueduct, 600791 (3)	
FOXE3	601094	FOXE3, FKHL12, ASMD Anterior segment mesenchymal dysgenesis, 107250 (3); Aphakia, congenital primary, 610256 (3)	
PMP22	601097	PMP22, CMT1A, CMT1E, DSS Charcot-Marie-Tooth disease, type 1A, 118220 (3); Dejerine-Sottas disease, 145900 (3); Neuropathy, recurrent, with pressure palsies, 162500 (3); Charcot-Marie-Tooth disease, type 1E, 118300 (3); Roussy-Levy syndrome, 180800 (3); Neuropathy, inflammatory demyelinating, 139393 (3)	
CTSK	601105	CTSK Pycnodysostosis, 265800 (3)	
ABCC2	601107	ABCC2, CMOAT Dubin-Johnson syndrome, 237500 (3)	
CYP2C9	601130	CYP2C9 Tolbutamide poor metabolizer (3); Warfarin sensitivity, 122700 (3)	
DCTN1	601143	DCTN1, HMN7B Neuropathy, distal hereditary motor, type VIIB, 607641 (3); {Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3); Perry syndrome, 168605 (3)	
CSTB	601145	CSTB, STFB, EPM1, PME, EPM1A, ULD Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg), 254800 (3)	
GDF5	601146	GDF5, CDMP1, SYNS2, OS5 Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3); Brachydactyly, type C, 113100 (3); Chondrodysplasia, Grebe type, 200700 (3); Fibular hypoplasia and complex brachydactyly, 228900 (3); Brachydactyly, type A2, 112600 (3); Symphalangism, proximal, 185800 (3); Multiple synostoses syndrome 2, 610017 (3); {Osteoarthritis}, 612400 (3)	
GDF6	601147	GDF6, MCOP4, KFS1, MCOPCB6 Klippel-Feil syndrome 1, autosomal dominant, 118100 (3); Microphthalmia, isolated 4, 613094 (3); Microphthalmia with coloboma 6, digenic, 613703 (3)	
DDX11	601150	DDX11, CHLR1, KRG2 Warsaw breakage syndrome, 613398 (3)	
CCL11	601156	CCL11, SCYA11 {HIV1, resistance to}, 609423 (3); {Asthma, susceptibility to}, 600807 (3)	
GCLM	601176	GCLM, GLCLR {Myocardial infarction, susceptibility to}, 608446 (3)	
RANBP2	601181	RANBP2, NUP358, ANE1, IIAE3 {Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)	
-	601188	ST12, PAC1 Prostate adenocarcinoma (2)	
PDE6H	601190	PDE6H, RCD3 Retinal cone dystrophy 3, 610024 (3)	
PLA2G5	601192	PLA2G5, FRFB Fleck retina, familial benign, 228980 (3)	
TLR1	601194	TLR1, TIL. LPRS5 {Leprosy, protection against}, 613223 (3); {Leprosy, susceptibility to, 5}, 613223 (3)	
SIX1	601205	SIX1, BOS3, DFNA23 Brachiootic syndrome 3, 608389 (3); Deafness, autosomal dominant 23, 605192 (3)	
ATR	601215	ATR, FRP1, SCKL1, FCTCS Seckel syndrome 1, 210600 (3); Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3)	
DTNA	601239	DTNA, D18S892E, DRP3, LVNC1 Left ventricular noncompaction 1, with or without congenital heart defects, 604169 (3)	
GAMT	601240	GAMT GAMT deficiency, 612736 (3)	
BIN1	601248	BIN1, AMPHL Myopathy, centronuclear, autosomal recessive, 255200 (3)	
CAV3	601253	CAV3, LGMD1C, LQT9 Muscular dystrophy, limb-girdle, type IC, 607801 (3); Rippling muscle disease, 606072 (3); Creatine phosphokinase, elevated serum, 123320 (3); Myopathy, distal, Tateyama type, 614321 (3); Cardiomyopathy, familial hypertrophic, 192600 (3); Long QT syndrome-9, 611818 (3)	
KIF1A	601255	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9 Spastic paraplegia 30, autosomal recessive, 610357 (3); Neuropathy, hereditary sensory, type IIC, 614213 (3); Mental retardation, autosomal dominant 9, 614255 (3)	
MAP2K2	601263	MAP2K2, PRKMK2, MEK2, MKK2 Cardiofaciocutaneous syndrome, 115150 (3)	
NODAL	601265	NODAL, HTX5 Heterotaxy, visceral, 5, 270100 (3)	
CCR2	601267	CCR2, CMKBR2 {HIV infection, susceptibility/resistance to} (3)	
PLEC	601282	PLEC1, PLEC, PLTN, EBS1, LGMD2Q Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3); Epidermolysis bullosa simplex, Ogna type, 131950 (3); Epidermolysis bullosa simplex with pyloric atresia, 612138 (3); Muscular dystrophy, limb-girdle, type 2Q, 613723 (3)	
ACVRL1	601284	ACVRL1, ACVRLK1, ALK1, HHT2 Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3)	
SLC10A2	601295	SLC10A2, NTCP2, PBAM Bile acid malabsorption, primary, 613291 (3)	
MUSK	601296	MUSK Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3)	
BMPR1A	601299	BMPR1A, ACVRLK3, ALK3 Polyposis, juvenile intestinal, 174900 (3); Polyposis syndrome, hereditary mixed, 2, 610069 (3); Juvenile polyposis syndrome, infantile form, 174900 (3)	
ACVR1B	601300	ACVR1B, ACVRLK4, ALK4 Pancreatic cancer, somatic (3)	
PTCH1	601309	PTCH1, NBCCS, BCNS, HPE7 Basal cell nevus syndrome, 109400 (3); Basal cell carcinoma, somatic, 605462 (3); Holoprosencephaly-7, 610828 (3)	
PKD1	601313	PKD1 Polycystic kidney disease, adult type I, 173900 (3)	
GUCY2C	601330	GUCY2C, GUC2C, DIAR6, MUCIL Diarrhea 6, 614616 (3); Meconium ileus, 614665 (3)	
MOGS	601336	GCS1, CDG2B Congenital disorder of glycosylation, type IIb, 606056 (3)	
CCR5	601373	CCR5, CMKBR5, CCCKR5, IDDM22 {HIV infection, susceptibility/resistance to} (3); {West nile virus, susceptibility to}, 610379 (3); {Hepatitis C virus, resistance to}, 609532 (3); {Diabetes mellitus, insulin-dependent, 22}, 612522 (3)	
TUSC3	601385	TUSC3, M33, D8S1992, MRT7, MRT22 Mental retardation, autosomal recessive 7, 611093 (3)	
TSG101	601387	TSG101 Breast cancer, somatic, 114480 (3)	
CCL3L1	601395	CCL3L1, SCYA3L1, LD78 {HIV/AIDS, susceptibility to}, 609423 (3)	
T	601397	T, TFT {Neural tube defects, susceptibility to}, 182940 (3)	
MLF1	601402	MLF1 Leukemia, acute myeloid, 601626 (1)	
CTRC	601405	CTRC, CLCR {Pancreatitis, chronic, susceptibility to}, 167800 (3)	
BCL7A	601406	BCL7A, BCL7 B-cell non-Hodgkin lymphoma, high-grade (3)	
SGCD	601411	SGCD, SGD, LGMD2F, CMD1L Muscular dystrophy, limb-girdle, type 2F, 601287 (3); Cardiomyopathy, dilated, 1L, 606685 (3)	
KARS	601421	KARS, CMTRIB Charcot-Marie-Tooth disease, recessive intermediate, B, 613641 (3)	
OXCT1	601424	OXCT1, OXCT, SCOT Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3)	
RNU4ATAC	601428	RNU4ATAC, U4ATAC, MOPD1, TALS Microcephalic osteodysplastic primordial dwarfism, type I, 210710 (3)	
ABCC9	601439	ABCC9, SUR2, CMD1O, ATFB12 Cardiomyopathy, dilated, 1O, 608569 (3); Atrial fibrillation, familial, 12, 614050 (3)	
CFL2	601443	CFL2, NEM7 Nemaline myopathy 7, 610687 (3)	
SLCO2A1	601460	SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2 Hypertrophic osteoarthropathy, primary, autosomal recessive 2, 614441 (3)	
DGUOK	601465	DGUOK, DGK, MTDPS3 Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), 251880 (3)	
CX3CR1	601470	CX3CR1, GPR13, V28 {Rapid progression to AIDS from HIV1 infection}, 609423 (3); {Coronary artery disease, resistance to}, 607339 (3); {Macular degeneration, age-related, 12}, 613784 (3)	
MYO1A	601478	MYO1A, DFNA48 Deafness, autosomal dominant 48, 607841 (3)	
MYO1E	601479	MYO1E, MYO1C, FSGS6 Glomerulosclerosis, focal segmental, 6, 614131 (3)	
DAZL	601486	DAZL, DAZH, SPGYLA {Spermatogenic failure, susceptibility to} (3)	
PPARG	601487	PPARG, PPARG1, PPARG2, CIMT1, GLM1 Obesity, severe, 601665 (3); [Obesity, resistance to] (3); {Glioblastoma, susceptibility to}, 137800 (3); Insulin resistance, severe, digenic, 604367 (3); Lipodystrophy, familial partial, type 3, 604367 (3); Carotid intimal medial thickness 1, 609338 (3); {Diabetes, type 2}, 125853 (3)	
NCF4	601488	NCF4, P40PHOX Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III, 613960 (3)	
SMO	601500	SMOH, SMO Basal cell carcinoma, somatic (3)	
VPS35	601501	VPS35, MEM3, PARK17 Parkinson disease 17, 614203 (3)	
FGF14	601515	FGF14, FHF4, SCA27 Spinocerebellar ataxia 27, 609307 (3)	
ATXN2	601517	ATXN2, ATX2, SCA2 Spinocerebellar ataxia 2, 183090 (3)	
CHI3L1	601525	CHI3L1, GP39, YKL40, ASRT7 {Schizophrenia, susceptibility to}, 181500 (3); {Asthma-related traits, susceptibility to, 7}, 611960 (3)	
ALX1	601527	ALX1, CART1, FND3 Frontonasal dysplasia 3, 613456 (3)	
SQSTM1	601530	SQSTM1, P62, PDB3 Paget disease of bone, 602080 (3)	
PROP1	601538	PROP1, CPHD2 Pituitary hormone deficiency, combined, 2, 262600 (3)	
PITX2	601542	PITX2, IDG2, RIEG1, RGS, IGDS2 Axenfeld-Rieger syndrome, type 1, 180500 (3); Iridogoniodysgenesis, type 2, 137600 (3); Ring dermoid of cornea, 180550 (3); Peters anomaly, 604229 (3)	
PAFAH1B1	601545	PAFAH1B1, LIS1 Lissencephaly 1, 607432 (3); Subcortical laminar heterotopia, 607432 (3)	
EFEMP1	601548	EFEMP1, FBNL, DHRD Doyne honeycomb degeneration of retina, 126600 (3)	
ATXN1	601556	ATXN1, ATX1, SCA1 Spinocerebellar ataxia 1, 164400 (3)	
PRSS2	601564	PRSS2, TRY2 {Pancreatitis, chronic, protection against}, 167800 (3)	
ING1	601566	ING1 Squamous cell carcinoma, head and neck, somatic, 275355 (3)	
LMAN1	601567	LMAN1, ERGIC53, F5F8D, MCFD1 Combined factor V and VIII deficiency, 227300 (3)	
WNT7A	601570	WNT7A Ulna and fibula, absence of, with sever limb deficiency, 276820 (3); Fuhrmann syndrome, 228930 (3)	
EZH2	601573	EZH2, EZH1, WVS2 Weaver syndrome 2, 614421 (3)	
TAF15	601574	TAF15, TAF2N, RBP56 Chondrosarcoma, extraskeletal myxoid, 612237 (1)	
RAPSN	601592	RAPSN, CMS1D, CMS1E Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3); Myasthenic syndrome, congenital, associated with facial dysmorphism and acetylcholine receptor deficiency, 608931 (3); Fetal akinesia deformation sequence, 208150 (3)	
BARD1	601593	BARD1 {Breast cancer, susceptibility to}, 114480 (3)	
TFAP2B	601601	TFAP2B, CHAR Char syndrome, 169100 (3)	
IL12RB1	601604	IL12RB1 {Mycobacterial and salmonella infections, susceptibility to}, 209950 (3)	
SMARCB1	601607	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15 Rhabdoid tumors, somatic, 609322 (3); Rhabdoid predisposition syndrome 1, 609322 (3); Mental retardation, autosomal dominant 15, 614608 (3)	
HADH	601609	HADHSC, SCHAD, HHF4 3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3); Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3)	
ABCA3	601615	ABCA3, ABC3, SMDP3 Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3)	
RDH5	601617	RDH5 Fundus albipunctatus, 136880 (3)	
SOX18	601618	SOX18, HLTS Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3)	
TBX5	601620	TBX5 Holt-Oram syndrome, 142900 (3)	
TBX3	601621	TBX3 Ulnar-mammary syndrome, 181450 (3)	
TWIST1	601622	TWIST1, ACS3, SCS, CRS1 Saethre-Chotzen syndrome, 101400 (3); Saethre-Chotzen syndrome with eyelid anomalies, 101400 (3); Craniosynostosis, type 1, 123100 (3); Robinow-Sorauf syndrome, 180750 (3)	
UBE3A	601623	UBE3A, ANCR Angelman syndrome, 105830 (3)	
SMN2	601627	SMN2 {Spinal muscular atrophy, type III, modifier of}, 253400 (3)	
MYOC	601652	MYOC, TIGR, GLC1A, JOAG, GPOA Glaucoma 1A, primary open angle, juvenile-onset, 137750 (3); Glaucoma 1A, primary open angle, recessive (3); Glaucoma, early-onset, digenic (3)	
EYA1	601653	EYA1, BOR, BOS1 Branchiootorenal syndrome 1, with or without cataracts, 113650 (3); Anterior segment anomalies with or without cataract, 113650 (3); Branchiootic syndrome 1, 602588 (3); Otofaciocervical syndrome, 166780 (3)	
GATA6	601656	GATA6, AVSD5, ASD9, AVSD5, PACHD Atrioventricular septal defect 5, 614474 (3); Atrial septal defect 9, 614475 (3); Pancreatic agenesis and congenital heart defects, 600001 (3); Persistent truncus arteriosus, 217095 (3); Tetralogy of Fallot, 187500 (3)	
SNRNP200	601664	SNRNP200, ASCC3L1, KIAA0788, RP33 Retinitis pigmentosa 33, 610359 (3)	
KRT12	601687	KRT12 Meesmann corneal dystrophy, 122100 (3)	
HPGD	601688	HPGD, PGDH1, PHOAR1 Cranioosteoarthropathy, 259100 (3); Hypertrophic osteoarthropathy, primary, autosomal recessive 1, 259100 (3); Digital clubbing, isolated congenital, 119900 (3)	
PLA2G7	601690	PLA2G7, PAFAH, PAFAD Platelet-activating factor acetylhydrolase deficiency, 614278 (3); {Asthma, susceptibility to}, 600807 (3); {Atopy, susceptibility to}, 147050 (3)	
ABCA4	601691	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2 Stargardt disease 1, 248200 (3); Retinitis pigmentosa 19, 601718 (3); Cone-rod dystrophy 3, 604116 (3); Macular degeneration, age-related, 2, 153800 (3); Fundus flavimaculatus, 248200 (3); Retinal dystrophy, early-onset severe, 248200 (3)	
TGFBI	601692	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD Corneal dystrophy, Groenouw type I, 121900 (3); Corneal dystrophy, lattice type I, 122200 (3); Corneal dystrophy, Reis-Bucklers type, 608470 (3); Corneal dystrophy, Avellino type, 607541 (3); Corneal dystrophy, lattice type IIIA, 608471 (3); Corneal dystrophy, Thiel-Behnke type, 602082 (3); Corneal dystrophy, epithelial basement membrane, 121820 (3)	
UCP2	601693	UCP2, BMIQ4 {Obesity, susceptibility to, BMIQ4}, 607447 (3)	
PTGIS	601699	PTGIS, CYP8A1, PGIS, CYP8 Hypertension, essential, 145500 (3)	
STXBP2	601717	STXBP2, UNC18B, FHL5 Hemophagocytic lymphohistiocytosis, familial, 5, 613101 (3)	
TBX4	601719	TBX4 Small patella syndrome, 147891 (3)	
NEUROD1	601724	NEUROD1, NIDDM {Diabetes mellitus, noninsulin-dependent}, 125853 (3); Maturity-onset diabetes of the young 6, 606394 (3)	
ATIC	601731	ATIC, PURH, AICAR AICA-ribosiduria due to ATIC deficiency, 608688 (3)	
OSMR	601743	OSMR, OSMRB, PLCA1 Amyloidosis, primary localized cutaneous, 1, 105250 (3)	
GLMN	601749	GLML, GVM, VMGLOM Glomuvenous malformations, 138000 (3)	
GALNT3	601756	GALNT3, HHS, HFTC Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)	
CASP10	601762	CASP10, MCH4, ALPS2 Autoimmune lymphoproliferative syndrome, type II, 603909 (3); Non-Hodgkin lymphoma, somatic, 605027 (3); Gastric cancer, somatic, 137215 (3)	
CASP8	601763	CASP8, MCH5, ALPS2B Immunodeficiency due to CASP8 deficiency, 607271 (3); Hepatocellular carcinoma, somatic, 114550 (3); {Breast cancer, protection against}, 114480 (3); {Lung cancer, protection against}, 211980 (3)	
HIP1	601767	HIP1 {Prostate cancer, progression of}, 176807 (1)	
SH3GL1	601768	SH3GL1, EEN Leukemia, acute myeloid, 601626 (1)	
VDR	601769	VDR Rickets, vitamin D-resistant, type IIA, 277440 (3); ?Osteoporosis, involutional, 166710 (1)	
CYP1B1	601771	CYP1B1, GLC3A Glaucoma 3A, primary congenital, 231300 (3); Peters anomaly, 604229 (3); Glaucoma, early-onset, digenic (3); Glaucoma, primary open angle, adult-onset, 137760 (3); Glaucoma, primary open angle, juvenile-onset, 137750 (3)	
PMM2	601785	PMM2, CDG1A Congenital disorder of glycosylation, type Ia, 212065 (3)	
MSTN	601788	GDF8, MSTN, MSLHP Muscle hypertrophy, 614160 (3)	
HESX1	601802	HESX1, RPX, CPHD5 Septooptic dysplasia, 182230 (3); Pituitary hormone deficiency, combined, 5, 182230 (3); Growth hormone deficiency with pituitary anomalies, 182230 (3)	
MCM6	601806	MCM6 Lactase persistance/nonpersistance, 223100 (3)	
FXYD2	601814	FXYD2, ATP1G1, HOMG2 Hypomagnesemia-2, renal, 154020 (3)	
NDUFS7	601825	NDUFS7, PSST Leigh syndrome, 256000 (3)	
LIG4	601837	LIG4 LIG4 syndrome, 606593 (3); {Multiple myeloma, resistance to}, 254500 (3); Severe combined immunodeficiency with sensitivity to ionizing radiation, 602450 (3)	
SLC5A5	601843	SLC5A5, NIS, TDH1 Thyroid dyshormonogenesis 1, 274400 (3)	
WNK4	601844	WNK4, PRKWNK4, PHA2B Pseudohypoaldosteronism, type IIB, 614491 (3)	
HSD17B4	601860	HSD17B4 D-bifunctional protein deficiency, 261515 (3); Perrault syndrome, 233400 (3)	
RFXAP	601861	RFXAP Bare lymphocyte syndrome, type II, complementation group D, 209920 (3)	
RFX5	601863	RFX5 Bare lymphocyte syndrome, type II, complementation group C, 209920 (3); Bare lymphocyte syndrome, type II, complementation group E, 209920 (3)	
PLOD2	601865	PLOD2, LH2, TLH Bruck syndrome 2, 609220 (3)	
RAX	601881	RAX, RX, MCOP3 Microphthalmia, isolated 3, 611038 (3)	
NBEAP1	601889	BCL8 Lymphoma, diffuse large cell (3)	
GHSR	601898	GHSR Short stature, 604271 (3)	
IRF4	601900	IRF4, LSIRF Multiple myeloma, 254500 (3)	
ORC1	601902	ORC1, ORC1L Meier-Gorlin syndrome 1, 224690 (3)	
WNT10B	601906	WNT10B, SHFM6 Split-hand/foot malformation 6, 225300 (3)	
SUMO1	601912	SUMO1, UBL1, SMT3, OFC10 Orofacial cleft 10, 613705 (3)	
KRT86	601928	KRT86, KRTHB6, HB6 Monilethrix, 158000 (3)	
CACNB4	601949	CACNB4, EJM6, EA5, EIG9 {Epilepsy, juvenile myoclonic, susceptibility to, 6}, 607682 (3); {Epilepsy, idiopathic generalized, susceptibility to, 9}, 607682 (3); Episodic ataxia, type 5, 613855 (3)	
TAPBP	601962	TAPBP, TPSN Bare lymphocyte syndrome, type I, 604571 (3)	
PKP1	601975	PKP1 Ectodermal dysplasia/skin fragility syndrome, 604536 (3)	
SIGMAR1	601978	SIGMAR1, SRBP, ALS16 Amyotrophic lateral sclerosis 16, juvenile, 614373 (3)	
OGG1	601982	OGG1 Renal cell carcinoma, clear cell, somatic, 144700 (3)	
NCOA4	601984	NCOA4, ELE1, PTC3 Thyroid carcinoma, papillary, 188550 (3)	
CCDC6	601985	CCDC6, D10S170, H4, TST1, PTC, TPC Thyroid papillary carcinoma, 188550 (1)	
TP73	601990	TP73 ?Neuroblastoma (1)	
SORL1	602005	SORL1, LR11, SORLA {Alzheimer disease, pathogenesis, association with}, 104300 (3)	
ST11	602011	ST11, PETS1 ?Pancreatic endocrine tumors (1)	
CLCNKB	602023	CLCNKB Bartter syndrome, type 3, 607364 (3); Bartter syndrome, type 4, digenic, 602522 (3)	
CLCNKA	602024	CLCNKA Bartter syndrome, type 4b, digenic, 613090 (3)	
PHYH	602026	PHYH, PAHX Refsum disease, 266500 (3)	
UCP3	602044	UCP3 {Obesity, severe, and type II diabetes}, 601665 (3)	
RAC2	602049	RAC2 Neutrophil immunodeficiency syndrome, 608203 (3)	
KLF6	602053	KLF6, COPEB, BCD1, ZF9 Prostate cancer, somatic, 176807 (3); Gastric cancer, somatic, 137215 (3)	
TBX1	602054	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR Conotruncal anomaly face syndrome, 217095 (3); DiGeorge syndrome, 188400 (3); Velocardiofacial syndrome, 192430 (3)	
TALDO1	602063	TALDO1 Transaldolase deficiency, 606003 (3)	
LTBP3	602090	LTBP3, LTBP2, STHAG6 Tooth agenesis, selective, 6, 613097 (3)	
LTBP2	602091	LTBP2, LTBP3, GLC3D, MSPKA Glaucoma 3, primary congenital, D, 613086 (3); Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma, 251750 (3)	
SH3BP2	602104	SH3BP2, CRPM Cherubism, 118400 (3)	
MATN3	602109	MATN3, EDM5, HOA, OS2 Epiphyseal dysplasia, multiple, 5, 607078 (3); {Osteoarthritis susceptibility 2}, 140600 (3); Spondyloepimetaphyseal dysplasia, 608728 (3)	
MLL2	602113	MLL2, ALR, KABUK1 Kabuki syndrome 1, 147920 (3)	
FGF10	602115	FGF10 Aplasia of lacrimal and salivary glands, 180920 (3); LADD syndrome, 149730 (3)	
NDN	602117	NDN Prader-Willi syndrome, 176270 (3)	
DIAPH1	602121	DIAPH1, DFNA1, LFHL1 Deafness, autosomal dominant 1, 124900 (3)	
SRP72	602122	SRP72, BMFF Bone marrow failure, familial, 614675 (3)	
COX10	602125	COX10 Encephalopathy, progressive mitochondrial, with proximal renal tubulopathy due to cytochrome c oxidase deficiency (3)	
MYO9B	602129	MYO9B, MYR5, CELIAC4 {Celiac disease, susceptibility to, 4}, 609753 (3)	
NDUFA2	602137	NDUFA2 Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	
NDUFS8	602141	NDUFS8 Leigh syndrome, 256000 (3)	
PLCD1	602142	PLCD1, NDNC3 Nail disorder, nonsyndromic congenital, 3, (leukonychia), 151600 (3)	
LHX4	602146	LHX4, CPHD4 Pituitary hormone deficiency, combined, 4, 262700 (3)	
PITX1	602149	PITX1, PTX1, BFT, POTX, CCF Clubfoot, congenital, 119800 (3)	
SNAI2	602150	SNAI2, SLUG, WS2D Waardenburg syndrome, type 2D, 608890 (3); Piebaldism, 172800 (3)	
KRT81	602153	KRT81, KRTHB1, HB1 Monilethrix, 158000 (3)	
ESRRB	602167	ESRRB, ESRL2, DFNB35 Deafness, autosomal recessive 35, 608565 (3)	
VRK1	602168	VRK1, PCH1A Pontocerebellar hypoplasia type 1A, 607596 (3)	
MYD88	602170	MYD88, MYD88D Pyogenic bacterial infections, recurrent, due to MYD88 deficiency, 612260 (3)	
SIPA1	602180	SIPA1, SPA1 Metastasis efficiency, modification of (1)	
NKX3-2	602183	NKX3-2, BAPX1, SMMD Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3)	
HTRA1	602194	HTRA1, PRSS11, ARMD7, CARASIL {Macular degeneration, age-related, 7}, 610149 (3); {Macular degeneration, age-related, neovascular type}, 610149 (3); CARASIL syndrome, 600142 (3)	
HSPB1	602195	HSPB1, HSP27, CMT2F, HMN2B Neuropathy, distal hereditary motor, type IIB, 608634 (3); Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3)	
ECM1	602201	ECM1 Lipoid proteinosis, 247100 (3)	
DDOST	602202	DDOST, OST, OST48, CDG1R Congenital disorder of glycosylation, type Ir, 614507 (3)	
RAB18	602207	RAB18, WARBM3 Warburg micro syndrome 3, 614222 (3)	
KCNJ10	602208	KCNJ10, SESAME SESAME syndrome, 612780 (3); Enlarged vestibular aqueduct, digenic, 600791 (3)	
STK11	602216	STK11, PJS, LKB1 Peutz-Jeghers syndrome, 175200 (3); Melanoma, malignant sporadic (3); Pancreatic cancer, sporadic (3); Testicular tumor, sporadic, 273300 (3)	
SALL1	602218	SALL1, HSAL1, TBS Townes-Brocks syndrome, 107480 (3); Townes-Brocks branchiootorenal-like syndrome, 107480 (3)	
CRX	602225	CRX, CORD2, CRD, LCA7 Cone-rod retinal dystrophy-2, 120970 (3); Leber congenital amaurosis 7, 613829 (3)	
TCF7L2	602228	TCF7L2, TCF4 {Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	
SOX10	602229	SOX10, WS4, WS4C, PCWH Waardenburg syndrome, type 4C, 613266 (3); Waardenburg syndrome, type 2E, with or without neurologic involvement, 611584 (3); PCWH syndrome, 609136 (3)	
KCNQ3	602232	KCNQ3, EBN2, BFNC2 Seizures, benign neonatal, type 2, 121201 (3)	
KCNQ2	602235	KCNQ2, EBN1, EIEE7, BFNS1 Seizures, benign neonatal, 1, 121200 (3); Myokymia, 121200 (3); Epileptic encephalopathy, early infantile, 7, 613720 (3)	
CD151	602243	CD151, PETA3, SFA1, MER2 Nephropathy with pretibial epidermolysis bullosa and deafness, 609057 (3); [Blood group, Raph], 179620 (3)	
DNASE1L3	602244	DNASE1L3, SLEB16 Systemic lupus erythematosus 16, 614420 (3)	
SCARB2	602257	SCARB2, CD36L2, LIMPII, AMRF, EPM4 Epilepsy, progressive myoclonic 4, with or without renal failure, 254900 (3)	
TCF4	602272	TCF4, SEF2, ITF2, PTHS Pitt-Hopkins syndrome, 610954 (3)	
GUCA1B	602275	GUCA1B, GCAP2, GUCA2, RP48 Retinitis pigmentosa 48, 613827 (3)	
PABPN1	602279	PABPN1, PABP2, PAB2 Oculopharyngeal muscular dystrophy, 164300 (3)	
TULP1	602280	TULP1, RP14, LCA15 Retinitis pigmentosa 14, 600132 (3); Leber congenital amaurosis 15, 613843 (3)	
SC5DL	602286	SC5DL, ERG3 Lathosterolosis, 607330 (3)	
TRIM32	602290	TRIM32, HT2A, LGMD2H, BBS11 Muscular dystrophy, limb-girdle, type 2H, 254110 (3); Bardet-Biedl syndrome 11, 209900 (3)	
AP4M1	602296	AP4M1, SPG50, CPSQ3 Spastic paraplegia 50, autosomal recessive, 612936 (3)	
RAB7A	602298	RAB7, CMT2B, PSN Charcot-Marie-Tooth disease, type 2B, 600882 (3)	
HR	602302	HR, AU, MUHH1 Alopecia universalis, 203655 (3); Atrichia with papular lesions, 209500 (3); Hypotrichosis, hereditary, Marie Unna type, 1, 146550 (3)	
AGRP	602311	AGRP, ART, AGRT {Obesity, late-onset}, 601665 (3); {Leanness, inherited} (3)	
TERC	602322	TERC, TRC3, TR, DKCA1 Dyskeratosis congenita, autosomal dominant 1, 127550 (3); Aplastic anemia, 609135 (3); {Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)	
ROR2	602337	ROR2, BDB1, BDB, NTRKR2 Brachydactyly, type B1, 113000 (3); Robinow syndrome, autosomal recessive, 268310 (3)	
WIPF1	602357	WIPF1, WASPIP, WIP Wiskott-Aldrich syndrome 2, 614493 (3)	
HCRT	602358	HCRT, OX, NRCLP1 Narcolepsy 1, 161400 (3)	
GATM	602360	GATM, AGAT AGAT deficiency, 612718 (3)	
CTSC	602365	CTSC, CPPI, PALS, PLS, HMS, JPD Papillon-Lefevre syndrome, 245000 (3); Haim-Munk syndrome, 245010 (3); Periodontitis, juvenile, 170650 (3)	
IFNAR2	602376	IFNAR2 {Hepatitis B virus, susceptibility to}, 610424 (3)	
DNM2	602378	DNM2, CMTDIB, CMTDI1, CMT2M Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3); Myopathy, centronuclear, 160150 (3); Charcot-Marie-Tooth disease, axonal, type 2M, 606482 (3)	
TUFM	602389	TUFM, EFTU, COXPD4 Combined oxidative phosphorylation deficiency 4, 610678 (3)	
ATP8B1	602397	ATP8B1, FIC1, BRIC, PFIC1 Cholestasis, progressive familial intrahepatic 1, 211600 (3); Cholestasis, benign recurrent intrahepatic, 243300 (3)	
FOXC2	602402	FOXC2, FKHL14, MFH1 Lymphedema-distichiasis syndrome, 153400 (3); Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus, 153400 (3)	
BLMH	602403	BLMH, BMH {Alzheimer disease, susceptibility to}, 104300 (3)	
MLLT10	602409	AF10 Leukemia, acute myeloid, 601626 (3); Leukemia, acute T-cell lymphoblastic (3)	
RPS24	602412	RPS24, DBA3 Diamond-blackfan anemia 3, 610629 (3)	
SDHC	602413	SDHC, PGL3 Paragangliomas 3, 605373 (3); Paraganglioma and gastric stromal sarcoma, 606864 (3); Gastrointestinal stromal tumor, 606764 (3)	
CFTR	602421	CFTR, ABCC7, CF, MRP7 Cystic fibrosis, 219700 (3); Congenital bilateral absence of vas deferens, 277180 (3); Sweat chloride elevation without CF (3); {Pancreatitis, idiopathic}, 167800 (3); {Hypertrypsinemia, neonatal} (3); {Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3)	
ROBO2	602431	ROBO2, SAX3, KIAA1568 Vesicoureteral reflux 2, 610878 (3)	
OPTN	602432	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12 Glaucoma 1, open angle, E, 137760 (3); {Glaucoma, normal tension, susceptibility to}, 606657 (3); Amyotrophic lateral sclerosis 12, 613435 (3)	
HSF4	602438	HSF4, CTM Cataract, Marner type, 116800 (3); Cataract, lamellar, 116800 (3)	
CISH	602441	CISH, BACTS2 {Tuberculosis, susceptibility to}, 607948 (3); {Malaria, susceptibility to}, 611162 (3); {Bacteremia, susceptibility to}, 614383 (3)	
SERPINI1	602445	SERPINI1, PI12 Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)	
PON2	602447	PON2 {Coronary artery disease, susceptibility to} (3)	
BUB1	602452	BUB1 Colorectal cancer with chromosomal instability (3)	
FADD	602457	FADD Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovasuclar malforamtions, 613759 (3)	
SORT1	602458	SORT1, NT3, LDLCQ6 [Low density lipoprotein cholesterol level QTL6], 613589 (3)	
POU4F3	602460	POU4F3, BRN3C Deafness, autosomal dominant 15, 602459 (3)	
TFG	602498	TFG Chondrosarcoma, extraskeletal myxoid, 612237 (1)	
TUBA1A	602529	TUBA1A, TUBA3, LIS3 Lissencephaly 3, 611603 (3)	
PARK7	602533	DJ1, PARK7 Parkinson disease 7, autosomal recessive early-onset, 606324 (3); Amyotrophic lateral sclerosis-Parkinsonism/dementia complex 2 (3)	
RAB3GAP1	602536	RAB3GAP1, WARBM1, P130 Warburg micro syndrome 1, 600118 (3)	
PARK2	602544	PRKN, PARK2, PDJ, LPRS2 Parkinson disease, juvenile, type 2, 600116 (3); Adenocarcinoma of lung, somatic, 211980 (3); Adenocarcinoma, ovarian, somatic, 167000 (3); {Leprosy, susceptibility to}, 607572 (3)	
MTRR	602568	MTRR Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3); {Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)	
SNCB	602569	SNCB Dementia, Lewy body, 127750 (3)	
TECTA	602574	TECTA, DFNA8, DFNA12, DFNB21 Deafness, autosomal dominant 8/12, 601543 (3); Deafness, autosomal recessive 21, 603629 (3)	
LMX1B	602575	LMX1B, NPS1 Nail-patella syndrome, 161200 (3)	
LFNG	602576	LFNG, SCDO3 Spondylocostal dysostosis, autosomal recessive 3, 609813 (3)	
CDSN	602593	CDSN, HTSS1, PSS Hypotrichosis simplex of scalp 1, 146520 (3); Peeling skin syndrome, 270300 (3)	
LRP8	602600	LRP8, APOER2, MCI1 {Myocardial infarction, susceptibility to}, 608446 (3)	
OLR1	602601	OLR1, LOX1 {Myocardial infarction, susceptibility to}, 608446 (3)	
CARTPT	602606	CART {Obesity, susceptibility to}, 601665 (3)	
MGAT2	602616	MGAT2, CDGS2, CDG2A Congenital disorder of glycosylation, type IIa, 212066 (3)	
FOXE1	602617	FOXE1, FKHL15, TITF2, TTF2 Bamforth-Lazarus syndrome, 241850 (3)	
FKBP5	602623	FKBP5, FKBP51 {Major depressive disorder and accelerated response to antidepressant drug treatment}, 608516 (3)	
CDC6	602627	CDC6, CDC18L Meier-Gorlin syndrome 5, 613805 (3)	
TGIF1	602630	TGIF, HPE4 Holoprosencephaly-4, 142946 (3)	
SLC22A18	602631	SLC22A1L, BWSCR1A, IMPT1 Breast cancer, somatic, 114480 (3); Rhabdomyosarcoma, somatic, 268210 (3); Lung cancer, somatic, 211980 (3)	
TNFSF11	602642	TNFSF11, OPGL, TRANCE, OPTB2 Osteopetrosis, autosomal recessive 2, 259710 (3)	
TNFRSF11B	602643	TNFRSF11B, OPG, OCIF Paget disease, juvenile, 239000 (3)	
TUBB3	602661	TUBB3, TUBB4, CFEOM3A, CDCBM Fibrosis of extraocular muscles, congenital, 3A, 600638 (3); Cortical dysplasia, complex, with other brain malformations, 614039 (3)	
MYO15A	602666	MYO15A, DFNB3 Deafness, autosomal recessive 3, 600316 (3)	
NBN	602667	NBS1, NBS Nijmegen breakage syndrome, 251260 (3); Leukemia, acute lymphoblastic (3)	
SLC37A4	602671	SLC37A4, G6PT1 Glycogen storage disease Ib, 232220 (3); Glycogen storage disease Ic, 232240 (3)	
MAD1L1	602686	MAD1L1, TXBP181 Lymphoma, somatic (3); Prostate cancer, somatic, 176807 (3)	
SDHD	602690	SDHD, PGL1 Paragangliomas 1, with or without deafness, 168000 (3); Pheochromocytoma, 171300 (3); Carcinoid tumors, intestinal, 114900 (3); Merkel cell carcinoma, somatic (3); Paraganglioma and gastric stromal sarcoma, 606864 (3); Cowden-like syndrome, 612359 (3)	
NDUFS4	602694	NDUFS4, AQDQ Leigh syndrome, 256000 (3); Mitochondrial complex I deficiency, 252010 (3)	
EP300	602700	EP300, RSTS2 Colorectal cancer, 114500 (3); Rubinstein-Taybi syndrome 2, 613684 (3)	
APBB2	602710	APBB2, FE65L1 {Alzheimer disease, late-onset}, 104300 (3)	
ADAM9	602713	ADAM9, MDC9, MCMP, CORD9 Cone-rod dystrophy 9, 612775 (3)	
NPHS1	602716	NPHS1, NPHN Nephrotic syndrome, type 1, 256300 (3)	
CLCN7	602727	CLCN7, CLC7, OPTA2, OPTB4 Osteopetrosis, autosomal recessive 4, 611490 (3); Osteopetrosis, autosomal dominant 2, 166600 (3)	
ACVR2B	602730	ACVR2B, ACTRIIB, HTX4 Heterotaxy, visceral, 4, autosomal, 613751 (3)	
PRKAG2	602743	PRKAG2, WPWS, CMH6 Wolff-Parkinson-White syndrome, 194200 (3); Cardiomyopathy, familial hypertrophic 6, 600858 (3); Glycogen storage disease of heart, lethal congenital, 261740 (3)	
GNPAT	602744	GNPAT, DHAPAT Chondrodysplasia punctata, rhizomelic, type 2, 222765 (3)	
PHOX2A	602753	PHOX2A, ARIX, CFEOM2 Fibrosis of extraocular muscles, congenital, 2, 602078 (3)	
KRT83	602765	KRT83, KRTHB3, HB3 Monilethrix, 158000 (3)	
KRT85	602767	KRT85, KRTHB5, HB5 Ectodermal dysplasia, 'pure' hair-nail type, 602032 (3)	
DLL3	602768	DLL3, SCDO1 Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)	
CBX2	602770	CBX2, M33, SRXY5 46XY sex reversal 5, 613080 (3)	
DIRC2	602773	DIRC2, RCC4 Renal cell carcinoma, 144700 (2)	
RAD51C	602774	RAD51C, FANCO, BROVCA3 Fanconi anemia, complementation group 0, 613390 (3); {Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3)	
SHOC2	602775	SHOC2, SIAA0862, SOC2, SUR8 Noonan-like syndrome with loose anagen hair, 607721 (3)	
SPG7	602783	PGN, SPG7, CMAR, CAR Spastic paraplegia 7, autosomal recessive, 607259 (3)	
KIF5A	602821	KIF5A, NKHC, SPG10 Spastic paraplegia 10, autosomal dominant, 604187 (3)	
GPR98	602851	GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C Febrile seizures, familial, 4, 604352 (3); Usher syndrome, type 2C, 605472 (3); Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)	
PSMA6	602855	PSMA6, PROS27, P27K {Myocardial infarcation, susceptibility to}, 608446 (3)	
DHCR7	602858	DHCR7, SLOS Smith-Lemli-Opitz syndrome, 270400 (3)	
BUB1B	602860	BUB1B, BUBR1 Colorectal cancer, 114500 (3); Mosaic variegated aneuploidy syndrome, 257300 (3); [Premature chromatid separation trait], 176430 (3)	
PKP2	602861	PKP2, ARVD9 Arrhythmogenic right ventricular dysplasia 9, 609040 (3)	
IGFBP7	602867	IGFBP7, MAC25, RAMSVPS Retinal arterial macroaneurysm with supravalvular pulmonic stenosis, 614224 (3)	
OCLN	602876	OCLN, BLCPMG Band-like calcification with simplified gyration and polymicrogyria, 251290 (3)	
EPB41L1	602879	EPB41L1, MRD11 Mental retardation, autosomal dominant 11, 614257 (3)	
GDF1	602880	GDF1, DTGA3, DORV Double-outlet right ventricle, 217095 (3); Tetralogy of Fallot, 187500 (3); Transposition of great arteries, dextro-looped 3, 613854 (3)	
MAPK10	602897	MAPK10, PRKM10, JNK3 Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)	
DNMT3B	602900	DNMT3B, ICF1 Immunodeficiency-centromeric instability-facial anomalies syndrome 1, 242860 (3)	
CACNG2	602911	CACNG2, MRD10 Mental retardation, autosomal dominant 10, 614256 (3)	
STXBP1	602926	STXBP1, UNC18, EIEE4 Epileptic encephalopathy, early infantile, 4, 612164 (2)	
SMAD7	602932	SMAD7, MADH7, CRCS3 {Colorectal cancer, susceptibility to, 3}, 612229 (3)	
CITED2	602937	CITED2, MRG1, P35SRJ, VSD2, ASD8 Ventricular septal defect 2, 614431 (3); Atrial septal defect 8, 614433 (3)	
BAAT	602938	BAAT Hypercholanemia, familial, 607748 (3)	
RAD51D	602954	RAD51L3, RAD51D, BROVCA4 {Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)	
FANCG	602956	XRCC9, FANCG Fanconi anemia, complementation group G, 614082 (3)	
AQP7	602974	AQP7, GLYCQTL [Glycerol quantitative trait locus], 614411 (3)	
NDUFS2	602985	NDUFS2 Mitochondrial complex I deficiency, 252010 (3)	
NOG	602991	NOG, SYM1, SYNS1 Symphalangism, proximal, 185800 (3); Multiple synostosis syndrome 1, 186500 (3); Tarsal-carpal coalition syndrome, 186570 (3); Stapes ankylosis with broad thumb and toes, 184460 (3); Brachydactyly, type B2, 611377 (3)	
CUBN	602997	CUBN, IFCR, MGA1 Megaloblastic anemia-1, Finnish type, 261100 (3)	
PAPSS2	603005	PAPSS2, ATPSK2 SEMD, Pakistani type, 612847 (3)	
DYSF	603009	DYSF, LGMD2B, MMD1 Muscular dystrophy, limb-girdle, type 2B, 253601 (3); Myopathy, distal, with anterior tibial onset, 606768 (3); Miyoshi muscular dystrophy 1, 254130 (3)	
IKZF1	603023	IKZF1, ZNFN1A1, IK1, LYF1 Leukemia, acute lymphoblastic (3)	
ARID1A	603024	ARID1A, C1orf4, B120, SMARCF1, MRD14 Mental retardation, autosomal dominant 14, 614607 (3)	
PICALM	603025	PICALM, CALM, CLTH, LAP Leukemia, acute myeloid, 601626 (3); Leukemia, acute T-cell lymphoblastic (3)	
PLAG1	603026	PLAG1, SGPA, PSA Adenomas, salivary gland pleomorphic, 181030 (3)	
TLR2	603028	TLR2, TIL4 {Leprosy, susceptibility to}, 246300 (3); {Colorectal cancer, susceptibility to}, 114500 (3)	
TLR3	603029	TLR3, IIAE2 Herpes simplex encephalitis, susceptibility to, 2, 613002 (3)	
TLR5	603031	TLR5, TIL3, SLEB1 {Legionaire disease, susceptibility to}, 608556 (3); {Systemic lupus erythematosus, resistance to}, 601744 (3); {Systemic lupus erythematosus, susceptibility to, 1}, 601744 (2)	
COLQ	603033	COLQ, EAD Endplate acetylcholinesterase deficiency, 603034 (3)	
PLAGL1	603044	PLAGL1, ZAC, LOT1 {Diabetes mellitus, transient neonatal}, 601410 (1)	
RNF139	603046	RNF139, TRC8, RCA1 Renal cell carcinoma, 144700 (3)	
AGPS	603051	AGPS, ADHAPS Rhizomelic chondrodysplasia punctata, type 3, 600121 (3)	
ORC4	603056	ORC4, ORC4L Meier-Gorlin syndrome 2, 613800 (3)	
PLOD3	603066	PLOD3, LH3 Lysyl hydroxylase 3 deficiency, 612394 (3)	
AURKA	603072	AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK {Colon cancer, susceptibility to}, 114500 (3)	
ZIC2	603073	ZIC2, HPE5 Holoprosencephaly-5, 609637 (3)	
BAP1	603089	BAP1, TPDS Tumor predisposition syndrome, 614327 (3)	
B3GALNT1	603094	B3GALT3, GLCT3, P [Blood group, P system], 111400 (3); {Urinary tract infection, susceptibility to} (1)	
AGPAT2	603100	AGPAT2, LPAAB, BSCL, BSCL1 Lipodystrophy, congenital generalized, type 1, 608594 (3)	
CPN1	603103	CPN1, SCPN, CPN Carboxypeptidase N deficiency, 212070 (3)	
SMAD3	603109	MADH3, SMAD3, LDS1C Loeys-Dietz syndrome, type 1C, 613795 (3)	
PPP2R1B	603113	PPP2R1B Lung cancer, 211980 (3)	
SIM1	603128	SIM1 Obesity, severe, 601665 (3)	
CUL3	603136	CUL3, PHA2E Pseudohypoaldosteronism, type IIE, 614496 (3)	
PTPN14	603155	PTPN14, PEZ Choanal atresia and lymphedema, 613611 (3)	
ALDH6A1	603178	ALDH6A1, MMSDH Methylmalonate semialdehyde dehydrogenase deficiency, 614105 (3)	
RTN2	603183	RTN2, NSPL1, SPG12 Spastic paraplegia 12, autosomal dominant, 604805 (3)	
COCH	603196	COCH, DFNA9 Deafness, autosomal dominant 9, 601369 (3)	
PNPLA6	603197	PNPLA6, NTE, SPG39, NTEMND Spastic paraplegia 39, autosomal recessive, 612020 (3)	
PTRF	603198	PTRF, CAVIN, CGL4 Lipodystrophy, congenital generalized, type 4, 613327 (3)	
RFXANK	603200	RFXANK MHC class II deficiency, complementation group B, 209920 (3)	
ABCB11	603201	ABCB11, BSEP, SPGP, PFIC2, BRIC2 Cholestasis, progressive familial intrahepatic 2, 601847 (3); Cholestasis, benign recurrent intrahepatic, 2, 605479 (3)	
LCT	603202	LCT, LAC, LPH Lactase deficiency, congenital, 223000 (3)	
KCNJ13	603208	KCNJ13, SVD, LCA16 Snowflake vitreoretinal degeneration, 193230 (3); Leber congenital amaurosis 16, 614186 (3)	
BFSP2	603212	BFSP2, CP49, CP47 Cataract, juvenile-onset, 604219 (3); Cataract, congenital, 604219 (3); Cataract, autosomal dominant, multiple types 1, 611597 (3)	
KIF22	603213	KIF22, KNSL4, KID, OBP, SEMDJL2 Spondyloepimetaphyseal dysplasia with joint laxity, type 2, 603546 (3)	
ABCC6	603234	ABCC6, ARA, ABC34, MLP1, PXE, GACI2 Pseudoxanthoma elasticum, 264800 (3); Pseudoxanthoma elasticum, forme fruste, 177850 (3); Arterial calcification, generalized, of infancy, 2, 614473 (3)	
BMPR1B	603248	BMPR1B, ALK6 Brachydactyly, type A2, 112600 (3); Chrondrodysplasia, acromesomelic, with genital anomalies, 609441 (3)	
SMARCA4	603254	SMARCA4, BRG1, RTPS2, MRD16 Rhabdoid tumor predisposition syndrome 2, 613325 (3); Mental retardation, autosomal dominant 16, 614609 (3)	
CA12	603263	CA12 Hyperchlorhidrosis, isolated, 143860 (3)	
TP63	603273	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8 Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3); Split-hand/foot malformation 4, 605289 (3); Hay-Wells syndrome, 106260 (3); ADULT syndrome, 103285 (3); Limb-mammary syndrome, 603543 (3); Rapp-Hodgkin syndrome, 129400 (3); Orofacial cleft 8, 129400 (3)	
RGS5	603276	RGS5 [Blood pressure regulation QTL], 145500 (2)	
KISS1	603286	KISS1 Hypogonadotropic hypogonadism, 146110 (3)	
PNPO	603287	PNPO Pyridoxamine 5'-phosphate oxidase deficiency, 610090 (3)	
KERA	603288	KERA, CNA2 Cornea plana congenita, recessive, 217300 (3)	
SHANK2	603290	SHANK2, CORTBP1, AUTS17 {Autism susceptibility 17}, 613436 (3)	
SMAD9	603295	MADH9, SMAD9, MADH6 Pulmonary hypertension, primary, 178600 (3)	
DYNC2H1	603297	DYNC2H1, DNCH2, DHC2, ATD3 Asphyxiating thoracic dystrophy 3, 613091 (3); Short rib-polydactyly syndrome, type III, 263510 (3); Short rib-polydactyly syndrome, type II, digenic, 263520 (3)	
KLF11	603301	KLF11, TIEG2, FKLF1, FKLF, MODY7 Maturity-onset diabetes of the young, type VII, 610508 (3)	
BFSP1	603307	BFSP1, CP115 Cataract, cortical, juvenile-onset, 611391 (3)	
ALG10	603313	ALG10, KCR1 {Acquired long QT syndrome, reduced susceptibility to}, 613688 (3)	
PTPRQ	603317	PTPRQ, PTPGMC1, DFNB84 Deafness, autosomal recessive 84, 613391 (3)	
DNAH5	603335	DNAH5, HL1, PCD, CILD3 Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 (3)	
DNAH11	603339	DNAH11, DNAHC11, CILD7, DNAHBL Ciliary dyskinesia, primary, 7, with or without situs inversus, 611884 (3)	
SLC4A4	603345	SLC4A4, NBC1, KNBC, SLC4A5 Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)	
EPAS1	603349	EPAS1, MOP2, HIF2A, ECYT4 Erythrocytosis, familial, 4, 611783 (3)	
GLE1	603371	GLE1, GLE1L, LCCS, LCCS1 Lethal congenital contracture syndrome 1, 253310 (3); Arthrogryposis, lethal, with anterior horn cell disease, 611890 (3)	
SLC22A5	603377	SLC22A5, OCTN2, CDSP, SCD Carnitine deficiency, systemic primary, 212140 (3)	
FLNB	603381	FLNB, SCT, AOI, LRS1 Spondylocarpotarsal synostosis syndrome, 272460 (3); Larsen syndrome, 150250 (3); Atelosteogenesis, type I, 108720 (3); Atelosteogenesis, type III, 108721 (3); Boomerang dysplasia, 112310 (3)	
SYNGAP1	603384	SYNGAP, MRD5 Mental retardation, autosomal dominant 5, 612621 (3)	
PDE8B	603390	PDE8B, PPNAD3, ADSD Pigmented nodular adrenocortical disease, primary, 3, 614190 (3); Striatal degeneration, autosomal dominant, 609161 (3)	
WISP3	603400	WISP3, PPAC, PPD Arthropathy, progressive pseudorheumatoid, of childhood, 208230 (3); Spondyloepiphyseal dysplasia tarda with progressive arthropathy, 208230 (3)	
AP3B1	603401	AP3B1, ADTB3A, HPS2 Hermansky-Pudlak syndrome 2, 608233 (3)	
TRIM24	603406	TRIM24, TIF1, TIF1A, PTC6 Thyroid carcinoma, papillary, 188550 (3)	
FZD6	603409	FZD6, NDNC10 Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails), 614157 (3)	
SCN9A	603415	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP Erythermalgia, primary, 133020 (3); Insensitivity to pain, channelopathy-associated, 243000 (3); Paroxysmal extreme pain disorder, 167400 (3); Febrile seizures, familial, 3B, 613863 (3); Epilepsy, generalized, with febrile seizures plus, type 7, 613863 (3); Small fiber neuropathy, 133020 (3); Dravet syndrome, 607208 (3)	
PDLIM4	603422	RIL {Osteoporosis, susceptibility to}, 166710 (3)	
PRKRA	603424	PRKRA, PACT, RAX, DYT16 Dystonia 16, 612067 (3)	
PER2	603426	PER2, FASPS, KIAA0347 Advanced sleep phase syndrome, familial, 604348 (3)	
CRADD	603454	CRADD, RAIDD, MRT34 Mental retardation, autosomal recessive 34, 614499 (3)	
ASS1	603470	ASS1, ASS Citrullinemia, 215700 (3)	
RPS19	603474	RPS19, DBA, DBA1 Diamond-Blackfan anemia 1, 105650 (3)	
CILP	603489	CILP {Lumbar disc disease, susceptibility to}, 603932 (3)	
WNT4	603490	WNT4, SERKAL SERKAL syndrome, 611812 (3); Mullerian aplasia and hyperandrogenism, 158330 (3)	
AURKC	603495	STK13, AIE2, SPGF5 Spermatogenic failure 5, 243060 (3)	
TNFRSF11A	603499	TNFRSF11A, RANK, ODFR, OFE, OPTB7 Osteolysis, familial expansile, 174810 (3); Paget disease of bone, 602080 (3); Osteopetrosis, autosomal recessive 7, 612301 (3)	
DPM1	603503	DPM1, MPDS, CDGIE Congenital disorder of glycosylation, type Ie, 608799 (3)	
LRP5	603506	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4 Osteoporosis-pseudoglioma syndrome, 259770 (3); [Bone mineral density variability 1], 601884 (3); Hyperostosis, endosteal, 144750 (3); van Buchem disease, type 2, 607636 (3); Osteosclerosis, 144750 (3); {Osteoporosis}, 166710 (3); Exudative vitreoretinopathy 4, 601813 (3); Osteopetrosis, autosomal dominant 1, 607634 (3)	
LRP6	603507	LRP6, ADCAD2 {Coronary artery disease, autosomal dominant, 2}, 610947 (3)	
BCL10	603517	BCL10 Lymphoma, MALT, somatic, 137245 (3); {Lymphoma, follicular, somatic}, 613024 (3); {Male germ cell tumor, somatic}, 273300, (3); {Sezary syndrome, somatic}, (3); Colon cancer, somatic, 114500 (3); {Mesothelioma, somatic}, 156240 (3)	
KCNQ4	603537	KCNQ4, DFNA2A Deafness, autosomal dominant 2A, 600101 (3)	
EYA4	603550	EYA4, DFNA10, CMD1J Deafness, autosomal dominant 10, 601316 (3); Cardiomyopathy, dilated, 1J, 605362 (3)	
MTMR2	603557	MTMR2, CMT4B1 Charcot-Marie-Tooth disease, type 4B1, 601382 (3)	
TRPM1	603576	TRPM1, MLSN1, CSNB1C Night blindness, congenital stationary, type 1C, 613216 (3)	
LARGE	603590	LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6 Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6, 613154 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6, 608840 (3)	
SLC7A7	603593	SLC7A7, LPI Lysinuric protein intolerance, 222700 (3)	
TNFSF4	603594	TNFSF4, GP34, OX4OL {Myocardial infarction, susceptibility to}, 608446 (3)	
PLA2G6	603604	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14 Infantile neuroaxonal dystrophy 1, 256600 (3); Neurodegeneration with brain iron accumulation 2B, 610217 (3); Karak syndrome, 610217 (3); Parkinson disease 14, 612953 (3)	
AIMP1	603605	AIMP1, SCYE1, EMAP2, EMAPII, HLD3 Leukodystrophy, hypomyelinating, 3, 260600 (3)	
TNFRSF10B	603612	TNFRSF10B, DR5, TRAILR2 Squamous cell carcinoma, head and neck, 275355 (3)	
RAD54L	603615	RAD54L, HR54, HRAD54 {Breast cancer, invasive ductal}, 114480 (3); Lymphoma, non-Hodgkin, somatic, 605027 (3); Adenocarcinoma, colonic, somatic (3)	
SLC24A1	603617	SLC24A1, NCKX1, CSNB1D Night blindness, congenital stationary, type 1D, 613830 (3)	
YARS	603623	YARS, CMTDIC, TYRRS, YTS, YRS Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)	
RPS10	603632	RPS10, DBA9 Diamond-Blackfan anemia 9, 613308 (3)	
RPL5	603634	RPL5, DBA6 Diamond-Blackfan anemia 6, 612561 (3)	
ADAM17	603639	ADAM17, TACE, NISBD Inflammatory skin and bowel disease, neonatal, 614328 (3)	
SCO1	603644	SCOD1, SCO1 Hepatic failure, early onset, and neurologic disorder (3)	
COX15	603646	COX15 Cardiomyopathy, hypertrophic, early-onset fatal (3); Leigh syndrome due to cytochrome c oxidase deficiency, 256000 (3)	
BCS1L	603647	BCS1L, FLNMS, GRACILE, BJS, PTD Mitochondrial complex III deficiency, 124000 (3); GRACILE syndrome, 603358 (3); Leigh syndrome, 256000 (3); Bjornstad syndrome, 262000 (3)	
BBS5	603650	BBS5 Bardet-Biedl syndrome 5, 209900 (3)	
TRPC6	603652	TRPC6, TRP6, FSGS2 Glomerulosclerosis, focal segmental, 2, 603965 (3)	
RPS7	603658	RPS7, DBA8 Diamond-Blackfan anemia 8, 612563 (3)	
STX16	603666	STX16, SYN16 Pseudohypoparathyroidism, type IB, 603233 (3)	
SLC25A12	603667	SLC25A12, ARALAR Hypomyelination, global cerebral, 612949 (3)	
PTCH2	603673	PTCH2 Medulloblastoma, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)	
ATXN8OS	603680	ATXN8OS, SCA8, KLHL1AS Spinocerebellar ataxia 8, 608768 (3)	
OTOF	603681	OTOF, DFNB9, NSRD9, AUNB1 Deafness, autosomal recessive 9, 601071 (3); Auditory neuropathy, autosomal recessive, 1, 601071 (3)	
SLC33A1	603690	SLC33A1, ACATN, AT1, SPG42, CCHLND Spastic paraplegia 42, autosomal dominant, 612539 (3); Congenital cataracts, hearing loss, and neurodegeneration, 614482 (3)	
ZFPM2	603693	ZFPM2, FOG2, DIH3 Tetralogy of Fallot, 187500 (3); Diaphragmatic hernia 3, 610187 (3)	
ALOX5AP	603700	ALOX5AP, FLAP {Stroke, susceptibility to}, 601367 (3)	
RPS26	603701	RPS26, DBA10 Diamond-Blackfan anemia 10, 613309 (3)	
MOCS1	603707	MOCS1, MOCOD Molybdenum cofactor deficiency, type A, 252150 (3)	
MOCS2	603708	MOCS2, MPTS Molybdenum cofactor deficiency, type B, 252150 (3)	
CYP7B1	603711	CYP7B1, CBAS3, SPG5A Bile acid synthesis defect, congenital, 3, 613812 (3); Spastic paraplegia 5A, autosomal recessive, 270800 (3)	
SIX3	603714	SIX3, HPE2 Holoprosencephaly-2, 157170 (3); Schizensephaly, 269160 (3)	
GCM2	603716	GCMB Hypoparathyroidism, familial isolated, 146200 (3)	
CLDN1	603718	CLDN1, SEMP1, ILVASC Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis, 607626 (3)	
IKBKAP	603722	IKBKAP, IKAP Dysautonomia, familial, 223900 (3)	
ALOX12B	603741	ALOX12B Ichthyosiform erythroderma, congenital, nonbullous, 1, 242100 (3)	
APOL1	603743	APOL1, FSGS4 {Glomerulosclerosis, focal segmental, 4, susceptibility to}, 612551 (3); {End-stage renal disease, nondiabetic, susceptibility to}, 612551 (3)	
ABCG2	603756	ABCG2, BCRP, ABCP, UAQTL1, GOUT1 [Junior blood group system], 614490 (3); [Uric acid concentration, serum, QTL1], 138900 (3)	
GSTZ1	603758	GSTZ1, MAAI Tyrosinemia, type Ib (1)	
KLK4	603767	KLK4, EMSP1, PRSS17, AI2A1 Amelogenesis imperfecta, type IIA1, 204700 (3)	
TCL1B	603769	TCL1B, TML1 Leukemia/lymphoma, T-cell (2)	
RECQL4	603780	RECQL4, RTS, RECQ4 Rothmund-Thomson syndrome, 268400 (3); RAPADILINO syndrome, 266280 (3); Baller-Gerold syndrome, 218600 (3)	
LITAF	603795	LITAF, CMT1C Charcot-Marie-Tooth disease, type 1C, 601098 (3)	
KCNE2	603796	KCNE2, MIRP1, LQT6, ATFB4 Long QT syndrome-6, 613693 (3); Atrial fibrillation, familial, 4, 611493 (3)	
CHST3	603799	CHST3, C6ST, C6ST1, HSD Spondyloepiphyseal dysplasia with congenital joint dislocations, 143095 (3)	
TGM5	603805	TGM5, TGX Peeling skin syndrome, acral type, 609796 (3)	
MED17	603810	MED17, CRSP6, CRSP77, TRAP80, DRIP80 Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3)	
BANF1	603811	BANF1, BAF, NGPS Nestor-Guillermo progeria syndrome, 614008 (3)	
AXIN1	603816	AXIN1, AXIN Hepatocellular carcinoma, somatic, 114550 (3); Caudal duplication anomaly, 607864 (3)	
GNE	603824	GNE, GLCNE, IBM2, DMRV, NM Sialuria, 269921 (3); Inclusion body myopathy, autosomal recessive, 600737 (3); Nonaka myopathy, 605820 (3)	
NDUFA9	603834	NDUFA9 Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	
NDUFA10	603835	NDUFA10 Leigh syndrome, 256000 (3)	
NDUFB3	603839	NDUFB3 Mitochondrial complex I deficiency, 252010 (3)	
NDUFS3	603846	NDUFS3 Leigh syndrome, 256000 (3)	
NDUFS6	603848	NDUFS6 Complex I, mitochondrial respiratory chain, deficiency of, 252010 (3)	
DNM1L	603850	DNM1L, DRP1, DVLP, DYMPLE, EMPF Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission, 614388 (3)	
PHOX2B	603851	PMX2B, NBPHOX, PHOX2B, NBLST2 Central hypoventilation syndrome, congenital, with or without Hirschsprung disease, 209880 (3); {Neuroblastoma, susceptibility to, 2}, 613013 (3); Neuroblastoma with Hirschsprung disease, 613013 (3)	
SLC25A13	603859	SLC25A13, CTLN2 Citrullinemia, adult-onset type II, 603471 (3); Citrullinemia, type II, neonatal-onset, 605814 (3)	
SLC25A15	603861	SLC25A15, ORNT1, HHH Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3)	
RAB27A	603868	RAB27A, RAM, GS2 Griscelli syndrome, type 2, 607624 (3)	
BAG3	603883	BAG3 Myopathy, myofibrillar, BAG3-related, 612954 (3); Cardiomyopathy, dilated, 1HH, 613881 (3)	
EFTUD2	603892	EFTUD2, KIAA0031, MFDM Mandibulofacial dysostosis with microcephaly, 610536 (3)	
ITM2B	603904	ITM2B, BRI, ABRI, FBD Dementia, familial British, 176500 (3); Dementia, familial Danish, 117300 (3)	
SUCLA2	603921	SUCLA2, MTDPS5 Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with methylmalonic aciduria), 612073 (3)	
HABP2	603924	HABP2, PHBP, HGFAL, FSAP {Carotid stenosis, susceptibility to} (3); {Venous thromboembolism, susceptibility to}, 188050 (3)	
GPHN	603930	GPHN, GPH, KIAA1385, GEPH Molybdenum cofactor deficiency, type C, 252150 (3)	
RP1	603937	RP1, ORP1 Retinitis pigmentosa 1, 180100 (3); {Hypertriglyceridemia, susceptibility to}, 145750 (3)	
SLC19A2	603941	SLC19A2, THTR1, TRMA, THMD1 Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)	
GYG1	603942	GYG1, GSD15 Glycogen storage disease XV, 613507 (3)	
EIF2B5	603945	EIF2B5, LVWM, CACH, CLE Leukoencephalopathy with vanishing white matter, 603896 (3); Ovarioleukodystrophy, 603896 (3)	
KCNMB1	603951	KCNMB1 {Hypertension, diastolic, resistance to}, 608622 (3)	
CLDN16	603959	CLDN16, PCLN1, HOMG3 Hypomagnesemia 3, renal, 248250 (3)	
SCN4A	603967	SCN4A, HYPP, NAC1A, HOKPP2 Hyperkalemic periodic paralysis, type 2, 170500 (3); Paramyotonia congenita, 168300 (3); Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3); Myasthenic syndrome, acetazolamide-responsive, 614198 (3); Hypokalemic periodic paralysis, type 2, 613345 (3)	
POLH	603968	POLH, XPV Xeroderma pigmentosum, variant type, 278750 (3)	
AKAP9	604001	AKAP9, YOTIAO, AKAP450 Long QT syndrome-11, 611820 (3)	
AXIN2	604025	AXIN2 Colorectal cancer, 114500 (3); Oligodontia-colorectal cancer syndrome, 608615 (3)	
GOSR2	604027	GOSR2, GS27, EPM6 Epilepsy, progressive myoclonic 6, 614018 (3)	
EIF2AK3	604032	EIF2AK3, PEK, PERK, WRS Wolcott-Rallison syndrome, 226980 (3)	
RAD50	604040	RAD50, NBSLD Nijmegen breakage syndrome-like disorder, 613078 (3)	
MPDU1	604041	MPDU1, SL15, CDGIF Congenital disorder of glycosylation, type If, 609180 (3)	
DLEC1	604050	DLEC1, DLC1 Lung cancer, 211980 (1); Esophageal cancer, 133239 (1)	
SEPT9	604061	SEPT9, MSF, MSF1, NAPB Leukemia, acute myeloid, therapy-related (1); Ovarian carcinoma (1); Amyotrophy, hereditary neuralgic, 162100 (3)	
RGS9	604067	RGS9, PERRS Bradyopsia, 608415 (3)	
PPP1R17	604088	GSBS {Hypercholesterolemia, susceptibility to}, 143890 (3)	
EDAR	604095	EDAR, DL, ED3, EDA3, HRM1 Ectodermal dysplasia, hypohidrotic, autosomal dominant, 129490 (3); Ectodermal dysplasia, hypohidrotic, autosomal recessive, 224900 (3); [Hair morphology 1, hair thickness], 612630 (3)	
GRM6	604096	GRM6, MGLUR6, CSNB1B Night blindness, congenital stationary, type 1B, 257270 (3)	
MYOT	604103	TTID, MYOT Muscular dystrophy, limb-girdle, type 1A, 159000 (3); Myotilinopathy, 609200 (3); Myopathy, spheroid body, 182920 (3)	
GPR56	604110	GPR56, TM7XN1, BFPP Polymicrogyria, bilateral frontoparietal, 606854 (3)	
PLCB2	604114	PLCB2 Platelet PLC beta-2 deficiency (1)	
KCNQ1OT1	604115	KCNQ10T1, LIT1 Beckwith-Wiedemann syndrome, 130650 (3)	
RBBP8	604124	RBBP8, RIM, SCKL2, JWDS Pancreatic carcinoma, somatic (3); Seckel syndrome 2, 606744 (3); Jawad syndrome, 251255 (3)	
TBX15	604127	TBX15 Cousin syndrome, 260660 (3)	
ADAMTS13	604134	ADAMTS13, VWFCP, TTP Thrombotic thrombocytopenic purpura, familial, 274150 (3)	
TYROBP	604142	TYROBP, PLOSL, DAP12 Nasu-Hakola disease, 221770 (3)	
SLC7A9	604144	SLC7A9, CSNU3 Cystinuria, 220100 (3)	
SGCE	604149	SGCE, DYT11 Dystonia-11, myoclonic, 159900 (3)	
SLC6A5	604159	SLC6A5, GLYT2, HKPX3 Hyperekplexia 3, 614618 (3)	
KISS1R	604161	KISS1R, GPR54 Hypogonadotropic hypogonadism, 146110 (3); Precocious puberty, central, 176400 (3)	
RPL11	604175	RPL11, DBA7 Diamond-Blackfan anemia 7, 612562 (3)	
SLC22A4	604190	SLC22A4, OCTN1 {Rheumatoid arthritis, susceptibility to}, 180300 (3)	
SLC27A4	604194	SLC27A4, FATP4, IPS Ichthyosis prematurity syndrome, 608649 (3)	
SNAP29	604202	SNAP29, CEDNIK Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome, 609528 (3)	
CRB1	604210	CRB1, RP12, LCA8 Retinitis pigmentosa-12, autosomal recessive, 600105 (3); Leber congenital amaurosis 8, 613835 (3); Pigmented paravenous chorioretinal atrophy, 172870 (3)	
KRIT1	604214	CCM1, CAM, KRIT1 Cerebral cavernous malformations-1, 116860 (3); Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 (3); Cavernous malformations of CNS and retina, 116860 (3)	
SLC34A2	604217	SLC34A2 Pulmonary alveolar microlithiasis, 265100 (3); ?Testicular microlithiasis, 610441 (3)	
CRLF1	604237	CRLF1, CISS Cold-induced sweating syndrome, 272430 (3); Crisponi syndrome, 601378 (3)	
CD2AP	604241	CD2AP, CMS Glomerulosclerosis, focal segmental, 3, 607832 (3)	
RNF6	604242	RNF6 Esophageal carcinoma, somatic, 133239 (3)	
DLC1	604258	DLC1 Colorectal cancer, somatic (3)	
STAT5B	604260	STAT5B Leukemia, acute promyelocytic, STAT5B/RARA type (3); Growth hormone insensitivity with immunodeficiency, 245590 (3)	
LRP4	604270	LRP4, MEGF7, CLSS, SOST2 Cenani-Lenz syndactyly syndrome, 212780 (3); Sclerosteosis 2, 614305 (3)	
SCO2	604272	SCO2 Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency, 604377 (3)	
CTNND2	604275	CTNND2, NPRAP Mental retardation in cri-du-chat syndrome, 123450 (2)	
SPAST	604277	SPAST, SPG4 Spastic paraplegia 4, autosomal dominant, 182601 (3)	
PRG4	604283	PRG4, CACP, MSF, SZP, HAPO Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)	
AGXT	604285	AGXT, SPAT Hyperoxaluria, primary, type 1, 259900 (3)	
RAD54B	604289	RAD54B Lymphoma, non-Hodgkin (3); Colon adenocarcinoma (3)	
GRHPR	604296	GRHPR, GLXR Hyperoxaluria, primary, type II, 260000 (3)	
HLA-DQB1	604305	HLA-DQB1, CELIAC1 {Creutzfeldt-Jakob disease, variant, resistance to}, 123400 (3); {Multiple sclerosis, susceptibility to}, 126200 (3); {Celiac disease, susceptibility to}, 212750 (3)	
PLDN	604310	PLDN, PA, HPS9 Hermansky-pudlak syndrome 9, 614171 (3)	
CST3	604312	CST3, ARMD11 Cerebral amyloid angiopathy, 105150 (3); Macular degeneration, age-related, 11, 611953 (3)	
GALK1	604313	GALK1 Galactokinase deficiency with cataracts, 230200 (3)	
TINF2	604319	TINF2, TIN2, DKCA3 Dyskeratosis congenita, autosomal dominant 3, 613990 (3); Revesz syndrome, 268130 (3)	
SLC17A5	604322	SLC17A5, SIASD, SLD Salla disease, 604369 (3); Sialic acid storage disorder, infantile, 269920 (3)	
PPP2R2B	604325	PPP2R2B Spinocerebellar ataxia 12, 604326 (3)	
B4GALT7	604327	B4GALT7, XGALT1, XGPT1 Ehlers-Danlos syndrome, progeroid form, 130070 (3)	
INTS6	604331	DDX26, DICE1 {Nonsmall cell lung cancer} (2)	
CHIC2	604332	CHIC2, BTL {Leukemia, acute myeloid}, 601626 (3)	
MAN1B1	604346	MAN1B1, MRT15 Mental retardation, autosomal recessive 15, 614202 (3)	
LAMC3	604349	LAMC3, OCCM Cortical malformations, occipital, 614115 (3)	
PROM1	604365	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4 Retinitis pigmentosa 41, 612095 (3); Cone-rod dystrophy 12, 612657 (3); Stargardt disease 4, 603786 (3); Macular dystrophy, retinal, 2, 608051 (3)	
DNAI1	604366	DNAI1, CILD1, ICS, PCD Ciliary dyskinesia, primary, 1, with or without situs inversus, 244400 (3)	
ATP2C1	604384	ATP2C1, BCPM, HHD Hailey-Hailey disease, 169600 (3)	
TRPS1	604386	TRPS1 Trichorhinophalangeal syndrome, type I, 190350 (3); Trichorhinophalangeal syndrome, type III, 190351 (3)	
AIPL1	604392	AIPL1, LCA4 Leber congenital amaurosis 4, 604393 (3); Retinitis pigmentosa, juvenile, 604393 (3); Cone-rod dystrophy, 604393 (3)	
MLH3	604395	MLH3, HNPCC7 Colorectal cancer, somatic, 114500 (3); Colon cancer, hereditary nonpolyposis, type 7, 614385 (3); Endometrial cancer, 608089 (3)	
ST3GAL5	604402	SIAT9, ST3GALV Amish infantile epilepsy syndrome, 609056 (3)	
GPC6	604404	GPC6, OMIMD1 Omodysplasia 1, 258315 (3)	
GJB6	604418	GJB6, CX30, DFNA3B, HED, ED2, DFNB1B Deafness, autosomal dominant 3B, 612643 (3); Ectodermal dysplasia, hidrotic, 129500 (3); Deafness, autosomal recessive 1B, 612645 (3); Deafness, digenic GJB2/GJB6, 220290 (3)	
KCNE3	604433	KCNE3, HOKPP, HYPP Brugada syndrome 6, 613119 (3)	
ACSL6	604443	ACSL6, FACL6, ACS2 Myelodysplastic syndrome (3); Myelogenous leukemia, acute (3)	
SARDH	604455	SARDH, SARD, SAR [Sarcosinemia], 268900 (2)	
SP110	604457	SP110, IFI41, IFI75, VODI Hepatic venoocclusive disease with immunodeficiency, 235550 (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	
IRAK3	604459	IRAK3, IRAKM, ASRT5 {Asthma susceptibility 5}, 611064 (3)	
NR2E3	604485	NR2E3, PNR, ESCS, RP37 Enhanced S-cone syndrome, 268100 (3); Retinitis pigmentosa 37, 611131 (3)	
TCAP	604488	TCAP, LGMD2G, CMD1N Muscular dystrophy, limb-girdle, type 2G, 601954 (3); Cardiomyopathy, dilated, 1N, 607487 (3)	
AMACR	604489	AMACR, CBAS4, AMACRD Alpha-methylacyl-CoA racemase deficiency, 614307 (3); Bile acid synthesis defect, congenital, 4, 214950 (3)	
SACS	604490	SACS, ARSACS Spastic ataxia, Charlevoix-Saguenay type, 270550 (3)	
TRIP11	604505	TRIP11, TRIP230, CEV14, ACG1A Achondrogenesis, type IA, 200600 (3)	
BLNK	604515	BLNK, SLP65, AGM4 Agammaglobulinemia 4, 613502 (3)	
IDH3B	604526	IDH3B, RP46 Retinitis pigmentosa 46, 612572 (3)	
ADAMTS2	604539	ADAMTS2, NPI Ehlers-Danlos syndrome, type VIIC, 225410 (3)	
ICOS	604558	ICOS, AILIM, CVID1 Immunodeficiency, common variable, 1, 607594 (3)	
ALG6	604566	ALG6, CDG1C Congenital disorder of glycosylation, type Ic, 603147 (3)	
CNTNAP2	604569	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1 Cortical dysplasia-focal epilepsy syndrome, 610042 (3); {Autism susceptibility 15}, 612100 (3); Pitt-Hopkins like syndrome 1, 610042 (3)	
FZD4	604579	FZD4, EVR1 Exudative vitreoretinopathy, 133780 (3); Retinopathy of prematurity, 133780 (3)	
FBLN5	604580	FBLN5, ARMD3, ADCL2, ARCL1A Cutis laxa, autosomal recessive, type IA, 219100 (3); Cutis laxa, autosomal dominant 2, 614434 (3); Macular degeneration, age-related, 3, 608895 (3)	
AFG3L2	604581	AFG3L2, SCA28, SPAX5 Spinocerebellar ataxia 28, 610246 (3); Ataxia, spastic, 5, autosomal recessive, 614487 (3)	
PDGFRL	604584	PDGFRL, PDGRL, PRLTS Hepatocellular cancer, 114550 (3); Colorectal cancer, 114500 (3)	
NEK1	604588	NEK1, SRPS2 Short rib-polydactyly syndorme, type II, 263520 (3)	
FCGR2B	604590	FCGR2B, CD32 {Systemic lupus erythematosus, susceptibility to}, 152700 (3); {Malaria, resistance to}, 611162 (3)	
TCIRG1	604592	TCIRG1, TIRC7, OC116, OPTB1 Osteopetrosis, autosomal recessive 1, 259700 (3)	
KALRN	604605	KALRN, HAPIP, DUO, CHDS5 {Coronary heart disease, susceptibility to, 5}, 608901 (3)	
BLM	604610	RECQL3, RECQ2, BLM, BS Bloom syndrome, 210900 (3)	
WRN	604611	RECQL2, RECQ3, WRN Werner syndrome, 277700 (3)	
TBX19	604614	TBX19 Adrenocorticotropic hormone deficiency, 201400 (3)	
LGI1	604619	LGI1, EPT, ETL1, ADLTE, ADPAEF Epilepsy, familial temporal lobe, 1, 600512 (3)	
HSPB3	604624	HSPB3, HSPL27, HMN2C, DHMN2C Neuronopathy, distal hereditary motor, type IIC, 613376 (3)	
MMP20	604629	MMP20, AI2A2 Amelogenesis imperfecta, type IIA2, 612529 (3)	
NR0B2	604630	NR0B2, SHP Obesity, mild, early-onset, 601665 (3)	
EFEMP2	604633	EFEMP2, FBLN4, UPH1, ARCL1B Cutis laxa, autosomal recessive, type IB, 614437 (3)	
ACTN4	604638	ACTN4, FSGS1, FSGS Glomerulosclerosis, focal segmental, 1, 603278 (3)	
MAPK8IP1	604641	MAPK8IP1, IB1 {Diabetes mellitus, noninsulin-dependent}, 125853 (3)	
SLC40A1	604653	SLC40A1, SLC11A3, FPN1, IREG1, HFE4 Hemochromatosis, type 4, 606069 (3)	
CD209	604672	CD209, CDSIGN {Dengue fever, protection against}, 614371 (3); {HIV type 1, susceptibility to}, 609423 (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	
MLLT11	604684	MLLT11, AF1Q Leukemia, acute myelomonocytic (3)	
HOXA2	604685	HOXA2 Microtia, hearing impairment, and cleft palate, 612290 (3)	
PTGDR	604687	PTGDR, AS1, ASRT1 {Asthma, susceptibility to, 1}, 607277 (3)	
AKAP10	604694	AKAP10 {Cardiac conduction defect, susceptibility to}, 115080 (3)	
MERTK	604705	MERTK, RP38 Retinitis pigmentosa 38, 613862 (3)	
LTBP4	604710	LTBP4, LTBP4S, LTBP4L Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities, 613177 (3)	
RRM2B	604712	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy), 612075 (3); Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 5, 613077 (3); Mitochondrial DNA depletion syndrome 8B (MNGIE type), 612075 (3)	
TSPYL1	604714	TSPYL1, TSPYL, SIDDT Sudden infant death with dysgenesis of the testes syndrome, 608800 (3)	
TFR2	604720	TFR2, HFE3 Hemochromatosis, type 3, 604250 (3)	
TSFM	604723	TSFM, COXPD3 Combined oxidative phosphorylation deficiency 3, 610505 (3)	
AKR1D1	604741	AKR1D1, SRD5B1, CBAS2 Bile acid synthesis defect, congenital, 2, 235555 (3)	
SYCP3	604759	SYCP3, SCP3, COR1, SPGF4 Spermatogenic failure 4, 270960 (3); {Pregnancy loss, susceptibility to} (3)	
ARHGEF12	604763	ARHGEF12, LARG, KIAA0382 Leukemia, acute myeloid, 601626 (3)	
NPHS2	604766	PDCN, NPHS2, SRN1 Nephrotic syndrome, type 2, 600995 (3)	
DEC1	604767	DEC1 Esophageal squamous cell carcinoma, 133239 (1)	
ACAD8	604773	ACAD8 Isobutyryl-CoA dehydrogenase deficiency, 611283 (3)	
ANGPTL3	604774	ANGPTL3, ANGPT5, FHBL2 Hypobetalipoproteinemia, familial, 2, 605019 (3)	
ABHD5	604780	ABHD5, CGI58, IECN2, NCIE2 Chanarin-Dorfman syndrome, 275630 (3)	
EVC	604831	EVC Ellis-van Creveld syndrome, 225500 (3); Weyers acrodental dysostosis, 193530 (3)	
SLCO1B1	604843	SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	
MALT1	604860	MALT1, MLT MALT lymphoma (3)	
CD207	604862	CD207, LANGERIN, CLEC4K [Birbeck granule deficiency], 613393 (3)	
LRAT	604863	LRAT, LCA14 Retinal dystrophy, early-onset severe, 613341 (3); Leber congenital amaurosis 14, 613341 (3); Retinitis pigmentosa, juvenile, 613341 (3)	
SLC12A6	604878	SLC12A6, KCC3A, KCC3B, KCC3, ACCPN Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)	
NEUROG3	604882	NEUROG3, NGN3, ATOH5 Diarrhea 4, malabsorptive, congenital, 610370 (3)	
TBX21	604895	TBX21, TBET {Asthma, aspirin-induced, susceptibility to}, 208550 (3); Asthma and nasal polyps, 208550 (3)	
MKKS	604896	MKKS, HMCS, KMS, MKS, BBS6 McKusick-Kaufman syndrome, 236700 (3); Bardet-Biedl syndrome 6, 209900 (3)	
TNFRSF13B	604907	TNFRSF13B, TACI, CVID2 Immunoglobulin A deficiency 2, 609529 (3); Immunodeficiency, common variable, 2, 240500 (3)	
CTDP1	604927	CTDP1, FCP1, CCFDN Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)	
MUTYH	604933	MUTYH, MYH Adenomas, multiple colorectal, 608456 (3); Gastric cancer, somatic, 137215 (3); Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas, 132600 (3)	
TBCE	604934	TBCE, KCS, KCS1, HRD Kenny-Caffey syndrome-1, 244460 (3); Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3)	
SLC26A5	604943	SLC26A5, PRES Deafness, autosomal recessive 61, 613865 (3)	
KIR3DL1	604946	KIR3DL1, NKAT3, NKB1, AMB11, KIR3DS1 {AIDS, delayed/rapid progression to}, 609423 (3)	
PDE11A	604961	PDE11A, PDE11A1, PDE11A2, PDE11A3, PPNAD2 Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)	
FCN3	604973	FCN3, HAKA1 Immunodeficiency due to ficolin 3 deficiency, 613860 (3)	
HPS1	604982	HPS1 Hermansky-Pudlak syndrome 1, 203300 (3)	
POLG2	604983	POLG2, POLGB, PEOA4 Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4, 610131 (3)	
SPTBN2	604985	SPTBN2, SCA5 Spinocerebellar ataxia 5, 600224 (3)	
SLC9A3R1	604990	SLC9A3R1, EBP50, NHERF1, NPHLOP2 Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3)	
SPINK5	605010	SPINK5, LEKTI Netherton syndrome, 256500 (3); Atopy, 147050 (3)	
STX11	605014	STX11, FHL4, HPLH4, HLH4 Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3)	
CYLD	605018	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS Cylindromatosis, familial, 132700 (3); Brooke-Spiegler syndrome, 605041 (3); Trichoepithelioma, multiple familial, 1, 601606 (3)	
VSX1	605020	VSX1, RINX, PPCD, PPD, KTCN1, CAASDS Keratoconus 1, 148300 (3); Corneal dystrophy, hereditary polymorphous posterior, 122000 (3); Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3)	
MED23	605042	MED23, MRT18 Mental retardation, autosomal recessive 18, 614249 (3)	
TRIM37	605073	TRIM37, MUL, KIAA0898 Mulibrey nanism, 253250 (3)	
TARDBP	605078	TARDBP, TDP43, ALS10 Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3); Frontotemporal lobar degeneration, TARDBP-related, 612069 (3)	
CNGB3	605080	CNGB3, ACHM3, ACHM1 Achromatopsia-3, 262300 (3); Macular degeneration, juvenile, 248200 (3)	
RASSF1	605082	RASSF1 Lung cancer, 211980 (2)	
FRZB	605083	FRZB, FRZB1, SRFP3, OS1 {Osteoarthritis susceptibility 1}, 165720 (3)	
TREM2	605086	TREM2 Nasu-Hakola disease, 221770 (3)	
SH2B3	605093	SH2B3, LNK Myelofibrosis, somatic, 254450 (3); Thrombocythemia, somatic, 187950 (3); Erythrocytosis, somatic, 133100 (3)	
PPM1D	605100	PPM1D, WIP1 Breast cancer, 114480 (3)	
TAB2	605101	TAB2, MAP3K7IP2, KIAA0733, CHTD2 Congenital heart disease, nonsyndromic, 2, 612863 (3)	
MASP2	605102	MASP2 MASP2 deficiency, 613791 (3)	
AASS	605113	AASS Hyperlysinemia, 238700 (3); Saccharopinuria, 268700 (1)	
SPINT2	605124	SPINT2, HAI2, DIAR3 Diarrhea 3, secretory sodium, congenital, syndromic, 270420 (3)	
WWOX	605131	WWOX, FOR Esophageal squamous cell carcinoma, 133239 (3)	
ANKH	605145	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD Craniometaphyseal dysplasia, 123000 (3); Chondrocalcinosis 2, 118600 (3)	
DIRAS3	605193	ARHI Ovarian cancer (1)	
CFC1	605194	CFC1, CRYPTIC, HTX2, DTGA2 Heterotaxy, visceral, 2, autosomal, 605376 (3); Double-outlet right ventricle, 217095 (3); Transposition of the great arteries, dextro-looped 2, 613853 (3)	
MESP2	605195	MESP2, SCDO2 Spondylocostal dysostosis, autosomal recessive 2, 608681 (3)	
TOR1A	605204	DYT1, TOR1A Dystonia-1, torsion, 128100 (3); Dystonia, early-onset atypical, with myoclonic features (3); {Dystonia-1, modifier of} (3)	
ADCY10	605205	SAC, HCA2 {Hypercalciuria, absorptive, susceptibility to}, 143870 (3)	
HCN4	605206	HCN4, SSS2 Sick sinus syndrome 2, 163800 (3); Brugada syndrome 8, 613123 (3)	
CYP26B1	605207	CYP26B1, CYP26A2, P450RAI2, RHFCA Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies, 614416 (3)	
DISC1	605210	DISC1, SCZD9 {Schizophrenia, susceptibility to}, 604906 (3); {Schizoaffective disorder, susceptibility to}, 181500 (3)	
DIABLO	605219	SMAC, DIABLO, DFNA64 Deafness, autosomal dominant 64, 614152 (3)	
WNK1	605232	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2 Pseudohypoaldosteronism, type IIC, 614492 (3); Neuropathy, hereditary sensory and autonomic, type II, 201300 (3)	
CORIN	605236	CORIN, CRN, TMPRSS10, ATC2, PEE5 Preeclampsia/eclampsia 5, 614595 (3)	
HNMT	605238	HNMT {Asthma, susceptibility to}, 600807 (3)	
ATP6V0A4	605239	ATP6V0A4, ATP6N1B, VPP2, RTA1C, RTADR Renal tubular acidosis, distal, autosomal recessive, 602722 (3)	
USH1C	605242	USH1C, DFNB18 Usher syndrome, type 1C, 276904 (3); Deafness, autosomal recessive 18, 602092 (3)	
MCOLN1	605248	MCOLN1, ML4 Mucolipidosis IV, 252650 (3)	
NCSTN	605254	NCSTN Acne inversa, familial, 1, 142690 (3)	
AICDA	605257	AICDA, AID, HIGM2 Immunodeficiency with hyper-IgM, type 2, 605258 (3)	
NDRG1	605262	NDRG1, HMSNL, CMT4D Charcot-Marie-Tooth disease, type 4D, 601455 (3)	
JPH2	605267	JPH2, JP2, CMH17 Cardiomyopathy, familial hypertrophic 17, 613873 (3)	
JPH3	605268	JPH3, JP3, HDL2 Huntington disease-like 2, 606438 (3)	
SGSH	605270	SGSH, MPS3A, SFMD Mucopolysaccharidisis type IIIA (Sanfilippo A), 252900 (3)	
SERPINA10	605271	SERPINA10, ZPI {Venous thrombosis, susceptibility to} (3)	
TSC1	605284	TSC1, LAM Tuberous sclerosis-1, 191100 (3); Lymphangioleiomyomatosis, 606690 (3); Focal cortical dysplasia, Taylor balloon cell type, 607341 (3)	
CAPN10	605286	CAPN10, NIDDM1 {Diabetes mellitus, noninsulin-dependent 1}, 601283 (3)	
OPA1	605290	OPA1, NTG, NPG Optic atrophy 1, 165500 (3); {Glaucoma, normal tension, susceptibility to}, 606657 (3); Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy, 125250 (3)	
CHST6	605294	CHST6, MCDC1 Macular corneal dystrophy, 217800 (3)	
TACC3	605303	TACC3 {?Bladder cancer susceptibility}, 109800 (2)	
RBM8A	605313	RBM8A, RBM8B, TAR, C1DELq21.1, DEL1q21.1 Thrombocytopenia-absent radius syndrome, 274000 (3)	
HDAC4	605314	HDAC4, HDACA, BDMR, AHO3 Brachydacytly-mental retardation syndrome, 600430 (3)	
FOXP2	605317	FOXP2, SPCH1, TNRC10, CAGH44 Speech-language disorder-1, 602081 (3)	
CYP3A5	605325	CYP3A5, P450PCN3 {Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)	
CFHR3	605336	CFHR3, FHR3, HLF4, CFHL3 {Macular degeneration, age-related, reduced risk of}, 603075 (3); {Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)	
PADI4	605347	PADI4, PADI5, PAD {Rheumatoid arthritis, susceptibility to}, 180300 (3)	
MFHAS1	605352	MFHAS1, MASL1 Malignant fibrous histiocytoma (2)	
GHRL	605353	GHRL {Obesity, susceptibility to}, 601665 (3)	
GAD1	605363	GAD1, SCP, CPSQ1 Cerebral palsy, spastic quadriplegic, 1, 603513 (3)	
ELAC2	605367	ELAC2, HPC2 {Prostate cancer, susceptibility to}, 176807 (3)	
ARHGAP26	605370	ARHGAP26, GRAF Leukemia, juvenile myelomonocytic, 607785 (3)	
ARFGEF2	605371	ARFGEF2, BIG2, PVNH2 Periventricular heterotopia with microcephaly, 608097 (3)	
DMPK	605377	DMPK, DM, DMK Myotonic dystrophy 1, 160900 (3)	
AAAS	605378	AAAS, AAA Achalasia-addisonianism-alacrimia syndrome, 231550 (3)	
GAN	605379	GAN, GAN1 Giant axonal neuropathy-1, 256850 (3)	
FGF23	605380	FGF23, ADHR, HPDR2, PHPTC Hypophosphatemic rickets, autosomal dominant, 193100 (3); Osteomalacia, tumor-induced (1); Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)	
IL21R	605383	IL21R Lymphoma, diffuse large B-cell (2); [IgE, elevated level of], 147050 (3)	
MINPP1	605391	MINPP1, HIPER1 Thyroid carcinoma, follicular, 188470 (3)	
FGFR1OP	605392	FGFR1OP, FOP Myeloproliferative disorder (2)	
ALX4	605420	ALX4, PFM2, FPP, FND2 Parietal foramina 2, 609597 (3); Frontonasal dysplasia 2, 613451 (3)	
DHH	605423	DHH, SRXY7, GDXYM 46XY partial gonadal dysgenesis, with minifascicular neuropathy, 607080 (3); 46XY sex reversal 7, 233420 (3)	
GJB4	605425	GJB4, CX30.3 Erythrokeratodermia variabilis with erythema gyratum repens, 133200 (3)	
TRPV4	605427	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1 Brachyolmia type 3, 113500 (3); Spondylometaphyseal dysplasia, Kozlowski type, 184252 (3); Metatropic dysplasia, 156530 (3); Hereditary motor and sensory neuropathy, type IIc, 606071 (3); Scapuloperoneal spinal muscular atrophy, 181405 (3); [Sodium serum level QTL 1], 613508 (3); Parastremmatic dwarfism, 168400 (3); SED, Maroteaux type, 184095 (3); Spinal muscular atrophy, distal, congenital nonprogressive, 600175 (3)	
PRKCH	605437	PRKCH, PKCL, PRKCL {Cerebral infarction, susceptibility to}, 601367 (3)	
ADIPOQ	605441	ADIPOQ, APM1, GBP28, ADIPQTL1 Adiponectin deficiency, 612556 (3)	
RPGRIP1	605446	RPGRIP1, LCA6, CORD13 Leber congenital amaurosis 6, 613826 (3); Cone-rod dystrophy 13, 608194 (3)	
ABCB6	605452	ABCB6, MTABC3, MCOPCB7, LAN Microphthalmia, isolated, with coloboma 7, 614497 (3); [Blood group, Langereis system], 111600 (3)	
ABCG5	605459	ABCG5 Sitosterolemia, 210250 (3)	
ABCG8	605460	ABCG8, GBD4 Sitosterolemia, 210250 (3); Gallbladder disease 4, 611465 (3)	
IL17RA	605461	IL17RA, IL17R, CANDF5 Candidiasis, familial, 5, autosomal recessive, 613953 (3)	
ASPM	605481	ASPM, MCPH5 Microcephaly, primary autosomal recessive, 5, 608716 (3)	
DNAI2	605483	DNAI2, CILD9 Ciliary dyskinesia, primary, 9, with or without situs inversus, 612444 (3)	
SLCO1B3	605495	SLCO1B3, OATP8, OATP1B3, SLC21A8, HBLRR Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	
CRTAP	605497	CRTAP, CASP, OI7 Osteogenesis imperfecta, type VII, 610682 (3)	
IL36RN	605507	IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP Psoriasis, generalized pustular, 614204 (3)	
TMPRSS3	605511	TMPRSS3, ECHOS1, DFNB8, DFNB10 Deafness, autosomal recessive 8, childhood onset, 601072 (3); Deafness, autosomal recessive 10, congenital, 605316 (3)	
ELOVL4	605512	ELOVL4, ADMD, STGD2, STGD3, ISQMR Stargardt disease 3, 600110 (3); Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3); Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3)	
PCDH15	605514	PCDH15, DFNB23, USH1F Usher syndrome, type 1F, 602083 (3); Deafness, autosomal recessive 23, 609533 (3); Usher syndrome, type 1D/F digenic, 601067 (3)	
FOXP1	605515	FOXP1, QRF1 Mental retardation with language impairment and autistic features, 613670 (3)	
CDH23	605516	CDH23, USH1D Usher syndrome, type 1D, 601067 (3); Deafness, autosomal recessive 12, 601386 (3); Usher syndrome, type 1D/F digenic, 601067 (3)	
LPIN1	605518	LPIN1 Myoglobinuria, acute recurrent, autosomal recessive, 268200 (3)	
LPIN2	605519	LPIN2 Majeed syndrome, 609628 (3)	
LMBR1	605522	LMBR1, ACHP, C7orf2, PPD2 Acheiropody, 200500 (3); Polydactyly, preaxial type II, 174500 (3); Triphalangeal thumb, type I, 174500 (3); Triphalangeal thumb-polysyndactyly syndrome, 174500 (3); Syndactyly, type IV, 186200 (3)	
CDT1	605525	CDT1 Meier-Gorlin syndrome 4, 613804 (3)	
GP6	605546	GP6, GPIV, BDPLT11 Bleeding disorder, platelet-type, 11, 614201 (3)	
CD244	605554	CD244, NAIL, NKR2B4, SLAMF4 {Rheumatoid arthritis, susceptibility to}, 180300 (3)	
AIP	605555	AIP, XAP2, ARA9 Pituitary adenoma, growth hormone-secreting, 102200 (3); Pituitary adenoma, prolactin-secreting, 600634 (3); Pituitary adenoma, ACTH-secreting, 219090 (3)	
RETN	605565	RETN, RSTN, FIZZ3 {Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3); {Hypertension, insulin resistance-related, susceptibility to}, 125853 (3)	
RTN4R	605566	RTN4R, NOGOR {Schizophrenia, susceptibility to}, 181500 (3)	
HSD17B3	605573	HSD17B3, EDH17B3 Pseudohermaphroditism, male, with gynecomastia, 264300 (3)	
IFITM3	605579	IFITM3 {Influenza, severe, susceptibility to} (3)	
SF3B1	605590	SF3B1, SF3B155, SAP155, MDS Myelodysplastic syndrome, somatic, 614286 (3)	
SF3B4	605593	SF3B4, SF3B49, SAP49, AFD1 Acrofacial dysostosis 1, Nager type, 154400 (3)	
FOXL2	605597	FOXL2, BPES, BPES1, PFRK, POF3 Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 (3); Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3); Premature ovarian failure 3, 608996 (3)	
MYOZ2	605602	MYOZ2, CMH16 Cardiomyopathy, familial hypertrophic, 16, 613838 (3)	
CLDN14	605608	CLDN14, DFNB29 Deafness, autosomal recessive 29, 614035 (3)	
PNKP	605610	PNKP, PNK, MCSZ, EIEE10 Epileptic encephalopathy, early infantile, 10, 613402 (3)	
SLC6A20	605616	SLC6A20, XT3 Hyperglycinuria, 138500 (3); Iminoglycinuria, digenic, 242600 (3)	
SLC35A1	605634	SLC35A1, CST, CDG2F Congenital disorder of glycosylation, type IIf, 603585 (3)	
SLC26A4	605646	SLC26A4, PDS, DFNB4, EVA, TDH2B Pendred syndrome, 274600 (3); Enlarged vestibular aqueduct, 600791 (3)	
FBXO7	605648	FBXO7, FBX7, FBX, PKPS, PARK15 Parkinson disease 15, autosomal recessive, 260300 (3)	
TRPM7	605692	TRPM7, LTRPC7, CHAK {Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1, susceptibility to}, 105500 (3)	
VAPB	605704	VAPB, VAPC, ALS8 Amyotrophic lateral sclerosis 8, 608627 (3); Spinal muscular atrophy, late-onset, Finkel type, 182980 (3)	
RIPK4	605706	RIPK4, NKRD3, DIK Popliteal pterygium syndrome, lethal type, 263650 (3)	
SPTLC1	605712	SPTLC1, LBC1, SPT1, HSN1, HSAN Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3)	
SPTLC2	605713	SPTLC2, KIAA0526, SPT2, LCB2, HSN1C, NSAN1C Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)	
PRX	605725	PRX, CMT4F Dejerine-Sottas disease, autosomal recessive, 145900 (3); Charcot-Marie-Tooth disease, type 4F, 145900 (3)	
SOST	605740	SOST, VBCH, CDD Sclerosteosis, 269500 (3); Van Buchem disease, 239100 (3); Craniodiaphyseal dysplasia, autosomal dominant, 122860 (3)	
TUBA8	605742	TUBA8, TUBAL2 Polymicrogyria with optic nerve hypoplasia, 613180 (3)	
LDLRAP1	605747	LDLRAP1, ARH, FHCB2, FHCB1 Hypercholesterolemia, familial, autosomal recessive, 603813 (3)	
BCMO1	605748	BCMO1, BCDO, BCO1 Hypercarotenemia and vitamin A deficiency, autosomal dominant, 115300 (3)	
TRIM33	605769	TRIM33, TIF1G, RFG7, PTC7 Thyroid carcinoma, papillary, 188550 (3)	
KLHL3	605775	KLHL3, PHA2D Pseudohypoaldosteronism, type IID, 614495 (3)	
AMN	605799	AMN Megaloblastic anemia-1, Norwegian type, 261100 (3)	
ZEB2	605802	ZEB2, ZFHX1B, SMADIP1, SIP1 Mowat-Wilson syndrome, 235730 (3)	
MRPS22	605810	MRPS22, C3orf5, COXPD5 Combined oxidative phosphorylation deficiency 5, 611719 (3)	
NUP62	605815	NUP62, SNDI, IBSN Striatonigral degeneration, infantile, 271930 (3)	
TMC6	605828	TMC6, EVER1, EV1 Epidermodysplasia verruciformis, 226400 (3)	
TMC8	605829	TMC8, EVER2, EV2 Epidermodysplasia verruciformis, 226400 (3)	
HERC2	605837	HERC2, SHEP1 [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3); [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)	
DMGDH	605849	DMGDH, DMGDHD Dimethylglycine dehydrogenase deficiency, 605850 (3)	
CLEC4M	605872	CLEC4M, CD209L, LSIGN, DCSIGNR SARS infection, protection against (2)	
KCNK9	605874	KCNK9, TASK3 Birk-Barel mental retardation dysmorphism syndrome, 612292 (3)	
KAT6B	605880	KAT6B, MYST4, MORF, GTPTS SBBYSS syndrome, 603736 (3); Genitopatellar syndrome, 606170 (3)	
SLC35C1	605881	SLC35C1, FUCT1, CDG2C Congenital disorder of glycosylation, type IIc, 266265 (3)	
BRIP1	605882	BRIP1, BACH1, FANCJ Breast cancer, early-onset, 114480 (3); Fanconi anemia, complementation group J, 609054 (3)	
LDB3	605906	LDB3, ZASP, CYPHER, KIAA01613, CMD1C, LVNC3 Myopathy, myofibrillar, ZASP-related, 609452 (3); Cardiomyopathy, dilated 1C, 601493 (3); Left ventricular noncompaction 3, with or without dilated cardiomyopathy, 601493 (3)	
ALG1	605907	ALG1, HMAT1, HMT1, CDG1K Congenital disorder of glycosylation, type Ik, 608540 (3)	
MLC1	605908	MLC1, LVM, VL Megalencephalic leukoencephalopathy with subcortical cysts, 604004 (3)	
STIM1	605921	STIM1 Immune dysfunction, with T-cell inactivation due to calcium entry defect 2, 612783 (3)	
PCNT	605925	PCNT, PCNT2, KEN, SCKL4, MOPD2 Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)	
PIGL	605947	PIGL, CHIME CHIME syndrome, 280000 (3)	
DPM3	605951	DPM3, CDG1O Congenital disorder of glycosylation, type Io, 612937 (3)	
NOD2	605956	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1 {Inflammatory bowel disease 1}, 266600 (3); Blau syndrome, 186580 (3); {Psoriatic arthritis, susceptibility to}, 607507 (3); Sarcoidosis, early-onset, 609464 (3)	
VPS13A	605978	VPS13A, CHAC Choreoacanthocytosis, 200150 (3)	
UBR1	605981	UBR1, JBS Johanson-Blizzard syndrome, 243800 (3)	
DCLRE1C	605988	DCLRE1C, ARTEMIS, SCIDA Severe combined immunodeficiency, Athabascan type, 602450 (3); Omenn syndrome, 603554 (3)	
PDP1	605993	PDP1, PPM2C, PDP1, PDPC Pyruvate dehydrogenase phosphatase deficiency, 608782 (3)	
KIF1B	605995	KIF1B, CMT2A, CMT2A1, NBLST1 Charcot-Marie-Tooth disease, type 2A1, 118210 (3); Pheochromocytoma, 171300 (3); {Neuroblastoma, susceptibility to, 1}, 256700 (3)	
HAX1	605998	HAX1, SCN3 Neutropenia, severe congenital 3, autosomal recessive, 610738 (3)	
BTNL2	606000	BTNL2, SS2 {Sarcoidosis, susceptibility to, 2}, 612387 (3)	
ALX3	606014	ALX3, FND1 Frontonasal dysplasia 1, 136760 (3)	
RNASEH2A	606034	RNASEH2A, RNHIA, AGS4 Aicardi-Goutieres syndrome 4, 610333 (3)	
CD96	606037	CD96, TACTILE C syndrome, 211750 (3)	
IFT122	606045	IFT122, WDR10, CED1 Cranioectodermal dysplasia 1, 218330 (3)	
TBX20	606061	TBX20, ASD4 Atrial septal defect 4, 611363 (3)	
SMC3	606062	CSPG6, SMC3, HCAP, BAM, CDLS3 Cornelia de Lange syndrome 3, 610759 (3)	
C10orf2	606075	C10orf2, TWINKLE, PEO1, PEOA3, IOSCA, MTDPS7 Progressive external ophthalmoplegia, autosomal dominant, 3, 609286 (3); Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3)	
RBM15	606077	RBM15, SPEN, OTT Megakaryoblastic leukemia, acute (2)	
MKL1	606078	MKL1, AMKL, MAL Megakaryoblastic leukemia, acute (3)	
PIGN	606097	PIGN, MCAHS1 Multiple congenital anomalies-hypotonia-seizures syndrome 1, 614080 (3)	
PIP5K1C	606102	PIP5K1C, LCCS3 Lethal congenital contractural syndrome 3, 611369 (3)	
HPS3	606118	HPS3 Hermansky-Pudlak syndrome 3, 614072 (3)	
SLURP1	606119	SLURP1, MDM Meleda disease, 248300 (3)	
SLC2A9	606142	SLC2A9, GLUT9, UAQTL2 {Uric acid concentration, serum, QTL 2}, 612076 (3); Hypouricemia, renal, 2, 612076 (3)	
RAB23	606144	RAB23 Carpenter syndrome, 201000 (3)	
SLC2A10	606145	SLC2A10, GLUT10, ATS Arterial tortuosity syndrome, 208050 (3)	
BBS2	606151	BBS2 Bardet-Biedl syndrome 2, 209900 (3)	
SLC19A3	606152	SLC19A3, THMD2, BBGD Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2), 607483 (3)	
ATP5E	606153	ATP5E, MC5DN3 Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3, 614053 (3)	
PANK2	606157	PANK2, NBIA1, PKAN, HARP Neurodegeneration with brain iron accumulation 1, 234200 (3); HARP syndrome, 607236 (3)	
BSCL2	606158	BSCL2, SPG17, HMN5 Lipodystrophy, congenital generalized, type 2, 269700 (3); Silver spastic paraplegia syndrome, 270685 (3); Neuropathy, distal hereditary motor, type V, 600794 (3)	
BHLHE41	606200	BHLHE41, BHLHB3, DEC2, SHARP1 [Short sleeper], 612975 (3)	
WFS1	606201	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL Wolfram syndrome, 222300 (3); Deafness, autosomal dominant 6/14/38, 600965 (3); Wolfram-like syndrome, autosomal dominant, 614296 (3); {Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3)	
SLC45A2	606202	SLC45A2, MATP, AIM1, SHEP5 Oculocutaneous albinism, type IV, 606574 (3); [Skin/hair/eye pigmentation 5, black/nonblack hair], 227240 (3); [Skin/hair/eye pigmentation 5, dark/fair skin], 227240 (3); [Skin/hair/eye pigmentation 5, dark/light eyes], 227240 (3)	
SEPN1	606210	SEPN1, SELN, RSMD1, CFTD Muscular dystrophy, rigid spine, 1, 602771 (3); Myopathy, congenital, with fiber-type disproportion, 255310 (3)	
NT5C3	606224	NT5C3, UMPH1, PSN1 Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)	
MFRP	606227	MFRP, MCOP5, NNO2 Microphthalmia, isolated 5, 611040 (3); Nanophthalmos 2, 609549 (3)	
SHANK3	606230	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15 Phelan-McDermid syndrome, 606232 (3); {Schizophrenia 15}, 613950 (3)	
ASPSCR1	606236	ASPSCR1, RCC17, ASPL, ASPS Alveolar soft-part sarcoma, 606243 (3)	
DICER1	606241	DICER1, HERNA, KIAA0928, MNG1 Pleuropulmonary blastoma, 601200 (3); Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3)	
SUZ12	606245	JJAZ1, KIAA0160 Endometrial stromal tumors (2)	
JAZF1	606246	JAZF1, TIP27 Endometrial stromal tumors (2)	
TIRAP	606252	TIRAP, BACTS1 {Pneumococcal disease, invasive, protection against}, 610799 (3); {Bacteremia, protection against}, 614382 (3); {Malaria, protection against}, 611162 (3); {Tuberculosis, protection against}, 607948 (3)	
CLEC7A	606264	CLEC7A, CLECSF12, DECTIN1, CANDF4 Candidiasis, familial, 4, autosomal dominant, 613108 (3); {Aspergillosis, susceptibility to}, 614079 (3)	
WNT10A	606268	WNT10A, SSPS, STHAG4, OODD Odontoonychodermal dysplasia, 257980 (3); Schopf-Schulz-Passarge syndrome, 224750 (3); Tooth agenesis, selective, 4, 150400 (3)	
TNFRSF13C	606269	TNFRSF13C, BAFFR, CVID4 Immunodeficiency, common variable, 4, 613494 (3)	
DISC2	606271	DISC2 Schizophrenia, 181500 (2)	
CTNS	606272	CTNS Cystinosis, nephropathic, 219800 (3); Cystinosis, ocular nonnephropathic, 219750 (3); Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3); Cystinosis, atypical nephropathic (3)	
EIF2B3	606273	EIF2B3 Leukoencephalopathy with vanishing white matter, 603896 (3)	
SIX6	606326	SIX6, MCOPCT2 Microphthalmia with cataract 2, 212550 (3)	
PSTPIP1	606347	PSTPIP1, PSTPIP, CD2BP1, PAPAS Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 (3)	
APTX	606350	APTX, AOA, AOA1 Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3)	
ESPN	606351	ESPN Deafness, autosomal recessive 36, 609006 (3); Deafness, neurosensory, without vestibular involvement, autosomal dominant (3)	
ALS2	606352	ALS2, ALSJ, PLSJ, IAHSP Amyotrophic lateral sclerosis, juvenile, 205100 (3); Primary lateral sclerosis, juvenile, 606353 (3); Spastic paralysis, infantile onset ascending, 607225 (3)	
APOA5	606368	APOA5 {Hypertriglyceridemia, susceptibility to}, 145750 (3); Hyperchylomicronemia, late-onset, 144650 (3)	
TPK1	606370	TPK1, THMD5 Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type), 614458 (3)	
B3GAT3	606374	B3GAT3, GLCATI Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects, 245600 (3)	
CATSPER1	606389	CATSPER1, CATSPER, SPGF7 Spermatogenic failure 7, 612997 (3)	
CLRN1	606397	CLRN1, USH3A, USH3, RP61 Usher syndrome, type 3A, 276902 (3); Retinitis pigmentosa 61, 614180 (3)	
ITCH	606409	ITCH, AIP4, NAPP1 Autoimmune disease, syndromic multisystem, 613385 (3)	
ANTXR1	606410	ANTXR1, TEM8, ATR {Hemangioma, capillary infantile, susceptibility to}, 602089 (3)	
BSND	606412	BSND Bartter syndrome, type 4a, 602522 (3); Sensorineural deafness with mild renal dysfunction, 602522 (3)	
NLRP3	606416	NLRP3, CIAS1, FCU, FCAS, NALP3, PYPAF1 Cold-induced autoinflammatory syndrome, familial, 120100 (3); Muckle-Wells syndrome, 191900 (3); CINCA syndrome, 607115 (3)	
DHCR24	606418	DHCR24, KIAA0018 Desmosterolosis, 602398 (3)	
PRPF31	606419	PRPF31, PRP31, RP11 Retinitis pigmentosa 11, 600138 (3)	
EGLN1	606425	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3 Erythrocytosis, familial, 3, 609820 (3)	
ATL1	606439	ATL1, SPG3A, HSN1D Spastic paraplegia 3A, autosomal dominant, 182600 (3); Neuropathy, hereditary sensory, type ID, 613708 (3)	
STRC	606440	STRC, DFNB16 Deafness, autosomal recessive 16, 603720 (3)	
HTRA2	606441	HTRA2, OMI, PARK13, PRSS25 Parkinson disease 13, 610297 (3)	
EIF2B2	606454	EIF2B2 Leukoencephalopathy with vanishing white matter, 603896 (3); Ovarioleukodystrophy, 603896 (3)	
GBA	606463	GBA Gaucher disease, type I, 230800(3); Gaucher disease, type II, 230900 (3); Gaucher disease, type III, 231000 (3); Gaucher disease, type IIIC, 231005 (3); Gaucher disease, perinatal lethal, 608013 (3); {Parkinson disease, late-onset, susceptibility to}, 168600 (3); {Lewy body dementia, susceptibility to}, 127750 (3)	
HAMP	606464	HAMP, LEAP1, HEPC, HFE2B Hemochromatosis, type 2B, 613313 (3)	
NHP2	606470	NOLA2, NHP2, DKCB2 Dyskeratosis congenita, autosomal recessive 2, 613987 (3)	
NOP10	606471	NOLA3, NOP10, DKCB1 Dyskeratosis congenita, autosomal recessive 1, 224230 (3)	
CD320	606475	CD320, 8D6, 8D6A, TCBLR Methylmalonic aciduria due to transcobalamin receptor defect, 613646 (3)	
ITPKC	606476	ITPKC {Kawasaki disease, susceptibility to}, 611775 (3)	
ZMPSTE24	606480	ZMPSTE24, FACE1, STE24, MADB Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3); Restrictive dermopathy, lethal, 275210 (3)	
EXOSC3	606489	EXOSC3, RRP40, PCH1B Pontocerebellar hypoplasia, type 1B, 614678 (3)	
ST3GAL3	606494	ST3GAL3, SIAT6, ST3GALII, MRT12 Mental retardation, autosomal recessive 12, 611090 (3)	
IL17F	606496	IL17F, ML1, CANDF6 Candidiasis, familial, 6, autosomal dominant, 613956 (3)	
HAVCR1	606518	HAVCR1, HAVCR {Atopy, resistance to}, 147050 (3)	
SLC25A19	606521	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4 Microcephaly, Amish type, 607196 (3); Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type), 613710 (3)	
GDF3	606522	GDF3, KFS3, MCOPCB6, MCOP7 Klippel-Feil syndrome 3, autosomal dominant, 613702 (3); Microphthalmia with coloboma 6, 613703 (3); Microphthalmia, isolated 7, 613704 (3)	
MLPH	606526	MLPH Griscelli syndrome, type 3, 609227 (3)	
CYP27A1	606530	CYP27A1, CYP27, CTX Cerebrotendinous xanthomatosis, 213700 (3)	
SCGB3A2	606531	SCGB3A2, UGRP1 {Asthma, susceptibility to}, 600807 (3)	
MYO5B	606540	MYO5B, KIAA1119 Microvillus inclusion disease, 251850 (3)	
LZTS1	606551	LZTS1, F37, FEZ1 Esophageal squamous cell carcinoma, 133239 (3)	
MYLK2	606566	MYLK2, MLCK Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)	
OPA3	606580	OPA3, MGA3 3-methylglutaconic aciduria, type III, 258501 (3); Optic atrophy 3 with cataract, 165300 (3)	
ENAM	606585	ENAM, AIH2, AI1C Amelogenesis imperfecta, type IB, 104500 (3); Amelogenesis imperfecta, type IC, 204650 (3)	
FKRP	606596	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5 Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, 613153 (3); Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)	
PAX3	606597	PAX3, WS1, HUP2, CDHS, WS3 Waardenburg syndrome, type 1, 193500 (3); Waardenburg syndrome, type 3, 148820 (3); Craniofacial-deafness-hand syndrome, 122880 (3); Rhabdomyosarcoma 2, alveolar, 268220 (3)	
GDAP1	606598	GDAP1, CMT4A, CMT2K, CMTRIA Charcot-Marie-Tooth disease, type 4A, 214400 (3); Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, 607706 (3); Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3); Charcot-Marie-Tooth disease, recessive intermediate, A, 608340 (3)	
EDARADD	606603	EDARADD, ED3, EDA3 Ectodermal dysplasia, anhidrotic, autosomal recessive, 224900 (3); Ectodermal dysplasia, anhidrotic, autosomal dominant, 129490 (3)	
TREX1	606609	TREX1, AGS1, CRV, HERNS Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3); Chilblain lupus, 610448 (3); Vasculopathy, retinal, with cerebral leukodystrophy, 192315 (3); {Systemic lupus erythematosus, susceptibility to}, 152700 (3)	
SMARCAL1	606622	SMARCAL1, HARP, SIOD Schimke immunoosseous dysplasia, 242900 (3)	
GNMT	606628	GNMT Glycine N-methyltransferase deficiency, 606664 (3)	
RIMS1	606629	RIMS1, RIM1, RIM, KIAA0340, CORD7 Cone-rod dystrophy 7, 603649 (3)	
SP7	606633	SP7, OSX, OI12 Osteogenesis imperfecta, type XII, 613849 (3)	
TMPRSS15	606635	PRSS7, ENTK Enterokinase deficiency, 226200 (3)	
NLRP1	606636	NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1 {Vitiligo-associated multiple autoimmune disease susceptibility 1}, 606579 (3)	
GFM1	606639	GFM1, EFG1, GFM, COXPD1 Combined oxidative phosphorylation deficiency 1, 609060 (3)	
RXFP2	606655	LGR8, GREAT Cryptorchidism, bilateral, 219050 (3)	
LGR4	606666	GPR48, LGR4 {Schizophrenia, susceptibility to}, 181500 (3)	
GP1BA	606672	GP1BA, BSS, BDPLT1, VWDP, BDPLT3 Bernard-Soulier syndrome, type A1 (recessive), 231200 (3); {Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3); Bernard-Soulier syndrome, type A2 (dominant), 153670 (3); von Willebrand disease, platelet-type, 177820 (3)	
UPB1	606673	UPB1, BUP1 Beta-ureidopropionase deficiency, 613161 (3)	
NSD1	606681	NSD1, ARA267, STO Sotos syndrome, 117550 (3); Leukemia, acute myeloid, 601626 (1); Weaver syndrome, 277590 (3); Beckwith-Wiedemann syndrome, 130650 (3)	
HPS4	606682	HPS4 Hermansky-Pudlak syndrome 4, 614073 (3)	
EIF2B1	606686	EIF2B1, EIF2BA Leukoencephalopathy with vanishing white matter, 603896 (3)	
EIF2B4	606687	EIF2B4 Leukoencephaly with vanishing white matter, 603896 (3); Ovarioleukodystrophy, 603896 (3)	
PKHD1	606702	FCYT, PKHD1, ARPKD Polycystic kidney and hepatic disease, 263200 (3)	
TMC1	606706	TMC1, DFNB7, DFNB11, DFNA36 Deafness, autosomal recessive 7, 600974 (3); Deafness, autosomal dominant 36, 606705 (3)	
PRSS12	606709	PRSS12, BSSP3, MRT1 Mental retardation, autosomal recessive 1, 249500 (3)	
SLC26A2	606718	SLC26A2, DTD, DTDST, D5S1708, EDM4 Diastrophic dysplasia, 222600 (3); Atelosteogenesis II, 256050 (3); Achondrogenesis Ib, 600972 (3); Epiphyseal dysplasia, multiple, 4, 226900 (3); Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3); De la Chapelle dysplasia, 256050 (3)	
CLN6	606725	CLN6, CLN4A Ceroid lipofuscinosis, neuronal, 6, 601780 (3); Ceroid lipofuscinosis, neuronal, Kufs type, adult onset, 204300 (3)	
TLL1	606742	TLL1, TLL, ASD6 Atrial septal defect 6, 613087 (3)	
SAMHD1	606754	SAMHD1, AGS5, DCIP, CHBL2 Aicardi-Goutieres syndrome 5, 612952 (3); Chilblain lupus 2, 614415 (3)	
DUOX2	606759	DUOX2, THOX2, TDH6 Thryoid dyshormonogenesis 6, 607200 (3)	
MLYCD	606761	MLYCD, MCD Malonyl-CoA decarboxylase deficiency, 248360 (3)	
TPO	606765	TPO, TPX, TDH2A Thyroid dyshormonogenesis 2A, 274500 (3)	
ST14	606797	ST14, MTSP1 Ichthyosis with hypotrichosis, 610765 (3)	
GAA	606800	GAA Glycogen storage disease II, 232300 (3)	
FTCD	606806	FTCD Glutamate formiminotransferase deficiency, 229100 (3)	
MYO3A	606808	MYO3A, DFNB30 Deafness, autosomal recessive 30, 607101 (3)	
PRODH	606810	PRODH, PRODH2, SCZD4 Hyperprolinemia, type I, 239500 (3); {Schizophrenia, susceptibility to, 4}, 600850 (3)	
ALDH4A1	606811	ALDH4A1, ALDH4, P5CDH Hyperprolinemia, type II, 239510 (3)	
COG5	606821	COG5, GOLTC1, GTC90, CDG2I Congenital disorder of glycosylation, type IIi, 613612 (3)	
POMGNT1	606822	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3 Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3)	
FXN	606829	FXN, FRDA, FARR, X25 Friedreich ataxia, 229300 (3); Friedreich ataxia with retained reflexes, 229300 (3)	
RB1CC1	606837	RB1CC1, CC1, KIAA0203 Breast cancer, somatic, 114480 (3)	
ALMS1	606844	ALMS1, ALSS, KIAA0328 Alstrom syndrome, 203800 (3)	
GOPC	606845	GOPC, PIST, FIG, CAL ?Globozoospermia, 102530 (1)	
TCOF1	606847	TCOF1, MFD1, TCS1 Treacher Collins syndrome 1, 154500 (3)	
MIPOL1	606850	MIPOL1 Mirror-image polydactyly, 135750 (1)	
GCLC	606857	GCLC, GLCLC Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency, 230450 (3); {Myocardial infarction, susceptibility to}, 608446 (3)	
SERPING1	606860	C1NH, HAE1, HAE2, SERPING1 Angioedema, hereditary, types I and II, 106100 (3); Complement component 4, partial deficiency of, 120790 (3)	
HEXA	606869	HEXA, TSD Tay-Sachs disease, 272800 (3); GM2-gangliosidosis, several forms, 272800 (3); [Hex A pseudodeficiency], 272800 (3)	
JAM3	606871	JAM3 Hemorrhagic destruction of the brain, subependymal calcification, and cataracts, 613730 (3)	
HEXB	606873	HEXB Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3)	
PHGDH	606879	PHGDH Phosphoglycerate dehydrogenase deficiency, 601815 (3)	
ATP7B	606882	ATP7B, WND Wilson disease, 277900 (3)	
IRAK4	606883	IRAK4, REN64, IPD1 IRAK4 deficiency, 607676 (3); Invasive pneumococcal disease, recurrent isolated, 1, 610799 (3)	
ACADS	606885	ACADS, SCAD Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)	
SUOX	606887	SUOX Sulfite oxidase deficiency, 272300 (3)	
GALC	606890	GALC Krabbe disease, 245200 (3)	
LYST	606897	CHS1, LYST Chediak-Higashi syndrome, 214500 (3)	
GOLGA5	606918	GOLGA5, RFG5, PTC5 Thyroid carcinoma, papillary, 188550 (3)	
TYR	606933	TYR, SHEP3, CMM8 Albinism, oculocutaneous, type IA, 203100 (3); Waardenburg syndrome/albinism, digenic, 103470 (3); Albinism, oculocutaneous, type IB, 606952 (3); [Skin/hair/eye pigmentation 3, light/dark/freckling skin], 601800 (3); {Melanoma, cutaneous malignant, susceptibility to, 8}, 601800 (3); [Skin/hair/eye pigmentation 3, blue/green eyes], 601800 (3)	
NDUFAF1	606934	NDUFAF1, CIA30, CGI65 Mitochondrial complex I deficiency, 252010 (3)	
TRPM4	606936	TRPM4, PFHB1B Progressive familial heart block, type IB, 604559 (3)	
UROS	606938	UROS Porphyria, congenital erythropoietic, 263700 (3)	
ZFHX4	606940	ZFHX4, ZFH4 ?Ptosis, congenital, 178300 (2)	
ALG9	606941	ALG9, DIBD1, CDG1L Congenital disorder of glycosylation, type Il, 608776 (3)	
LDLR	606945	LDLR, FHC, FH, LDLCQ2 Hypercholesterolemia, familial, 143890 (3); LDL cholesterol level QTL2, 143890 (3)	
GALE	606953	GALE Galactose epimerase deficiency, 230350 (3)	
LCAT	606967	LCAT Norum disease, 245900 (3); Fish-eye disease, 136120 (3)	
COG1	606973	COG1, LDLB, KIAA1381, CDG2G Congenital disorder of glycosylation, type IIg, 611209 (3)	
COG4	606976	COG4, COD1, CDG2J Congenital disorder of glycosylation, type IIj, 613489 (3)	
COG6	606977	COG6, COD2, KIAA1134, CDG2L Congenital disorder of glycosylation, type IIl, 614576 (3)	
COG7	606978	COG7, CDG2E Congenital disorder of glycosylation, type IIe, 608779 (3)	
COG8	606979	COG8, DOR1, CDG2H Congenital disorder of glycosylation, type IIh, 611182 (3)	
ADCK3	606980	CABC1, COQ8, ADCK3, SCAR9, ARCA2, COQ10D4 Coenzyme Q10 deficiency, primary, 4, 612016 (3)	
MPO	606989	MPO Myeloperoxidase deficiency, 254600 (3); {Alzheimer disease, susceptibility to}, 104300 (3); {Lung cancer, protection against, in smokers} (3)	
GALT	606999	GALT Galactosemia, 230400 (3)	
EHMT1	607001	EHMT1, EUHMTASE1, DEL9q34 Kleefstra syndrome, 610253 (3)	
PROK2	607002	PROK2, PK2, BV8, KAL4 Kallmann syndrome 4, 610628 (3); Hypogonadism, hypogonadotropic, 146110 (3)	
ACADM	607008	ACADM, MCAD Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)	
TRPM6	607009	TRPM6, CHAK2, HOMG1 Hypomagnesemia 1, intestinal, 602014 (3)	
LIAS	607031	LIAS, PDHLD Pyruvate dehydrogenase lipoic acid synthetase deficiency, 614462 (3)	
SUFU	607035	SUFU, SUFUXL, SUFUH Medulloblastoma, desmoplastic, 155255 (3)	
IVD	607036	IVD Isovaleric acidemia, 243500 (3)	
OTOA	607038	OTOA, DFNB22 Deafness, autosomal recessive 22, 607039 (3)	
ABCC11	607040	ABCC11, MRP8, EWWD, WW [Earwax, wet/dry], 117800 (3); [Axillary odor, variation in], 117800 (3); [Colostrum secretion, variation in], 117800 (3)	
CLN3	607042	CLN3, BTS Ceroid lipofuscinosis, neuronal, 3, 204200 (3)	
TRAF3IP2	607043	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13 {Psoriasis susceptibility 13}, 614070 (3)	
ATXN3	607047	ATXN3, MJD, SCA3 Machado-Joseph disease, 109150 (3)	
IMPG2	607056	IMPG2, IPM200, RP56 Retinitis pigmentosa 56, 613581 (3); Maculopathy, IMPG2-related, 613581 (3)	
SLC39A4	607059	SLC39A4, ZIP4 Acrodermatitis enteropathica, 201100 (3)	
FKBP10	607063	FKBP10, FKBP65, OI11 Osteogenesis imperfecta, type XI, 610968 (3)	
TRPV3	607066	TRPV3, OLMS Olmsted syndrome, 614594 (3)	
HYAL1	607071	HYAL1 Mucopolysaccharidosis type IX, 601492 (3)	
WHSC1L1	607083	WHSC1L1, NSD3 Leukemia, acute myeloid, 601626 (3)	
MTHFR	607093	MTHFR Homocystinuria due to MTHFR deficiency, 236250 (3); {Schizophrenia, susceptibility to}, 181500 (3); {Vascular disease, susceptibility to} (3); {Neural tube defects, susceptibility to}, 601634 (3); {Thromboembolism, susceptibility to}, 188050 (3)	
SLC22A12	607096	SLC22A12, OAT4L, URAT1 Hypouricemia, renal, 220150 (3)	
NPHP1	607100	NPHP1, NPH1, SLSN1, JBTS4 Nephronophthisis 1, juvenile, 256100 (3); Senior-Loken syndrome-1, 266900 (3); Joubert syndrome 4, 609583 (3)	
WT1	607102	WT1, NPHS4 Wilms tumor, type 1, 194070 (3); Denys-Drash syndrome, 194080 (3); Nephrotic syndrome, type 4, 256370 (3); Frasier syndrome, 136680 (3); Meacham syndrome, 608978 (3); Mesothelioma, somatic, 156240 (3)	
PAX6	607108	PAX6, AN2, MGDA Aniridia, 106210 (3); Peters anomaly, 604229 (3); Cataract with late-onset corneal dystrophy, 604219 (3); Keratitis, 148190 (3); Foveal hyperplasia, 136520 (3); Morning glory disc anomaly, 120430 (3); Optic nerve hypoplasia, 165550 (3); Coloboma, ocular, 120200 (3); Coloboma of optic nerve, 120430 (3); Gillespie syndrome, 206700 (3)	
SPG20	607111	SPG20 Troyer syndrome, 275900 (3)	
MCPH1	607117	MCPH1 Microcephaly, primary autosomal recessive, 1, 251200 (3)	
MRPL3	607118	MRPL3, MRL3, COXPD9 Combined oxidative phosphorylation deficiency 9, 614582 (3)	
PLCB1	607120	PLCB1, KIAA0581, PLCB1A, PLCB1B, EIEE12 Epileptic encephalopathy, early infantile, 12, 613722 (3)	
PROKR2	607123	PROKR2, PKR2, GPR73L1, KAL3 Kallmann syndrome 3, 244200 (3)	
FANCA	607139	FANCA, FACA, FA1, FA, FAA Fanconi anemia, complementation group A, 227650 (3)	
ALG12	607144	ALG12, CDG1G Congenital disorder of glycosylation, type Ig, 607143 (3)	
DTNBP1	607145	DTNBP1, HPS7 {Schizophrenia}, 181500 (2); Hermansky-Pudlak syndrome 7, 614076 (3)	
CRELD1	607170	CRELD1, AVSD2 {Atrioventricular septal defect, susceptibility to, 2}, 606217 (3); Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3)	
FYCO1	607182	FYCO1, CATC2 Cataract, autosomal recessive congenital 2, 610019 (3)	
PTF1A	607194	PTF1A Diabetes mellitus, permanent neonatal, with cerebellar agenesis, 609069 (3)	
TDP1	607198	TDP1 Spinocerebellar ataxia, autosomal recessive with axonal neuropathy, 607250 (3)	
IRF6	607199	IRF6, VWS, LPS, PIT, PPS, OFC6 van der Woude syndrome, 119300 (3); Popliteal pterygium syndrome, 119500 (3); Orofacial cleft 6, 608864 (3)	
ALOXE3	607206	ALOXE3 Ichthyosiform erythroderma, congenital, nonbullous, 1, 242100 (3)	
CARD14	607211	CARD14, CARMA2, BIMP2, PSORS2, PSS1 {Psoriasis susceptibility 2}, 602723 (3)	
CARD9	607212	CARD9, CANDF2 Candidiasis, familial, 2, autosomal recessive, 212050 (3) 212050 (3)	
ORC6	607213	ORC6, ORC6L Meier-Gorlin syndrome 3, 613803 (3)	
NPHP4	607215	NPHP4, SLSN4 Nephronophthisis 4, 606966 (3); Senior-Loken syndrome 4, 606996 (3)	
IRF5	607218	IRF5, IBD14, SLEB10 {Inflammatory bowel disease 14}, 612245 (3); {Systemic lupus erythematosus, susceptibility to, 10}, 612251 (3)	
SMOC2	607223	SMOC2, SMAP2, DTDP1 Dentin dysplasia, type I, with microdontia and misshapen teeth, 125400 (3)	
TMIE	607237	TMIE, DFNB6 Deafness, autosomal recessive 6, 600971 (3)	
AP4S1	607243	AP4S1, CPSQ6, SPG52 Spastic paraplegia 52, autosomal recessive, 614067 (3)	
AP4E1	607244	AP4E1, SPG51, CPSQ4 Spastic paraplegia 51, autosomal recessive, 613744 (3)	
AP4B1	607245	AP4B1, SPG47, CPSQ5 Spastic paraplegia 47, autosomal recessive, 614066 (3)	
APOL2	607252	APOL2 {Schizophrenia}, 181500 (1)	
APOL4	607254	APOL4 {Schizophrenia}, 181500 (1)	
EVC2	607261	LBN, EVC2 Ellis-van Creveld syndrome, 225500 (3)	
FLCN	607273	FLCN, BHD Birt-Hogg-Dube syndrome, 135150 (3); Pneumothorax, primary spontaneous, 173600 (3); Renal carcinoma, chromophobe, somatic, 144700 (3); Colorectal cancer, somatic, 114500 (3)	
SEMA4A	607292	SEMA4A, SEMB, RP35, CORD10 Retinitis pigmentosa 35, 610282 (3); Cone-rod dystrophy 10, 610283 (3)	
PRPF8	607300	PRPF8, PRPC8, RP13 Retinitis pigmentosa 13, 600059 (3)	
PRPF3	607301	HPRP3, RP18 Retinitis pigmentosa 18, 601414 (3)	
PGR	607311	PGR ?Progesterone resistance, 264080 (2)	
RP9	607331	RP9 Retinitis pigmentosa 9, 180104 (3)	
GABBR2	607340	GPR51, GABBR2 {Nicotine dependence, susceptibility to}, 188890 (3); {Nicotine dependence, protection against}, 188890 (3)	
SALL4	607343	SALL4, HSAL4 Duane-radial ray syndrome, 607323 (3); IVIC syndrome, 147750 (3)	
AIRE	607358	AIRE, APECED, APS1 Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia, 240300 (3)	
LIPH	607365	LIPH, LAH2, ARWH2 Hypotrichosis, localized, autosomal recessive 2, 604379 (3); Woolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 (3)	
NF2	607379	NF2 Neurofibromatosis, type 2, 101000 (3); Meningioma, NF2-related, somatic, 607174 (3); Schwannomatosis, 162091 (3)	
CDC73	607393	HRPT2, C1orf28 Hyperparathyroidism-jaw tumor syndrome, 145001 (3); Hyperparathyroidism, familial primary, 145000 (3); Parathyroid adenoma with cystic changes, 145001 (3); Parathyroid carcinoma, 608266 (3)	
MC2R	607397	MC2R Glucocorticoid deficiency, due to ACTH unresponsiveness, 202200 (3)	
IL28B	607402	IL28B {Hepatitis C virus infection, response to therapy of}, 609532 (3)	
DAOA	607408	DAOA, G72 {Schizophrenia}, 181500 (2)	
NME8	607421	TXNDC3, SPTRX2, CILD6 Ciliary dyskinesia, primary, 6, 610852 (3)	
POMT1	607423	POMT1, MDDGA1, MDDGB1, MDDGC1 Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1, 236670 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1, 613155 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3)	
PDSS1	607429	PDSS1, TPT, COQ1, COQ10D2 Coenzyme Q10 deficiency, primary, 2, 614651 (3)	
POMT2	607439	POMT2, MDDGA2, MDDGB2, MDDGC2 Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2, 613150 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2, 613156 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3)	
FKTN	607440	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4 Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, 253800 (3); Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3); Cardiomyopathy, dilated, 1X, 611615 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)	
SBDS	607444	SBDS, SDS Shwachman-Bodian-Diamond syndrome, 260400 (3)	
CIRH1A	607456	CIRH1A, NAIC, TEX292, KIAA1988 Cirrhosis, North American Indian childhood type, 604901 (3)	
DYM	607461	DYM, FLJ90130, DMC, SMC Dyggve-Melchior-Clausen disease, 223800 (3); Smith-McCort dysplasia, 607326 (3)	
ATN1	607462	ATN1, DRPLA, HRS, NOD Dentatorubro-pallidoluysian atrophy, 125370 (3)	
CDAN1	607465	CDAN1, CDA1 Anemia, congenital dyserythropoietic, type I, 224120 (3)	
HGD	607474	HGD, AKU Alkaptonuria, 203500 (3)	
TPH2	607478	TPH2, NTPH, ADHD7 {Unipolar depression, susceptibility to}, 608516 (3); {Attention deficit-hyperactivity disorder, susceptibility to, 7}, 613003 (3)	
APCDD1	607479	APCDD1, HHS, HTS Hypotrichosis simplex, 605389 (3)	
MMAA	607481	MMAA Methylmalonic aciduria, vitamin B12-responsive, 251100 (3)	
ADAMTS17	607511	ADAMTS17 Weill-Marchesani-like syndrome, 613195 (3)	
ADAMTS18	607512	ADAMTS18, KNO2 Knobloch syndrome 2, 608454 (3)	
HPS5	607521	HPS5, RU2, KIAA1017 Hermansky-Pudlak syndrome 5, 614074 (3)	
HPS6	607522	HPS6, RU Hermansky-Pudlak syndrome 6, 614075 (3)	
CRTC1	607536	CRTC1, MECT1, KIAA0616, FLJ14027 Mucoepidermoid salivary gland carcinoma (3)	
MAML2	607537	MAML2, MAM3 Mucoepidermoid salivary gland carcinoma (3)	
KCNQ1	607542	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2 Long QT syndrome-1, 192500 (3); Jervell and Lange-Nielsen syndrome, 220400 (3); Atrial fibrillation, familial, 3, 607554 (3); Short QT syndrome-2, 609621 (3); {Long QT syndrome 1, acquired, susceptibility to}, 192500 (3)	
LRPPRC	607544	LRPPRC, LRP130, LSFC Leigh syndrome, French-Canadian type, 220111 (3)	
TWIST2	607556	TWIST2, DERMO1, SETLSS Setleis syndrome, 227260 (3)	
SLC17A8	607557	SLC17A8, VGLUT3, DFNA25 Deafness, autosomal dominant 25, 605583 (3)	
IL23R	607562	IL23R, IBD17 {Inflammatory bowel disease 17, protection against}, 612261 (3); {Psoriasis, protection against}, 605606 (3)	
EPM2A	607566	EPM2A, MELF, EPM2 Epilepsy, progressive myoclonic 2A (Lafora), 254780 (3)	
MMAB	607568	MMAB Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type, 251110 (3)	
ARSA	607574	ARSA Metachromatic leukodystrophy, 250100 (3)	
ATM	607585	ATM, ATA, AT1 Ataxia-telangiectasia, 208900 (3); Lymphoma, B-cell non-Hodgkin, somatic (3); {Breast cancer, susceptibility to}, 114480 (3); Lymphoma, mantle cell (3); T-cell prolymphocytic leukemia, sporadic (3)	
BBS7	607590	BBS7 Bardet-Biedl syndrome 7, 209900 (3)	
KCNV2	607604	KCNV2, KV11.1, RCD3B Retinal cone dystrophy 3B, 610356 (3)	
KRT9	607606	KRT9, EPPK Epidermolytic palmoplantar keratoderma, 144200 (3)	
SMPD1	607608	SMPD1, NPD Niemann-Pick disease, type A, 257200 (3); Niemann-Pick disease, type B, 607616 (3)	
NPC1	607623	NPC1, NPC Niemann-Pick disease, type C1, 257220 (3); Niemann-Pick disease, type D, 257220 (3)	
PSENEN	607632	PSENEN, PEN2 Acne inversa, familial, 2, 613736 (3)	
XDH	607633	XDH Xanthinuria, type I, 278300 (3)	
ATXN7	607640	ATXN7, SCA7, OPCA3 Spinocerebellar ataxia 7, 164500 (3)	
RAI1	607642	RAI1, SMCR, SMS Smith-Magenis syndrome, 182290 (3)	
FSCN2	607643	FSCN2, RFSN, RP30 Retinitis pigmentosa 30, 607921 (3)	
OSTM1	607649	OSTM1, GL, OPTB5 Osteopetrosis, autosomal recessive 5, 259720 (3)	
CTH	607657	CTH Cystathioninuria, 219500 (3); Homocysteine, total plasma, elevated (3)	
GNS	607664	GNS, G6S Mucopolysaccharidosis type IIID, 252940 (3)	
CLCF1	607672	CLCF1, BSF3, CLC Cold-induced sweating syndrome 1, 610313 (3)	
SAR1B	607690	SAR1B, CMRD, SARA2, ANDD Chylomicron retention disease, 246700 (3)	
SECISBP2	607693	SECISBP2, SBP2 Thyroid hormone metabolism, abnormal, 609698 (3)	
USH1G	607696	SANS, USH1G Usher syndrome, type 1G, 606943 (3)	
SBF2	607697	SBF2, MTMR13, CMT4B2 Charcot-Marie-Tooth disease, type 4B2, 604563 (3)	
KANK1	607704	KANK1, KANK, ANKRD15, KIAA0172, CPSQ2 Cerebral palsy, spastic quadriplegic, 2, 612900 (3)	
TJP2	607709	TJP2, ZO2 Hypercholanemia, familial, 607748 (3)	
TAS2R38	607751	TAS2R38, T2R61, PTC [Phenylthiocarbamide tasting], 171200 (3)	
ITGA2B	607759	ITGA2B, GP2B, CD41B, GT, BDPLT2 Glanzmann thrombasthenia, 273800 (3); Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)	
KIRREL3	607761	KIRREL3, NEPH2, KIAA1867, KIRRE, MRD4 Mental retardation, autosomal dominant 4, 612581 (3)	
HSD3B7	607764	HSD3B7, CBAS1 Bile acid synthesis defect, congenital, 1, 607765 (3)	
PLEKHA1	607772	PLEKHA1, TAPP1 {Age-related maculopathy, susceptibility to}, 603075 (2)	
PCSK9	607786	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1 Hypercholesterolemia, familial, 3, 603776 (3); {Low density lipoprotein cholesterol level QTL 1}, 603776 (3)	
MCFD2	607788	MCFD2, F5F8D2 Factor V and factor VIII, combined deficiency of, 613625 (3)	
PHF11	607796	PHF11, NYREN34 [IgE levels QTL], 147050 (3); {Asthma}, 600807 (3)	
ABCA12	607800	ABCA12, ICR2B, LI2 Ichthyosis, lamellar 2, 601277 (3); Ichthyosis, harlequin, 242500 (3)	
CNNM2	607803	CNNM2, ACDP2 Hypomagnesemia 6, renal, 613882 (3)	
CNNM4	607805	CNNM4, ACDP4 Jalili syndrome, 217080 (3)	
ACAT1	607809	ACAT1 Alpha-methylacetoacetic aciduria, 203750 (3)	
RGS9BP	607814	RGS9BP, R9AP, RGS9, PERRS Bradyopsia, 608415 (3)	
VPS13B	607817	COH1 Cohen syndrome, 216550 (3)	
ZNF365	607818	ZNF365, UAN {Nephrolithiasis, uric acid, susceptibility to}, 605990 (3)	
FRAS1	607830	FRAS1 Fraser syndrome, 219000 (3)	
CLN8	607837	CLN8, EPMR Ceroid lipofuscinosis, neuronal, 8, 600143 (3); Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant, 610003 (3)	
GNPTG	607838	GNPTAG Mucolipidosis III gamma, 252605 (3)	
GBE1	607839	GBE1 Glycogen storage disease IV, 232500 (3)	
GNPTAB	607840	GNPTAB, GNPTA Mucolipidosis III alpha/beta, 252600 (3); Mucolipidosis II alpha/beta, 252500 (3)	
LEMD3	607844	LEMD3, MAN1 Osteopoikilosis, 166700 (3); Buschke-Ollendorff syndrome, 166700 (3); Melorheostosis with osteopoikilosis, 155950 (3)	
BEST1	607854	BEST1, VMD2, ARB, RP50 Best macular dystrophy, 153700 (3); Maculopathy, bull's-eye (3); Vitelliform macular dystrophy, adult-onset, 608161 (3); Bestrophinopathy, 611809 (3); Vitreoretinochoroidopathy, 193220 (3); Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma, 193220 (3); Retinitis pigmentosa-50, 613194 (3); Retinitis pigmentosa, concentric, 613194 (3)	
RCBTB1	607867	RCBTB1, CLLD7, GLP [Beta-glycopyranoside tasting] (3); {Alcohol dependence, susceptibility to}, 103780 (3)	
DSG4	607892	DSG4, LAH Hypotrichosis, localized, autosomal recessive, 607903 (3)	
FERMT1	607900	KIND1, URP1, C20orf42 Kindler syndrome, 173650 (3)	
FERMT3	607901	KIND3, URP2, MIG2B, FERMT3 Leukocyte adhesion deficiency, type III, 612840 (3)	
CACNA1H	607904	CACNA1H, EIG6, ECA6 {Epilepsy, idiopathic generalized, susceptibility to, 6}, 611942 (3); {Epilepsy, childhood absence, susceptibility to, 6}, 611942 (3)	
ALG2	607905	ALG2, CDGII Congenital disorder of glycosylation, type Ii, 607906 (3)	
A4GALT	607922	A4GALT, PK [Blood group, P system], 111400 (3)	
DFNB31	607928	WHRN, CIP98, KIAA1526, DFNB31, USH2D Deafness, autosomal recessive 31, 607084 (3); Usher syndrome, type 2D, 611383 (3)	
CCM2	607929	C7orf22, CCM2, MGC4067 Cerebral cavernous malformations-2, 603284 (3)	
SUMF1	607939	SUMF1, FGE Multiple sulfatase deficiency, 272200 (3)	
CEP57	607951	CEP57, PIG8, TSP57, KIAA0092, MVA2 Mosaic variegated aneuploidy syndrome 2, 614114 (3)	
BBS9	607968	PTHB1, BBS9 Bardet-Biedl syndrome 9, 209900 (3)	
COX4I2	607976	COX4I2 Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis, 612714 (3)	
GORAB	607983	GORAB, SCYL1BP1, NTKLBP1, GO Geroderma osteodysplasticum, 231070 (3)	
TPP1	607998	TPP1, CLN2 Ceroid lipofuscinosis, neuronal, 2, 204500 (3)	
NPHP3	608002	NPHP3, NPH3, RHPD, MKS7 Nephronophthisis 3, 604387 (3); Renal-hepatic-pancreatic dysplasia, 208540 (3); Meckel syndrome 7, 267010 (3)	
SIL1	608005	SIL1, BAP, MSS Marinesco-Sjogren syndrome, 248800 (3)	
HSPB8	608014	HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A Neuropathy, distal hereditary motor, type IIA, 158590 (3); Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)	
ASPA	608034	ASPA Canavan disease, 271900 (3)	
ANTXR2	608041	ANTXR2, CMG2, JHF, ISH Fibromatosis, juvenile hyaline, 228600 (3); Hyalinosis, infantile systemic, 236490 (3)	
ETFA	608053	ETFA, GA2, MADD Glutaric acidemia IIA, 231680 (3)	
HES7	608059	HES7, SCDO4 Spondylocostal dysostosis 4, autosomal recessive, 613686 (3)	
NHLRC1	608072	NHLRC1, EPM2A, EPM2B Epilepsy, progressive myoclonic 2B (Lafora), 254780 (3)	
APOC2	608083	APOC2 Hyperlipoproteinemia, type Ib, 207750 (3)	
PALLD	608092	PALLD, KIAA0992, PNCA1 {Pancreatic cancer, susceptibility to, 1}, 606856 (3)	
NFU1	608100	NFU1, HIRIP, MMDS1 Multiple mitochondrial dysfunctions syndrome 1, 605711 (3)	
CLN5	608102	CLN5 Ceroid lipofuscinosis, neuronal, 5, 256731 (3)	
ALG8	608103	ALG8, CDG1H Congenital disorder of glycosylation, type Ih, 608104 (3)	
MEFV	608107	MEFV, MEF, FMF Familial Mediterranean fever, AR, 249100 (3); Familial Mediterranean fever, AD, 134610 (3)	
PUS1	608109	PUS1, MLASA1 Mitochondrial myopathy and sideroblastic anemia 1, 600462 (3)	
FANCL	608111	PHF9, FANCL Fanconi anemia, complementation group L, 614083 (3)	
XYLT1	608124	XYLT1, XT1 {Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)	
XYLT2	608125	XYLT2, XT2 {Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)	
TTC8	608132	TTC8, BBS8, RP51 Bardet-Biedl syndrome 8, 209900 (3); Retinitis pigmentosa 51, 613464 (3)	
ASPN	608135	ASPN, PLAP1, OS3 {Osteoarthritis susceptibility 3}, 607850 (3); {Lumbar disc degeneration}, 603932 (3)	
ARHGEF10	608136	ARHGEF10, KIAA0294 Slowed nerve conduction velocity, AD, 608236 (3)	
NELF	608137	NELF Hypogonadotropic hypogonadism, 146110 (3)	
NIPA1	608145	NIPA1, SPG6 Spastic paraplegia 6, autosomal dominant, 600363 (3)	
SATB2	608148	SATB2, KIAA1034 Cleft palate and mental retardation, 119540 (3)	
WDR19	608151	WDR19, ATD5, NPHP13, CED4 Asphyxiating thoracic dystrophy 5, 614376 (3); Nephronophthisis 13, 614377 (3); Cranioectodermal dysplasia 4, 614378 (3)	
SOX9	608160	SOX9, CMD1, SRA1 Campomelic dysplasia with autosomal sex reversal, 114290 (3); Acampomelic campomelic dysplasia, 114290 (3); Campomelic dysplasia, 114290 (3)	
SEMA3E	608166	SEMA3E, SEMAH, KIAA0331 CHARGE syndrome, 214800 (3)	
CACNA2D4	608171	CACNA2D4, RCD4 Retinal cone dystrophy 4, 610478 (3)	
DHDDS	608172	DHDDS, HDS, RP59 Retinitis pigmentosa 59, 613861 (3)	
EXT1	608177	EXT1 Exostoses, multiple, type 1, 133700 (3); Chondrosarcoma, 215300 (3)	
ATCAY	608179	ATCAY, CLAC, KIAA1872 Ataxia, cerebellar, Cayman type, 601238 (3)	
SPG21	608181	ACP33, MAST, SPG21 Mast syndrome, 248900 (3)	
CHSY1	608183	CHSY1, KIAA0990, TPBS Temtamy preaxial brachydactyly syndrome, 605282 (3)	
CDK5RAP2	608201	CDK5RAP2, KIAA1633, MCPH3 Microcephaly, primary autosomal recessive, 3, 604804 (3)	
UNC93B1	608204	UNC93B1, IIAE1 Herpes simplex encephalitis, susceptibility to, 1, 610551 (3)	
SH3TC2	608206	SH3TC2, KIAA1985, MNMN Charcot-Marie-Tooth disease, type 4C, 601596 (3); Mononeuropathy of the median nerve, mild, 613353 (3)	
EXT2	608210	EXT2 Exostoses, multiple, type 2, 133701 (3)	
IRGM	608212	IRGM, LRG47, IFI1, IBD19 {Mycobacterium tuberculosis, protection against}, 607948 (3); Inflammatory bowel disease 19, 612278 (3)	
SCN3B	608214	SCN3B, SCNB3 Brugada syndrome 7, 613120 (3)	
MASTL	608221	MASTL, FLJ14813, GWL, THC2 Thrombocytopenia-2, 188000 (3)	
ADSL	608222	ADSL Adenylosuccinase deficiency, 103050 (3)	
SNIP1	608241	SNIP1, PMRED Psychomotor retardation, epilepsy, and craniofacial dysmorphism, 614501 (3)	
KRT74	608248	KRT74, K6IRS4, KRT6IRS4, HTSS2 Woolly hair, autosomal dominant, 194300 (3); Hypotrichosis simplex of the scalp 2, 613981 (3)	
PAXIP1	608254	PACIP1, PAXIP1L, PTIP {Alzheimer disease, susceptibility to}, 104300 (3)	
SCN4B	608256	SCN4B Long QT syndrome-10, 611819 (3)	
NEU1	608272	NEU1, NEU, SIAL1 Sialidosis, type I, 256550 (3); Sialidosis, type II, 256550 (3)	
KIF21A	608283	KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B Fibrosis of extraocular muscles, congenital, 1, 135700 (3); Fibrosis of extraocular muscles, congenital, 3B, 135700 (3)	
IGF2BP2	608289	IGF2BP2, IMP2 {Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	
NAGS	608300	NAGS N-acetylglutamate synthase deficiency, 237310 (3)	
PINK1	608309	PINK1, PARK6 Parkinson disease 6, early onset, 605909 (3)	
ASL	608310	ASL Argininosuccinic aciduria, 207900 (3)	
ARG1	608313	ARG1 Argininemia, 207800 (3)	
SLC36A2	608331	SLC36A2, PAT2 Iminoglycinuria, digenic, 242600 (3); Hyperglycinuria, 138500 (3)	
DCXR	608347	DCXR, P34H Pentosuria, 260800 (1)	
BCKDHA	608348	BCKDHA, MSUD1 Maple syrup urine disease, type Ia, 248600 (3)	
LRRC8A	608360	LRRC8A, KIAA1437, AGM5 Agammaglobulinemia 5, 613506 (3)	
KIAA1199	608366	KIAA1199 ?Deafness, nonsyndromic (3)	
HFE2	608374	HJV, HFE2A Hemochromatosis, type 2A, 602390 (3)	
CERKL	608381	CERKL, RP26 Retinitis pigmentosa 26, 608380 (3)	
SLC9A9	608396	SLC9A9, AUTS16 {Autism susceptibility 16}, 613410 (3)	
USH2A	608400	USH2A, RP39 Usher syndrome, type 2A, 276901 (3); Retinitis pigmentosa 39, 613809 (3)	
PLCE1	608414	PLCE1, KIAA1516, NPHS3 Nephrotic syndrome, type 3, 610725 (3)	
MCEE	608419	MCEE Methylmalonyl-CoA epimerase deficiency, 251120 (3)	
CHST14	608429	CHST14, D4ST1, ATCS Ehlers-Danlos syndrome, musculocontractural type , 601776 (3)	
SYNE1	608441	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4 Spinocerebellar ataxia, autosomal recessive 8, 610743 (3); Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3)	
SYNE2	608442	SYNE2, NUANCE, KIAA1011, EDMD5 Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3)	
ETHE1	608451	ETHE1, HSCO, D83198 Ethylmalonic encephalopathy, 602473 (3)	
PYGM	608455	PYGM McArdle disease, 232600 (3)	
SETX	608465	SETX, SCAR1, AOA2, ALS4 Ataxia-ocular apraxia-2, 606002 (3); Amyotrophic lateral sclerosis 4, juvenile, 602433 (3)	
SMOC1	608488	SMOC1, OAS Microphthalmia with limb anomalies, 206920 (3)	
PRICKLE1	608500	PRICKLE1, RILP, EPM1B Epilepsy, progressive myoclonic 1B, 612437 (3)	
PRICKLE2	608501	PRICKLE2, EPM5 Epilepsy, progressive myoclonic 5, 613832 (3)	
MFN2	608507	MFN2, KIAA0214, CMT2A2 Charcot-Marie-Tooth disease, type 2A2, 609260 (3); Hereditary motor and sensory neuropathy VI, 601152 (3)	
NCF1	608512	NCF1 Chronic granulomatous disease due to deficiency of NCF-1, 233700 (3)	
NCF2	608515	NCF2 Chronic granulomatous disease due to deficiency of NCF-2, 233710 (3)	
VHL	608537	VHL von Hippel-Lindau syndrome, 193300 (3); Renal cell carcinoma, somatic, 144700 (3); Pheochromocytoma, 171300 (3); Hemangioblastoma, cerebellar, somatic (3); Erythrocytosis, familial, 2, 263400 (3)	
GLIS2	608539	GLIS2, NPHP7 Nephronophthisis 7, 611498 (3)	
VKORC1	608547	VKORC1, VKOR, VKCFD2, FLJ00289 Vitamin K-dependent clotting factors, combined deficiency of, 2, 607473 (3); Warfarin resistance, 122700 (3)	
HMCN1	608548	HMCN1, FBLN6, FIBL6, ARMD1 {Macular degeneration, age-related, 1}, 603075 (3)	
VPS33B	608552	VPS33B Arthrogryposis, renal dysfunction, and cholestasis 1, 208085 (3)	
MYH14	608568	MYH14, KIAA2034, DFNA4A, PNMHH Deafness, autosomal dominant 4A, 600652 (3); Peripheral neuropathy, myopathy, hoarseness, and hearing loss, 614369 (3)	
GRHL2	608576	GRHL2, TFCP2L3, DFNA28 Deafness, autosomal dominant 28, 608641 (3)	
RP1L1	608581	RP1L1 Occult macular dystrophy, 613587 (3)	
NPSR1	608595	NPSR1, GPR154, GPRA, VRR1, PGR14, ASRT2 {Asthma, susceptibility to, 2}, 608584 (3)	
CYP4V2	608614	CYP4V2, BCD Bietti crystalline corneoretinal dystrophy, 210370 (3)	
STRADA	608626	STRADA, STRAD, LYK5 Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3)	
ROBO3	608630	ROBO3, RBIG1, RIG1, HGPPS Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)	
CASP12	608633	CASP12, CASP12P1 {Sepsis, susceptibility to} (3)	
SEC63	608648	SEC63 Polycystic liver disease, 174050 (3)	
ANO5	608662	ANO5, TMEM16E, GDD1, LGMD2L Gnathodiaphyseal dysplasia, 166260 (3); Muscular dystrophy, limb-girdle, type 2L, 611307 (3); Miyoshi muscular dystrophy 3, 613319 (3)	
ANO6	608663	ANO6, TMEM16F, SCTS, BDPLT7 Scott syndrome, 262890 (3)	
PSMC3IP	608665	PSMC3IP, TBPIP, GT198, HOP2, ODG3 Ovarian dysgenesis 3, 614324 (3)	
NIPBL	608667	NIPBL, CDLS1 Cornelia de Lange syndrome 1, 122470 (3)	
FIGLA	608697	FIGLA, POF6 Premature ovarian failure 6, 612310 (3)	
BMPER	608699	BMPER, CV2 Diaphanospondylodysostosis, 608022 (3)	
DYX1C1	608706	DYX1C1, DYXC1, DYX1 {Dyslexia, susceptibility to, 1}, 127700 (3)	
CDON	608707	CDON, CDO, HPE11 Holoprosencephaly 11, 614226 (3)	
CYP2R1	608713	CYP2R1 Rickets due to defect in vitamin D 25-hydroxylation, 600081 (3)	
SLC39A13	608735	SLC39A13 Spondylocheirodysplasia, Ehlers-Danlos syndrome-like, 612350 (3)	
ALG3	608750	ALG3, NOT56L, CDGS4, CDG1D Congenital disorder of glycosylation, type Id, 601110 (3)	
C1QTNF5	608752	C1QTNF5, CTRP5, LORD Retinal degeneration, late-onset, autosomal dominant, 605670 (3)	
TSEN2	608753	TSEN2, SEN2, PCH2B Pontocerebellar hypoplasia type 2B, 612389 (3)	
TSEN34	608754	TSEN34, PCH2C, LENG5, SEN34 Pontocerebellar hypoplasia type 2C, 612390 (3)	
TSEN54	608755	TSEN54, SEN54, PCH2A, PCH4 Pontocerebellar hypoplasia type 2A, 277470 (3); Pontocerebellar hypoplasia type 4, 225753 (3)	
PDHX	608769	PDX1 Lacticacidemia due to PDX1 deficiency, 245349 (3)	
DLAT	608770	DLAT, PDCE2 Pyruvate dehydrogenase E2 deficiency, 245348 (3)	
MED13L	608771	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025 Transposition of the great arteries, dextro-looped 1, 608808 (3)	
GTF2H5	608780	GTF2H5, TTDA, TFB5, C6orf175 Trichothiodystrophy, complementation group A, 601675 (3)	
PC	608786	PC Pyruvate carboxylase deficiency, 266150 (3)	
GIPC3	608792	GIPC3, DFNB15, DFNB72, DFNB95 Deafness, autosomal recessive 15, 601869 (3)	
DFNA5	608798	DFNA5 Deafness, autosomal dominant 5, 600994 (3)	
GCDH	608801	GCDH Glutaricaciduria, type I, 231670 (3)	
GJC2	608803	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C Leukodystrophy, hypomyelinating, 2, 608804 (3); Spastic paraplegia, 44, 613206 (3); Lymphedema, hereditary, IC, 613480 (3)	
EFHC1	608815	EFHC1, FLJ10466, EJM1, JAE, EJA1 {Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3); {Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3)	
SUMO4	608829	SUMO4, IDDM5 {Diabetes mellitus, insulin-dependent, 5}, 600320 (3)	
RDH12	608830	RDH12, LCA13 Leber congenital amaurosis 13, 612712 (3)	
ARL6	608845	ARL6, BBS3, RP55 Bardet-Biedl syndrome 3, 209900 (3); {Bardet-Biedl syndrome 1, modifier of}, 209900 (3); Retinitis pigmentosa 55, 613575 (3)	
PPARGC1B	608886	PPARGC1B, PGC1B, PERC {Obesity, variation in}, 601665 (3)	
CHD7	608892	CHD7, IS3, KAL5 CHARGE syndrome, 214800 (3); {Scoliosis, idiopathic 3}, 608765 (3); Kallmann syndrome 5, 612370 (3); Hypogonadotropic hypogonadism, 146110 (3)	
SLC6A19	608893	SLC6A19, HND Hartnup disorder, 234500 (3); Iminoglycinuria, digenic, 242600 (3); Hyperglycinuria, 138500 (3)	
AHI1	608894	AHI1 Joubert syndrome-3, 608629 (3)	
SGCG	608896	SGCG, LGMD2C, DMDA1, SCG3 Muscular dystrophy, limb-girdle, type 2C, 253700 (3)	
UNC13D	608897	UNC13D, MUNC13-4, HPLH3, HLH3, FHL3 Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)	
ATPAF2	608918	ATPAF2, ATP12, MC5DN1 Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1, 604273 (3)	
PITPNM3	608921	PITPNM3, NIR1, CORD5 Cone-rod dystrophy 5, 600977 (3)	
ARL13B	608922	ARL13B, ARL2L1, JBTS8 Joubert syndrome 8, 612291 (3)	
FREM1	608944	FREM1, C9orf154, BNAR, MOTA, TRIGNO2 Bifid nose with or without anorectal and renal anomalies, 608980 (3); Manitoba oculotrichoanal syndrome, 248450 (3); Trigonocephaly 2, 614485 (3)	
FREM2	608945	FREM2 Fraser syndrome, 219000 (3)	
ADA	608958	ADA Severe combined immunodeficiency due to ADA deficiency, 102700 (3); Adenosine deaminase deficiency, partial, 102700 (3)	
CABP4	608965	CABP4, CSNB2B Night blindness, congenital stationary, type 2B, 610427 (3)	
MAFB	608968	MAFB, KRML, MCTO Multicentric carpotarsal osteolysis syndrome, 166300 (3)	
DNAJC19	608977	DNAJC19, TIM14 3-methylglutaconic aciduria, type V, 610198 (3)	
ADAMTS10	608990	ADAMTS10, WMS1 Weill-Marchesani syndrome 1, recessive, 277600 (3)	
LRRK2	609007	LRRK2, PARK8 Parkinson disease 8, 607060 (3)	
MCCC1	609010	MCCC1, MCCA 3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)	
MCCC2	609014	MCCC2, MCCB 3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3)	
ERMAP	609017	ERMAP, SC, RD [Blood group, Scianna system], 111750 (3); [Blood group, Radin], 111620 (3)	
HLCS	609018	HLCS, HCS Holocarboxylase synthetase deficiency, 253270 (3)	
BTD	609019	BTD Biotinidase deficiency, 253260 (3)	
PNKD	609023	MR1, TAHCCP2, KIPP1184, BRP17, PNKD, FPD1, PDC, DYT8 Paroxysmal nonkinesigenic dyskinesia, 118800 (3)	
KRT75	609025	KRT75, K6HF, PFB {Pseudofolliculitis barbae, susceptibility to}, 612318 (3)	
O3FAR1	609044	O3FAR1, GPR120, PGR4, BMIQ10 {Obesity, susceptibility to}, 607514 (3)	
MUT	609058	MUT, MCM Methylmalonic aciduria, mut(0) type, 251000 (3)	
PNPLA2	609059	PNPLA2, TTS2, ATGL Neutral lipid storage disease with myopathy, 610717 (3)	
POU6F2	609062	POU6F2, WTSL, WT5 {Wilms tumor susceptibility-5}, 601583 (3)	
FBXO33	609103	FBXO33, FBX33, BMND12 [Bone mineral density QTL 12], 612560 (3)	
PDCD10	609118	PDCD10, TFAR15, CCM3 Cerebral cavernous malformations 3, 603285 (3)	
REEP1	609139	REEP1, C2ORF23, SPG31 Spastic paraplegia 31, autosomal dominant, 610250 (3)	
FLVCR1	609144	FLVCR1, AXPC1, PCARP Ataxia, posterior column, with retinitis pigmentosa, 609033 (3)	
D2HGDH	609186	D2HGDH, D2HGD D-2-hydroxyglutaric aciduria, 600721 (3)	
C7orf10	609187	C7orf10 [Glutaric aciduria III], 231690 (3)	
MPLKIP	609188	C7orf11, ABHS, TTDN1 Trichothiodystrophy, nonphotosensitive 1, 234050 (3)	
MRAP	609196	MRAP, FALP, C21orf61, GCCD2, FGD2 Glucocorticoid deficiency 2, 607398 (3)	
MRPS16	609204	MRPS16, COXPD2 Combined oxidative phosphorylation deficiency 2, 610498 (3)	
IQCB1	609237	IQCB1, NPHP5, KIAA0036 Senior-Loken syndrome 5, 609254 (3)	
LPAR6	609239	LPAR6, P2RY5, P2Y5, LAH3, ARWH1 Hypotrichosis 8, 278150 (3); Woolly hair, autosomal recessive 1, with or without hypotrichosis, 278150 (3)	
GPSM2	609245	GPSM2, LGN, PINS, DFNB82 Deafness, autosomal recessive 82, 613557 (3)	
LIPI	609252	LIPI, LPDL, PRED5 {Hypertriglyceridemia, susceptibility to}, 145750 (3)	
CRBN	609262	CRBN, MRT2 Mental retardation, autosomal recessive 2, 607417 (3)	
KIAA0319	609269	KIAA0319, DYX2, DYLX2, DLX2 {Dyslexia, susceptibility to, 2}, 600202 (3)	
RAB3GAP2	609275	RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2 Martsolf syndrome, 212720 (3); Warburg micro syndrome 2, 614225 (3)	
CENPJ	609279	CENPJ, CPAP, MCPH6, SCKL4 Microcephaly, primary autosomal recessive, 6, 608393 (3); Seckel syndrome 4, 613676 (3)	
SPRED1	609291	SPRED1, NFLS Legius syndrome, 611431 (3)	
CYP17A1	609300	CYP17A1, CYP17, P450C17 17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3); 17,20-lyase deficiency, isolated, 202110 (3)	
SLC25A22	609302	SLC25A22, GC1, EIEE3 Epileptic encephalopathy, early infantile, 3, 609304 (3)	
MSH2	609309	MSH2, COCA1, FCC1, HNPCC1 Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3); Muir-Torre syndrome, 158320 (3); Mismatch repair cancer syndrome, 276300 (3)	
DBH	609312	DBH [Dopamine-beta-hydroxylase activity levels, plasma] (3); Dopamine beta-hydroxylase deficiency, 223360 (3)	
GIF	609342	GIF, IF Intrinsic factor deficiency, 261000 (3)	
ESCO2	609353	ESCO2 Roberts syndrome, 268300 (3); SC phocomelia syndrome, 269000 (3)	
KIAA1279	609367	KIAA1279 Goldberg-Shprintzen megacolon syndrome, 609460 (3)	
IER3IP1	609382	IER3IP1, MEDS Microcephaly, epilepsy, and diabetes syndrome, 614231 (3)	
NIPAL4	609383	NIPAL4, ICHYN Ichthyosis, congenital, autosomal recessive, 612281 (3)	
FIG4	609390	FIG4, KIAA0274, SAC3, ALS11 Charcot-Marie-Tooth disease, type 4J, 611228 (3); Amyotrophic lateral sclerosis 11, 612577 (3)	
STOX1	609397	STOX1, PEE4 Preeclampsia/eclampsia 4, 609404 (3)	
ERCC8	609412	ERCC8, CKN1, CSA, UVSS2 Cockayne syndrome, type A, 216400 (3); UV-sensitive syndrome 2, 614621 (3)	
ERCC6	609413	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1 Cockayne syndrome, type B, 133540 (3); Cerebrooculofacioskeletal syndrome 1, 214150 (3); De Sanctis-Cacchione syndrome, 278800 (3); {Macular degeneration, age-related, susceptibility to 5}, 613761 (3); UV-sensitive syndrome 1, 600630 (3); {Lung cancer, susceptibility to}, 211980 (3)	
PIKFYVE	609414	PIKFYVE, PIP5K3 Corneal fleck dystrophy, 121850 (3)	
MIR17HG	609415	MIR17HG, MIRH1, MIHG1, MIRHG1, C13orf25, FGLDS2 Feingold syndrome 2, 614326 (3)	
LHFPL5	609427	LHFPL5, TMHS, DFNB67 Deafness, autosomal recessive 67, 610265 (3)	
NDUFA13	609435	NDUFA13, GRIM19 {Thyroid carcinoma, Hurthle cell}, 607464 (3)	
NDE1	609449	NDE1, NUDE, LIS4 Lissencephaly 4 (with microcephaly), 614019 (3)	
HAL	609457	HAL, HSTD [Histidinemia], 235800 (3)	
MAN2B1	609458	MAN2B1, MANB Mannosidosis, alpha-, types I and II, 248500 (3)	
MANBA	609489	MANBA, MANB1 Mannosidosis, beta, 248510 (3)	
CDHR1	609502	CDHR1, PCDH21, PRCAD, CORD15 Cone-rod dystrophy 15, 613660 (3)	
CYP27B1	609506	CYP27B1, VDD1, PDDR Vitamin D-dependent rickets, type I, 264700 (3)	
TOPORS	609507	TOPORS, P53BP3, LUN, RP31 Retinitis pigmentosa 31, 609923 (3)	
IL31RA	609510	IL31RA, GLMR, GPL, PLCA2 Amyloidosis, primary localized cutaneous, 2, 613955 (3)	
THAP1	609520	THAP1, DYT6 Dystonia 6, torsion, 602629 (3)	
ALDH3A2	609523	ALDH3A2, ALDH10, SLS, FALDH Sjogren-Larsson syndrome, 270200 (3)	
CPA6	609562	CPA6, CPAH, ETL5, FEB11 Epilepsy, familial temporal lobe, 5, 614417 (3); Febrile seizures, familial, 11, 614418 (3)	
ACADVL	609575	ACADVL, VLCAD VLCAD deficiency, 201475 (3)	
CUL7	609577	CUL7 3-M syndrome 1, 273750 (3)	
L2HGDH	609584	L2HGDH, C14orf160 L-2-hydroxyglutaric aciduria, 236792 (3)	
GLRX5	609588	GLRX5, C14orf87, PRO1238, FLB4739 Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive, 205950 (3)	
RSPO1	609595	RSPO1, FLJ40906 Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal, 610644 (3); Palmoplantar hyperkeratosis and true hermaphroditism, 610644 (3)	
PVRL4	609607	PVRL4, PRR4, EDSS1 Ectodermal dysplasia-syndactyly syndrome 1, 613573 (3)	
FANCM	609644	FANCM, KIAA1596 Fanconi anemia, complementation group M, 614087 (3)	
NLRP12	609648	NALP12, PYPAF7, RNO, FCAS2 Familial cold autoinflammatory syndrome 2, 611762 (3)	
NDUFAF2	609653	NDUFAF2, NDUFA12L, MMTN, B17.2L Mitochondrial complex I deficiency, 252010 (3); Leigh syndrome, 256000 (3)	
NLRP7	609661	NALP7, NOD12, PYPAF3, HYDM Hydatidiform mole, 231090 (3)	
WDR36	609669	WDR36, TAWDRP, GLC1G Glaucoma 1, open angle, G, 609887 (3)	
SLITRK1	609678	SLITRK1, KIAA1910, TTM Tourette syndrome, 137580 (3); Trichotillomania, 613229 (3)	
HPD	609695	HPD Tyrosinemia, type III, 276710 (3); Hawkinsinuria, 140350 (3)	
NAGLU	609701	NAGLU, MPS3B Mucopolysaccharidosis type IIIB (Sanfilippo B), 252920 (3)	
PKLR	609712	PKLR, PK1 Pyruvate kinase deficiency, 266200 (3); Adenosine triphosphate, elevated, of erythrocytes, 102900 (3)	
ILDR1	609739	ILDR1, DFNB42 Deafness, autosomal recessive 42, 609646 (3)	
ACOX1	609751	ACOX1, ACOX, SCOX Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)	
TRIOBP	609761	TRIOBP, KIAA1662 Deafness, autosomal recessive 28, 609823 (3)	
BLOC1S3	609762	BLOC1S3, BLOS3, HPS8 Hermansky-Pudlak syndrome 8, 614077 (3)	
NEK8	609799	NEK8, JCK, NPHP9 Nephronophthisis 9, 613824 (3)	
SLC24A5	609802	SLC24A5, NCKX5, SHEP4 [Skin/hair/eye pigmentation 4, fair/dark skin], 113750 (3)	
HMBS	609806	HMBS, PBGD, UPS Porphyria, acute intermittent, 176000 (3); Porphyria, acute intermittent, nonerythroid variant, 176000 (3)	
COQ2	609825	COQ2, COQ10D1 Coenzyme Q10 deficiency, primary, 1, 607426 (3)	
SLC34A3	609826	SLC34A3, NPTIIC, HHRH Hypophosphatemic rickets with hypercalciuria, 241530 (3)	
MMACHC	609831	MMACHC Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3)	
SLC24A4	609840	SLC24A4, NCKX4, SHEP6 [Skin/hair/eye pigmentation 6, blond/brown hair], 210750 (3); [Skin/hair/eye pigmentation 6, blue/green eyes], 210750 (3)	
SI	609845	SI Sucrase-isomaltase deficiency, congenital, 222900 (3)	
SPATA16	609856	SPATA16, SPGF6 Spermatogenic failure 6, 102530 (3)	
TMPRSS6	609862	TMPRSS6, IRIDA Iron-refractory iron deficiency anemia, 206200 (3)	
TCTN1	609863	TECT1, JBTS13 Joubert syndrome 13, 614173 (3)	
SPATA7	609868	SPATA7, HSD3, LCA3 Leber congenital amaurosis 3, 604232 (3); Retinitis pigmentosa, juvenile, autosomal recessive, 268000 (3)	
MKS1	609883	MKS1, MKS, BBS13 Meckel syndrome, type 1, 249000 (3); Bardet-Biedl syndrome 13, 209900 (3)	
TMEM67	609884	TMEM67, MKS3, JBTS6, NPHP11 Meckel syndrome, type 3, 607361 (3); Joubert syndrome 6, 610688 (3); {Bardet-Biedl syndrome 14, modifier of}, 209900 (3); COACH syndrome, 216360 (3); Nephronophthisis 11, 613550 (3)	
EHBP1	609922	EHBP1, KIAA0903, HPC12 {Prostate cancer, hereditary, 12}, 611868 (3)	
CLDN19	610036	CLDN19, HOMG5 Hypomagnesemia 5, renal, with ocular involvement, 248190 (3)	
ALDH5A1	610045	ALDH5A1, SSADH Succinic semialdehyde dehydrogenase deficiency, 271980 (3)	
TUBGCP6	610053	TUBGCP6, GCP6, KIAA1669, MCCRP Microcephaly and chorioretinopathy with or without mental retardation, 251270 (3)	
CC2D1A	610055	CC2D1A, MRT3 Mental retardation, autosomal recessive 3, 608443 (3)	
TECR	610057	TECR, GPSN2, TER, SC2, MRT14 Mental retardation, autosomal recessive 14, 614020 (3)	
POLR1C	610060	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3 Treacher Collins syndrome 3, 248390 (3)	
DNAL1	610062	DNAL1, C14orf168, CILD16 Ciliary dyskinesia, primary, 16, 614017 (3)	
SIAE	610079	SIAE, AIS6 {Autoimmune disease, susceptibility to, 6}, 613551 (3)	
ADAMTSL4	610113	ADAMTSL4, TSRC1 Ectopia lentis, isolated, autosomal recessive, 225100 (3)	
VANGL1	610132	VANGL1, STBM2 Caudal regression syndrome, 600145 (3); Neural tube defects, 182940 (3)	
CEP290	610142	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14 Joubert syndrome 5, 610188 (3); Senior-Loken syndrome 6, 610189 (3); Leber congenital amaurosis 10, 611755 (3); Meckel syndrome type 4, 611134 (3); Bardet-Biedl syndrome 14, 209900 (3)	
BBS10	610148	BBS10, C12orf58, FLJ23560 Bardet-Biedl syndrome 10, 209900 (3)	
CCT5	610150	CCT5, KIAA0098, CCTE Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)	
CCDC28B	610162	CCDC28B, MGC1203 {Bardet-Biedl syndrome, modifier of}, 209900 (3)	
GLIS3	610192	GLIS3, ZNF515 Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3)	
MED25	610197	MED25, PTOV2, ARC92, CMT2B2 Charcot-Marie-Tooth disease, type 2B2, 605589 (3)	
SLC4A11	610206	SLC4A11, BTR1, NABC1, CHED2, CDPD, FECD4 Corneal endothelial dystrophy 2, autosomal recessive, 217700 (3); Corneal endothelial dystrophy and perceptive deafness, 217400 (3); Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)	
DFNB59	610219	PJVK, DFNB59 Deafness, autosomal recessive 59, 610220 (3)	
RIN2	610222	RIN2, MACS Macrocephaly, alopecia, cutis laxa, and scoliosis, 613075 (3)	
ZNF750	610226	ZNF750, FLJ13841 Seborrhea-like dermatitis with psoriasiform elements, 610227 (3)	
TRMU	610230	TRMU, MTO2, TRNT1 {Deafness, mitochondrial, modifier of}, 580000 (3); Liver failure, transient infantile, 613070 (3)	
ZFYVE27	610243	ZFYVE27, SPG33 Spastic paraplegia 33, autosomal dominant, 610244 (3)	
PIGM	610273	PIGM Glycosylphosphatidylinositol deficiency, 610293 (3)	
PIGV	610274	PIGV Mabry syndrome, 239300 (3)	
ORAI1	610277	ORAI1, TMEM142A, CRACM1 Immune dysfunction with T-cell inactivation due to calcium entry defect 1, 612782 (3)	
DOK7	610285	DOK7, C4orf25, CMS1B Myasthenia, limb-girdle, familial, 254300 (3); Fetal akinesia deformation sequence, 208150 (3)	
GALNT12	610290	GALNT12, CRCS1 {Colorectal cancer, susceptibility to, 1}, 608812 (3)	
BANK1	610292	BANK1, FLJ20706, BANK {Systemic lupus erythematosus, association with}, 152700 (3)	
B3GALTL	610308	B3GALTL; B3GTL, B3GLCT Peters-plus syndrome, 261540 (3)	
RNASEH2B	610326	RNASEH2B, DLEU8, FLJ11712, AGS2 Aicardi-Goutieres syndrome 2, 610181 (3)	
RNASEH2C	610330	RNASEH2C, AYP1, FLJ20974, AGS3 Aicardi-Goutieres syndrome 3, 610329 (3)	
LEPRE1	610339	LEPRE1, P3H1, GROS1, OI8 Osteogenesis imperfecta, type VIII, 610915 (3)	
LEPREL1	610341	LEPREL1, P3H2, MCVD Myopia, high, with cataract and vitreoretinal degeneration, 614292 (3)	
AGK	610345	AGK, MULK, MTDPS10 Sengers syndrome, 212350 (3)	
PALB2	610355	PALB2, FANCN, PNCA3 Fanconi anemia, complementation group N, 610832 (3); {Breast cancer, susceptibility to}, 114480 (3); {Pancreatic cancer, susceptibility to, 3}, 613348 (3)	
RAX2	610362	RAXL1, QRX, CORD11, ARMD6 Macular degeneration, age-related, 6, 613757 (3); Cone-rod dystrophy 11, 610381 (3)	
LAMTOR2	610389	MAPBPIP, p14 Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3)	
HGSNAT	610453	HGSNAT, TMEM76, MPS3C Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3)	
SAMD9	610456	SAMD9, NFTC Tumoral calcinosis, familial, normophosphatemic, 610455 (3)	
SEC23A	610511	SEC23A, CLSD Craniolenticulosutural dysplasia, 607812 (3)	
SEC23B	610512	SEC23B, CDAN2, HEMPAS Anemia, dyserythropoietic congenital, type II, 224100 (3)	
ATP13A2	610513	ATP13A2, PARK9, KRPPD Parkinson disease 9, 606693 (3)	
GLYCTK	610516	GLYCTK, GLYCTK1 D-glyceric aciduria, 220120 (3)	
CEP41	610523	CEP41, TSGA14, JBTS15 Joubert syndrome 15, 614464 (3)	
FAM126A	610531	FAM126A, DRCTNNB1A, HLD5 Leukodystrophy, hypomyelinating, 5, 610532 (3)	
GNAS-AS1	610540	GNASAS1, GNASAS, SANG, NESPAS Pseudohypoparathyroidism, type IB, 603233 (3)	
MAT1A	610550	MAT1A, MATA1, SAMS1 Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency, 250850 (3); Methionine adenosyltransferase deficiency, autosomal recessive, 250850 (3)	
PDSS2	610564	PDSS2, DLP1, C6orf210, COQ10D3 Coenzyme Q10 deficiency, primary, 3, 614652 (3)	
MARVELD2	610572	MARVELD2, MARVD2, TRIC, DFNB49 Deafness, autosomal recessive 49, 610153 (3)	
RSPO4	610573	RSPO4, CRISTIN4 Anonychia congenita, 206800 (3)	
PRCD	610598	PRCD, RP36 Retinitis pigmentosa 36, 610599 (3)	
CYP11B1	610613	CYP11B1, P450C11, FHI Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, 202010 (3); Aldosteronism, glucocorticoid-remediable, 103900 (3)	
F12	610619	F12, HAF, HAE3 Factor XII deficiency, 234000 (3); Angioedema, hereditary, type III, 610618 (3)	
CTHRC1	610635	CTHRC1 Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	
NAT8L	610647	NAT8L, CML3, NACED N-acetylaspartate deficiency, 614063 (3)	
KIAA0196	610657	KIAA0196, SPG8 Spastic paraplegia 8, autosomal dominant, 603563 (3)	
PFKM	610681	PFKM, GSD7 Glycogen storage disease VII, 232800 (3)	
BBS12	610683	BBS12, FLJ35630, C4orf24 Bardet-Biedl syndrome 12, 209900 (3)	
HIBCH	610690	HIBCH 3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3)	
HYLS1	610693	HYLS1, FLJ32915 Hydrolethalus syndrome, 236680 (3)	
STRA6	610745	STRA6, MCOPS9 Microphthalmia, syndromic 9, 601186 (3)	
DOLK	610746	TMEM15, DK1, SEC59, KIAA1094, CDG1M Congenital disorder of glycosylation, type Im, 610768 (3)	
ATG16L1	610767	ATG16L1, APG16L, IBD10 {Inflammatory bowel disease 10}, 611081 (3)	
SLC35D1	610804	SLC35D1, UGTREL7, KIAA0260 Schneckenbecken dysplasia, 269250 (3)	
SLC25A38	610819	SLC25A38 Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive, 205950 (3)	
SPG11	610844	SPG11, KIAA1840, FLJ21439 Spastic paraplegia 11, autosomal recessive, 604360 (3)	
ANKRD26	610855	ANKRD26, KIAA1074, THC2 Thrombocytopenia 2, 188000 (3)	
AGL	610860	AGL, GDE Glycogen storage disease IIIa, 232400 (3); Glycogen storage disease IIIb, 232400 (3)	
FLVCR2	610865	FLVCR2, C14orf58, CCT, PVHH, EPV Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome, 225790 (3)	
CHMP4B	610897	CHMP4B, SNF7, CTPP3 Cataract, posterior polar, 3, 605387 (3)	
ARHGAP31	610911	ARHGAP31, CDGAP, KIAA1204, AOS1 Adams-Oliver syndrome 1, 100300 (3)	
NSUN2	610916	NSUN2, TRM4, SAKI, MISU, MRT5 Mental retardation, autosomal recessive 5, 611091 (3)	
SOX17	610928	SOX17, VUR3 Vesicoureteral reflux 3, 613674 (3)	
ZFAT	610931	ZFAT1, ZNF406, AITD3 {Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)	
LRSAM1	610933	LRSAM1, TAL, RIFLE, CMT2P Charcot-Marie-Toothe disease, axonal, type 2P, 614436 (3)	
NOBOX	610934	NOBOX, POF5 Premature ovarian failure 5, 611548 (3)	
PSAT1	610936	PSAT1, PSAT, EPIP Phosphoserine aminotransferase deficiency, 610992 (3)	
RPGRIP1L	610937	RPGRIP1L, KIAA1005, JBTS7, MKS5 Joubert syndrome 7, 611560 (3); Meckel syndrome, type 5, 611561 (3); COACH syndrome, 216360 (3)	
SYT14	610949	SYT14, SCAR11 Spinocerebellar ataxia, autosomal recessive 11, 614229 (3)	
DARS2	610956	DARS2, ASPRS. LBSL Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3)	
YARS2	610957	YARS2, TYRRS, MLASA2 Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3)	
FTO	610966	FTO Growth retardation, developmental delay, coarse facies, and early death, 612938 (3)	
INF2	610982	INF2, FSGS5, C14orf173, CMTDIE Glomerulosclerosis, focal segmental, 5, 613237 (3); Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3)	
OBSL1	610991	OBSL1, KIAA0657, 3M2 3-M syndrome 2, 612921 (3)	
FA2H	611026	FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35 Spastic paraplegia 35, autosomal recessive, 612319 (3)	
SLC17A3	611034	SLC17A3, NPT4 ?Glycogen storage disease Ic, 232240 (3)	
G6PC3	611045	G6PC3, UGRP, SCN4 Neutropenia, severe congenital 4, autosomal recessive, 612541 (3); Darsun syndrome, 612541 (3)	
CCDC50	611051	CCDC50, C3orf6, DFNA44 Deafness, autosomal dominant 44, 607453 (3)	
SETBP1	611060	SETBP1, KIAA0437, SEB Schinzel-Giedion midface retraction syndrome, 269150 (3)	
FAM20C	611061	FAM20C, DMP4 Raine syndrome, 259775 (3)	
FAM20A	611062	FAM20A, AIGFS Amelogenesis imperfecta and gingival fibromatosis syndrome, 614253 (3)	
MIAT	611082	MIAT, C22orf35 {Myocardial infarction, susceptibility to}, 608446 (3)	
MTMR14	611089	MTMR14, C3orf29, HJUMPY {Centronuclear myopathy, autosomal, modifier of}, 160150 (3)	
PLEKHG5	611101	PLEKHG5, KIAA0720, DSMA4 Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3)	
ACAD9	611103	ACAD9 ACAD9 deficiency, 611126 (3)	
FGD4	611104	FGD4, FRABIN, CMT4H Charcot-Marie-Tooth disease, type 4H, 609311 (3)	
KLHL7	611119	KLHL7, RP42 Retinitis pigmentosa 42, 612943 (3)	
MFSD8	611124	MFSD8, MGC33302, CLN7 Ceroid lipofuscinosis, neuronal, 7, 610951 (3)	
SLC30A8	611145	SLC30A8, ZNT8 {Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	
SLC30A10	611146	SLC30A10, ZNT10, HMDPC Hypermanganesemia with dystonia, polycythemia, and cirrhosis, 613280 (3)	
ATXN10	611150	ATXN10, SCA10 Spinocerebellar ataxia 10, 603516 (3)	
XPA	611153	XPA, XPAC Xeroderma pigmentosum, group A, 278700 (3)	
IFT80	611177	IFT80, KIAA1374, WDR56, ATD2 Asphyxiating thoracic dystrophy 2, 611263 (3)	
ANKRD11	611192	ANKRD11, ANCO1, KBGS KBG syndrome, 148050 (3)	
DNAJC5	611203	DNAJC5, DNAJC5A, CSP, CLN4B Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)	
SUCLG1	611224	SUCLG1, SUCLA1, MTDPS9 Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria), 245400 (3)	
KIF7	611254	KIF7, HLS2, ACLS, JBTS12 Hydrolethalus syndrome 2, 614120 (3); Acrocallosal syndrome, 200990 (3); Joubert syndrome 12, 200990 (3)	
TDRD7	611258	TDRD7, KIAA1529, TRAP, CATC4 Cataract, autosomal recessive congenital 4, 613887 (3)	
CDKAL1	611259	CDKAL1 {Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	
NHEJ1	611290	NHEJ1, XLF Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation, 611291 (3)	
ARMS2	611313	LOC387715, ARMD8 {Macular degeneration, age-related, 8}, 613778 (3)	
DNAJB6	611332	DNAJB6, MRJ, DJ4, LGMD1E Muscular dystrophy, limb-girdle, type 1E, 603511 (3)	
RNF135	611358	RNF135, MMFD Macrocephaly, macrosomia, facial dysmorphism syndrome, 614192 (3)	
FANCI	611360	FANCI, KIAA1794 Fanconi anemia, complementation group I, 609053 (3)	
DIP2B	611379	DIP2B, KIAA1463 Mental retardation, FRA12A type, 136630 (3)	
LCA5	611408	LCA5, C6orf152 Leber congenital amaurosis 5, 604537 (3)	
OCA2	611409	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1 Albinism, oculocutaneous, type II, 203200 (3); Albinism, brown oculocutaneous, 203200 (3); [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3); [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)	
CALR3	611414	CALR3, CRT2, CMH19 Cardiomyopathy, familial hypertrophic, 19, 613875 (3)	
SRCAP	611421	SRCAP, SWR1, KIAA0309, FLHS Floating-Harbor syndrome, 136140 (3)	
CEP135	611423	CEP135, KIAA0635, MCPH8 Microcephaly 8, primary, autosomal recessive, 614673 (3)	
DOCK8	611432	DOCK8, MRD2 Mental retardation, autosomal dominant 2, 614113 (3); Hyper-IgE recurrent infection syndrome, autosomal recessive, 243700 (3)	
GLB1	611458	GLB1, MPS4B GM1-gangliosidosis, type I, 230500 (3); GM1-gangliosidosis, type II, 230600 (3); GM1-gangliosidosis, type III, 230650 (3); Mucopolysaccharidosis type IVB (Morquio), 253010 (3)	
PLEKHM1	611466	PLEKHM1, AP162, KIAA0356, OPTB6 Osteopetrosis, autosomal recessive 6, 611497 (3)	
MBD5	611472	MBD5, KIAA1461, MRD1 Mental retardation, autosomal dominant 1, 156200 (3)	
CA2	611492	CA2 Osteopetrosis, autosomal recessive 3, with renal tubular acidosis, 259730 (3)	
CYP4F22	611495	CYP4F22, LI3 Ichthyosis, lamellar, 3, 604777 (3)	
GUSB	611499	GUSB, MPS7 Mucopolysaccharidosis VII, 253220 (3)	
CISD2	611507	CISD2, WFS2, ZCD2, ERIS Wolfram syndrome 2, 604928 (3)	
RARS2	611524	RARS2, RARSL, PCH6 Pontocerebellar hypoplasia, type 6, 611523 (3)	
EMG1	611531	EMG1, NEP1, C2F, BWCNS Bowen-Conradi syndrome, 211180 (3)	
FOXD3	611539	FOXD3, AIS1, VAMAS2 {Autoimmune disease, susceptibility to, 1}, 607836 (3)	
ARSB	611542	ARSB, MPS6 Mucopolysaccharidosis type VI (Maroteaux-Lamy), 253200 (3)	
NCR3	611550	NCR3, 1C7, NKP30, CD337, MALS {Malaria, mild, susceptibility to}, 609148 (3)	
UPK3A	611559	UPK3A, UPK3, UPIII Renal adysplasia, 191830 (3); Urogenital adysplasia, 191830 (3)	
FBP1	611570	FBP1 Fructose-1,6-bidphosphatase deficiency, 229700 (3)	
ERLIN2	611605	ERLIN2, SPFH2, C8orf2, SPG18 Spastic paraplegia 18, autosomal recessive, 611225 (3)	
MIR96	611606	MIR96, MIRN96, DFNA50 Deafness, autosomal dominant 50, 613074 (3)	
UBIAD1	611632	UBIAD1, TERE1, SCCD Corneal dystrophy, crystalline, of Schnyder, 121800 (3)	
HEPACAM	611642	HEPACAM, MLC2A, MLC2B Megalencephalic leukoencephalopathy with subcortical cysts 2A, 613925 (3); Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation, 613926 (3)	
SLC46A1	611672	SLC46A1, HCP1, PCFT Folate malabsorption, hereditary, 229050 (3)	
SART3	611684	SART3, P100, KIAA0156, TIP110, DSAP1 Porokeratosis, disseminated superficial actinic, 1, 175900 (3)	
KHDC3L	611687	C6orf221, ECAT1, HYDM2 Hydatidiform mole, recurrent, 2, 614293 (3)	
TTBK2	611695	TTBK2, SCA11 Spinocerebellar ataxia 11, 604432 (3)	
SRD5A3	611715	SRD5A3, SRD5A2L, CDG1Q, KRIZI Congenital disorder of glycosylation, type Iq, 612379 (3); Kahrizi syndrome, 612713 (3)	
ATP6V0A2	611716	ATP6V0A2, WSS, ARCL2A Cutis laxa, autosomal recessive, type IIA, 219200 (3); Wrinkly skin syndrome, 278250 (3)	
KCTD7	611725	KCTD7, EPM3 Epilepsy, progressive myoclonic 3, 611726 (3)	
APC	611731	APC, GS, FPC, BTPS2 Adenomatous polyposis coli, 175100 (3); Gastric cancer, somatic, 613659 (3); Adenoma, periampullary, somatic (3); Hepatoblastoma, somatic, 114550 (3); Desmoid disease, hereditary, 135290 (3); Gardner syndrome (3); Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2 (3)	
LMF1	611761	LMF1, TMEM112 Lipase deficiency, combined, 246650 (3)	
NKX2-6	611770	NKX2-6, CSX2 Persistent truncus arteriosus, 217095 (3)	
NDUFAF4	611776	NDUFAF4, HRPAP20, C6orf66 Mitochondrial complex I deficiency, 252010 (3)	
GPD1L	611778	GPD1L, KIAA0089 Brugada syndrome 2, 611777 (3)	
RFT1	611908	RFT1, CDG1N Congenital disorder of glycosylation, type In, 612015 (3)	
SLC16A12	611910	SLC16A12, MCT12, CJMG Cataract, juvenile, with microcornea and glucosuria, 612018 (3)	
ISCU	611911	ISCU, HML Myopathy with lactic acidosis, hereditary, 255125 (3)	
FAM83H	611927	FAM83H, AI3 Amelogenesis imperfecta, type 3, 130900 (3)	
MMADHC	611935	C2orf25, MMADHC Homocystinuria, cblD type, variant 1, 277410 (3); Methylmalonic aciduria, cblD type, variant 2, 277410 (3); Methylmalonic aciduria and homocystinuria, cblD type, 277410 (3)	
B9D2	611951	B9D2, MKS10 Meckel syndrome 10, 614175 (3)	
TRAPPC9	611966	TRAPPC9, NIBP, KIAA1882, MRT13 Mental retardation, autosomal recessive 13, 613192 (3)	
GIGYF2	612003	GIGYF2, KIAA0642, PARK11 Parkinson disease 11, 607688 (3)	
ZFYVE26	612012	ZFYVE26, KIAA0321, SPG15 Spastic paraplegia 15, autosomal recessive, 270700 (3)	
CC2D2A	612013	CC2D2A, KIAA1345, MKS6 Joubert syndrome 9, 612285 (3); Meckel syndrome, type 6, 612284 (3); COACH syndrome, 216360 (3)	
TTC21B	612014	TTC21B, THM1, NPHP12, ATD4 Nephronophthisis 12, 613820 (3); Asphyxiating thoracic dystrophy 4, 613819 (3)	
IYD	612025	IYD, DEHAL1, TDH4 Thyroid dyshormonogenesis 4, 274800 (3)	
AARS2	612035	AARS2, KIAA1270, MTALARS, COXPD8 Combined oxidative phosphorylation deficiency 8, 614096 (3)	
RNF212	612041	RNF212, ZHP3 Recombination rate QTL 1, 612042 (3)	
TMEM43	612048	TMEM43, ARVD5, ARVC5 Arrhythmogenic right ventricular dysplasia 5, 604400 (3)	
BEAN1	612051	BEAN, SCA31 Spinocerebellar ataxia 31, 117210 (3)	
RBM28	612074	RBM28 Alopecia, neurologic defects, and endocrinopathy syndrome, 612079 (3)	
ZNF469	612078	ZNF469, KIAA1858, BCS Brittle cornea syndrome, 229200 (3)	
UQCRQ	612080	UQCRQ, QPC Mitochondrial complex III deficiency, 124000 (3)	
TPCN2	612163	TPCN2, TPC2, SHEP10 [Skin/hair/eye pigmentation 10, blond/brown hair], 612267 (3)	
FCGR2C	612169	FCGR2C, CD32C Thrombocytopenic purpura, autoimmune, 188030 (1)	
NAT2	612182	NAT2, AAC2 [Acetylation, slow], 243400 (3)	
ZFP57	612192	ZFP57, TNDM1 Diabetes mellitus, transient neonatal, 1, 601410 (3)	
GALNS	612222	GALNS, MPS4A Mucopolysaccharidosis IVA, 253000 (3)	
ADAMTSL2	612277	ADAMTSL2, KIAA0605, GPHYSD1 Geleophysic dysplasia 1, 231050 (3)	
FUCA1	612280	FUCA1 Fucosidosis, 230000 (3)	
PROC	612283	PROC, PC, THPH3, THPH4 Thrombophilia due to protein C deficiency, autosomal dominant, 176860 (3); Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)	
F5	612309	F5, THPH2, RPRGL1 Factor V deficiency, 227400 (3); {Thrombophilia, susceptibility to, due to factor V Leiden}, 188055 (3); {Stroke, ischemic, susceptibility to}, 601367 (3); {Budd-Chiari syndrome}, 600880 (3); Thrombophilia due to activated protein C resistance, 188055 (3); {Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3)	
FASTKD2	612322	FASTKD2, KIAA0971 Mitochondrial complex IV deficiency, 220110 (3)	
ICK	612325	ICK, MRK, KIAA0936, ECO Endocrine-cerebroosteodysplasia, 612651 (3)	
PAH	612349	PAH, PKU1 Phenylketonuria, 261600 (3); [Hyperphenylalaninemia, non-PKU mild], 261600 (3)	
KNG1	612358	KNG1, KNG [Kininogen deficiency], 228960 (3); [High molecular weight kininogen deficiency], 228960 (3)	
NDUFAF5	612360	C20orf7 Mitochondrial complex 1 deficiency, 252010 (3)	
SLC29A3	612373	SLC29A3, ENT3, PHID, HCLAP Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)	
FECH	612386	FECH, FCE Protoporphyria, erythropoietic, autosomal recessive, 177000 (3)	
NDUFAF6	612392	C8orf38 Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	
CHKB	612395	CHKB, CHKL, CKEKB, EKB, MDCMC Muscular dystrophy, congenital, megaconial type, 602541 (3)	
LRTOMT	612414	LRTOMT, LRTOMT1, LRTOMT2, DFNB63 Deafness, autosomal recessive 63, 611451 (3)	
TMEM70	612418	TMEM70, MC5DN2 Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2, 614052 (3)	
EYS	612424	EYS, RP25 Retinitis pigmentosa 25, 602772 (3)	
KANSL1	612452	KANSL1, KIAA1267, MSL1V1 Mental retardation, autosomal dominant 17, 610443 (3)	
MEGF10	612453	MEGF10, KIAA1780, EMARDD Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, 614399 (3); Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant, 614399 (3)	
COLEC11	612502	COLEC11, CLK1, 3MC2 3MC syndrome 2, 265050 (3)	
DCAF17	612515	DCAF17, C20orf37 Woodhouse-Sakati syndrome, 241080 (3)	
DNAAF2	612517	KTU, C14orf104, CILD10 Ciliary dyskinesia, primary, 10, 612518 (3)	
FBN2	612570	FBN2, CCA Contractural arachnodactyly, congenital, 121050 (3)	
LMBRD1	612625	LMBRD1, LMBD1, NESI Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3)	
NDUFA11	612638	NDUFA11 Mitochondrial complex I deficiency, 252010 (3)	
ANK1	612641	ANK1, SPH2 Spherocytosis, type 1, 182900 (3)	
RSPH4A	612647	RSPH4A, CILD11 Ciliary dyskinesia, primary, 11, 612649 (3)	
RSPH9	612648	RSPH9, CILD12 Ciliary dyskinesia, primary, 12, 612650 (3)	
RFX6	612659	RFX6, RFXDC1, MTFS Martinez-Frias syndrome, 601346 (3)	
WRAP53	612661	WRAP53, TCAB1, WDR79, DKCB3 Dyskeratosis congenita, autosomal recessive 3, 613988 (3)	
QDPR	612676	QDPR, DHPR Hyperphenylalaninemia, BH4-deficient, C, 261630 (3)	
RNF168	612688	RNF168 RIDDLE syndrome, 611943 (3)	
PTS	612719	PTS Hyperphenylalaninemia, BH4-deficient, A, 261640 (3)	
ALDOB	612724	ALDOB Fructose intolerance, 229600 (3)	
CPOX	612732	CPOX Coproporphyria, 121300 (3); Harderoporphyria, 121300 (3)	
CCBE1	612753	CCBE1, KIAA1983 Hennekam lymphangiectasia-lymphedema syndrome, 235510 (3)	
SMARCAD1	612761	SMARCAD1, KIAA1122, ETL1, HEL1, ADERM Adermatoglyphia, 136000 (3)	
DUOXA2	612772	DUOXA2, TDH5 Thyroid dyshormonogenesis 5, 274900 (3)	
BCAM	612773	LU, AU, BCAM [Blood group, Lutheran system], 111200 (3); [Blood group, Auberger system], 111200 (3); [Blood group, Lutheran null], 247420 (3)	
DPYD	612779	DPYD, DPD Dihydropyrimidine dehydrogenase deficiency, 274270 (3); 5-fluorouracil toxicity, 274270 (3)	
SARS2	612804	SARS2 Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis, 613845 (3)	
COQ9	612837	COQ9, C16orf49, COQ10D5 Coenzyme Q10 deficiency, primary, 5, 614654 (3)	
TET2	612839	TET2, KIAA1546, MDS Myelodysplastic syndrome, somatic, 614286 (3)	
SDHAF1	612848	SDHAF1 Mitochondrial complex II deficiency, 252011 (3)	
TUBB2B	612850	TUBB2B Polymicrogyria, asymmetric, 610031 (3)	
TUBB1	612901	TUBB1 Macrothrombocytopenia, autosomal dominant, TUBB1-related, 613112 (3)	
NDUFAF3	612911	NDUFAF3 Mitochondrial complex I deficiency, 252010 (3)	
PGAM2	612931	PGAM2, PGAMM, GSD10 Glycogen storage disease X, 261670 (3)	
RNASET2	612944	RNASET2, RNASE6PL Leukoencephalopathy, cystic, without megalencephaly, 612951 (3)	
PDZD7	612971	PDZD7 {Retinal disease in Usher syndrome type IIA, modifier of}, 276901 (3); Usher syndrome, type IIC, GPR98/PDZD7 digenic, 605472 (3)	
TMEM126A	612988	TMEM126A, OPA7 Optic atrophy-7, 612989 (3)	
ASXL1	612990	ASXL1, KIAA0978, BOPS, MDS Bohring-Opitz syndrome, 605039 (3); Myelodysplastic syndrome, somatic, 614286 (3)	
HTT	613004	HTT, HD, IT15 Huntington disease, 143100 (3)	
SEPSECS	613009	SEPSECS, SLA, LP, PCH2D Pontocerebellar hypoplasia type 2D, 613811 (3)	
UROC1	613012	UROC1 Urocanase deficiency, 276880 (3)	
TAT	613018	TAT Tyrosinemia, type II, 276600 (3)	
SDHAF2	613019	SDHAF2, SDH5, PGL2 Paragangliomas 2, 601650 (3)	
OGDH	613022	OGDH Alpha-ketoglutarate dehydrogenase deficiency, 203740 (1)	
INPP5E	613037	INPP5E, MORMS, JBTS1, CORS1 Mental retardation, truncal obesity, retinal dystrophy, and micropenis, 610156 (3); Joubert syndrome 1, 213300 (3)	
LOXHD1	613072	LOXHD1, DFNB77 Deafness, autosomal recessive 77, 613079 (3)	
GM2A	613109	GM2A GM2-gangliosidosis, AB variant, 272750 (3)	
CTSA	613111	CTSA, PPGB, GSL, NGBE, GLB2 Galactosialidosis, 256540 (3)	
NF1	613113	NF1, VRNF, WSS, NFNS Neurofibromatosis, type 1, 162200 (3); Leukemia, juvenile myelomonocytic, 607785 (3); Melanoma, desmoplastic neurotrophic (2); Neurofibromatosis, familial spinal, 162210 (3); Neurofibromatosis-Noonan syndrome, 601321 (3); Watson syndrome, 193520 (3)	
FAM134B	613114	FAM134B, HSAN2B Neuropathy, hereditary sensory and autonomic, type IIB, 613115 (3)	
NEXN	613121	NEXN, NELIN, CMD1CC, CMH20 Cardiomyopathy, dilated, 1CC, 613122 (3); Cardiomyopathy, familial hypertrophic, 20, 613876 (3)	
CTC1	613129	CTC1, CRMCC, C17orf68, AAF132 Cerebroretinal microangiopathy with calcifications and cysts, 612199 (3)	
TSPAN12	613138	TSPAN12, NET2, EVR5 Exudative vitreoretinopathy 5, 613310 (3)	
MIR184	613146	MIR184, MIRN184, KTCNCT, EDICT EDICT syndrome, 614303 (3)	
VWF	613160	VWF, F8VWF von Willebrand disease, type 2A, 2B, 2M, and 2N, 613554 (3); von Willebrand disease, type 1, 193400 (3); von Willibrand disease, type 3, 277480 (3)	
CANT1	613165	CANT1, SCAN1, DBQD Desbuquois dysplasia, 251450 (3)	
SERPINF2	613168	PLI, SERPINF2 Alpha-2-plasmin inhibitor deficiency, 262850 (3)	
KLHDC8B	613169	KLHDC8B Hodgkin lymphoma, 236000 (3)	
RBM20	613171	RBM20 Cardiomyopathy, dilated, 1DD, 613172 (3)	
BOLA3	613183	BOLA3, MMDS2 Multiple mitochondrial dysfunctions syndrome 2, 614299 (3)	
DNAAF1	613190	LRRC50, ODA7, CILD13 Ciliary dyskinesia, primary, 13, 613193 (3)	
XPC	613208	XPC, XPCC Xeroderma pigmentosum, group C, 278720 (3)	
CYB5R3	613213	CYB5R3, DIA1, B5R Methemoglobinemia, type I, 250800 (3); Methemoglobinemia, type II, 250800 (3)	
WDR72	613214	WDR72, AI2A3 Amelogenesis imperfecta, hypomaturation type, IIA3, 613211 (3)	
CYB5A	613218	CYB5A, MCB5 Methemoglobinemia, type IV, 250790 (3)	
AGA	613228	AGA Aspartylglucosaminuria, 208400 (3)	
PEPD	613230	PEPD Prolidase deficiency, 170100 (3)	
KCNJ18	613236	KCNJ18, KIR2.6, TTPP2 {Thyrotoxic periodic paralysis, susceptibility to, 2}, 613239 (3)	
C16orf57	613276	C16orf57, PN Poikiloderma with neutropenia, 604173 (3)	
TMEM216	613277	TMEM216, JBTS2, CORS2, MKS2 Joubert syndrome 2, 608091 (3); Meckel syndrome, type 2, 603194 (3)	
SLX4	613278	SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP Fanconi anemia, complementation group P, 613951 (3)	
GRXCR1	613283	GRXCR1 Deafness, autosomal recessive 25, 613285 (3)	
ATXN8	613289	ATXN8 Spinocerebellar ataxia 8, 608768 (3)	
SH3PXD2B	613293	SH3PXD2B, TKS4, KIAA1295, FTHS Frank-ter Haar syndrome, 249420 (3)	
DPYS	613326	DPYS, DHP Dihydropyrimidinuria, 222748 (3)	
OAT	613349	OAT, GACR Gyrate atrophy of choroid and retina with or without ornithinemia, 258870 (3)	
SLC52A3	613350	C20orf54, RFT2, BVVLS Brown-Vialetto-Van Laere syndrome, 211530 (3); Fazio-Londe disease, 211500 (3)	
TPRN	613354	TPRN, C9orf75, DFNB79 Deafness, autosomal recessive 79, 613307 (3)	
CBS	613381	CBS Homocystinuria, B6-responsive and nonresponsive types, 236200 (3); Thrombosis, hyperhomocysteinemic, 236200 (3)	
POMP	613386	POMP, UMP1 Keratosis linearis with ichthyosis congenita and sclerosing keratoderma, 601952 (3)	
C14orf133	613401	VIPAR, SPE39, C14orf133 Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3)	
TMEM127	613403	TMEM127 {Pheochromocytoma, susceptibility to}, 171300 (3)	
MIR2861	613405	MIR2861, MIRN2861, BMND15 [Bone mineral density QTL 15], 613418 (3)	
C2orf71	613425	C2orf71 Retinitis pigmentosa 54, 613428 (3)	
TCN2	613441	TCN2, TC2 Transcobalamin II deficiency, 275350 (3)	
ASAH1	613468	ASAH1, AC Farber lipogranulomatosis, 228000 (3)	
HPSE2	613469	HPSE2, HPA2, UFS Urofacial syndrome, 236730 (3)	
LIPA	613497	LIPA, CESD Wolman disease, 278000 (3); Cholesteryl ester storage disease, 278000 (3)	
UROD	613521	UROD Porphyria cutanea tarda, 176100 (3); Porphyria, hepatoerythropoietic, 176100 (3)	
OPN1SW	613522	OPN1SW, BCP, CBT Colorblindness, tritan, 190900 (3)	
SDCCAG8	613524	SDCCAG8, CCCAP SLSN7 Senior-Loken syndrome 7, 613615 (3)	
CEP152	613529	CEP152, KIAA0912, MCPH4, SCKL5 Microcephaly, primary autosomal recessive, 4, 604321 (3); Seckel syndrome 5, 613823 (3)	
C12orf65	613541	C12orf65, COXPD7 Combined oxidative phosphorylation deficiency 7, 613559 (3)	
XPNPEP3	613553	XPNPEP3, APP3, NPHPL1 Nephronophthisis-like nephropathy 1, 613159 (3)	
TBC1D24	613577	TBC1D24, KIAA1171, FIME Myoclonic epilepsy, infantile, familial, 605021 (3)	
WDPCP	613580	C2orf86, BBS15 Bardet-Biedl syndrome 15, 209900 (3)	
WDR62	613583	WDR62, C19orf14, MCPH2 Microcephaly 2, primary, autosomal recessive, with or without cortical malformations, 604317 (3)	
FAM161A	613596	FAM161A, RP28 Retinitis pigmentosa 28, 606068 (3)	
HOGA1	613597	DHDPSL, HP3 Hyperoxaluria, primary, type III, 613616 (3)	
ZNF513	613598	ZNF513, RP58 Retinitis pigmentosa 58, 613617 (3)	
ABHD12	613599	ABHD12, PHARC Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract, 612674 (3)	
WDR35	613602	WDR35, NAOFEN, KIAA1336, CED2 Cranioectodermal dysplasia 2, 613610 (3); Short rib-polydactyly syndrome, type V, 614091 (3)	
HFE	613609	HFE, HLA-H, HFE1, MVCD7, TFQTL2 Hemochromatosis, 235200 (3); {Microvascular complications of diabetes 7}, 612635 (3); {Porphyria variegata, susceptibility to}, 176200 (3); {Porphyria cutanea tarda, susceptibility to}, 176100 (3); {Alzheimer disease, susceptibility to}, 104300 (3); [Transferrin serum level QTL2], 614193 (3)	
SCARF2	613619	SCARF2, SREC2, VDEGS Van den Ende-Gupta syndrome, 600920 (3)	
NUBPL	613621	NUBPL, IND1 Mitochondrial complex I deficiency, 252010 (3)	
FOXRED1	613622	FOXRED1 Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3); Mitochondrial complex I deficiency, 252010 (3)	
ZNF592	613624	ZNF592, KIAA0211, SCAR5, CAMOS Spinocerebellar ataxia, autosomal recessive 5, 606937 (3)	
AP5Z1	613653	KIAA0415, SPG48 Spastic paraplegia 48, autosomal recessive, 613647 (3)	
KCNK18	613655	KCNK18, TRESK, TRIK, MGR13 {Migraine, with or without aura, susceptibility to, 13}, 613656 (3)	
DARC	613665	DARC, FY, GPD, WBCQ1 [Blood group, Duffy system], 110700 (3); {Malaria, vivax, protection against}, 611162 (3); [White blood cell count QTL], 611862 (3)	
ALG11	613666	ALG11, KIAA1266, CDG1P Congenital disorder of glycosylation, type Ip, 613661 (3)	
SOBP	613667	SOBP, JXC1, MRAMS Mental retardation, anterior maxillary protrusion, and strabismus, 613671 (3)	
MTPAP	613669	MTPAP, PAPD1, SPAX4 Ataxia, spastic, 4, 613672 (3)	
SLC25A20	613698	SLC25A20, CACT, CAC Carnitine-acylcarnitine translocase deficiency, 212138 (3)	
POLR1D	613715	POLR1D, RPA16, RPAC2, TCS2 Treacher Collins syndrome 2, 613717 (3)	
MSRB3	613719	MSRB3, DFNB74 Deafness, autosomal recessive 74, 613718 (3)	
ANO10	613726	ANO10, TMEM16K, SCAR10 Spinocerebellar ataxia, autosomal recessive 10, 613728 (3)	
KBTBD13	613727	KBTBD13, NEM6 Nemaline myopathy 6, 609273 (3)	
MEN1	613733	MEN1 Multiple endocrine neoplasia 1, 131100 (3); Carcinoid tumor of lung (3); Parathyroid adenoma, somatic (3); Lipoma, somatic (3); Angiofibroma, somatic (3); Adrenal adenoma, somatic (3)	
PYGL	613741	PYGL Glycogen storage disease VI, 232700 (3)	
G6PC	613742	G6PC, G6PT Glycogen storage disease Ia, 232200 (3)	
RNF213	613768	RNF213, ALO17, KIAA1618, MYMY2 {Moyamoya disease 2, susceptibility to}, 607151 (3)	
C1R	613785	C1R C1r/C1s deficiency, combined, 216950 (1)	
CCDC39	613798	CCDC39 Ciliary dyskinesia, primary, 14, 613807 (3)	
CCDC40	613799	CCDC40, KIAA1640 Ciliary dyskinesia, primary, 15, 613808 (3)	
TTC19	613814	TTC19 Mitochondrial complex III deficiency, 124000 (3)	
CYP21A2	613815	CYP21A2, CYP21, CA21H Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, 201910 (3); Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3)	
TCTN2	613846	TCTN2, TECT2, MKS8 Meckel syndrome, type 8, 613885 (3)	
PRSS56	613858	PRSS56, MCOP6 Microphthalmia, isolated 6, 613517 (3)	
SLC14A1	613868	SLC14A1, JK, UTE, UT1 [Blood group, Kidd], 111000 (3)	
FAH	613871	FAH Tyrosinemia, type I, 276700 (3)	
F10	613872	F10 Factor X deficiency, 227600 (3)	
F7	613878	F7 Factor VII deficiency, 227500 (3); {Myocardial infarction, decreased susceptibility to}, 608446 (3)	
TRH	613879	TRH Thyrotropin-releasing hormone deficiency, 275120 (1)	
KEL	613883	KEL [Blood group, Kell], 110900 (3)	
HSD3B2	613890	HSD3B2 3-beta-hydroxysteroid dehydrogenase, type II, deficiency, 201810 (3)	
UMPS	613891	UMPS, OPRT Orotic aciduria, 258900 (3)	
DPY19L2	613893	DPY19L2, SPGF9 Spermatogenic failure 9, 613958 (3)	
BPGM	613896	BPGM Erythrocytosis due to bisphosphoglycerate mutase deficiency, 222800 (3)	
FANCF	613897	FANCF Fanconi anemia, complementation group F, 603467 (3)	
HMGCL	613898	HMGCL HMG-CoA lyase deficiency, 246450 (3)	
FANCC	613899	FANCC, FACC Fanconi anemia, complementation group C, 227645 (3)	
TGM6	613900	TGM6, TG6, TGY, SCA35 Spinocerebellar ataxia 35, 613908 (3)	
COA5	613920	C2orf64, PET191 Mitochondrial complex IV deficiency, 220110 (3)	
LIPN	613924	LIPN, LIPL4, LI4 Ichthyosis, lamellar, 4, 613943 (3)	
C2	613927	C2 C2 deficiency, 217000 (3); {Macular degeneration, age-related, reduced risk of}, 603075 (3)	
FANCE	613976	FANCE, FACE Fanconi anemia, complementation group E, 600901 (3)	
PRPF6	613979	PRPF6, PRP6, ANT1, TOM, C20orf14 Retinitis pigmentosa 60, 613983 (3)	
FANCD2	613984	FANCD2, FANCD, FACD, FAD Fanconi anemia, complementation group D2, 227646 (3)	
IMPAD1	614010	IMPAD1, GPAPP, IMPA3 Chondrodysplasia with joint dislocations, GRAPP type, 614078 (3)	
RB1	614041	RB1 Retinoblastoma, 180200 (3); Osteosarcoma, somatic, 259500 (3); Bladder cancer, somatic, 109800 (3); Small cell cancer of the lung, somatic, 182280 (3); Retinoblastoma, trilateral, 180200 (3)	
KHK	614058	KHK [Fructosuria], 229800 (3)	
ZBTB24	614064	ZBTB24, PATZ2, ZNF450, KIAA0441, ICF2 Immunodeficiency-centromeric instability-facial anomalies syndrome-2, 614069 (3)	
IFT43	614068	IFT43, C14orf179, CED3 Cranioectodermal dysplasia 3, 614099 (3)	
ICAM4	614088	ICAM4, CD242, LW [Blood group, Landsteiner-Wiener], 111250 (3)	
PCK2	614095	PCK2, PEPCK2 PEPCK deficiency, mitochondrial, 261650 (1)	
TMCO1	614123	TMCO1, CFSMR Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome, 614132 (3)	
SPECC1L	614140	SPECC1L, KIAA0376, OBLFC1 Facial clefting, oblique, 1, 600251 (3)	
B9D1	614144	B9D1, MKSR1, MKS9 Meckel syndrome 9, 614209 (3)	
CCDC8	614145	CCDC8, 3M3 Three M syndrome 3, 614205 (3)	
NOP56	614154	NOP56, SCA36 Spinocerebellar ataxia 36, 614153 (3)	
ZNF644	614159	ZNF644, MYP21 Myopia 21, autosomal dominant, 614167 (3)	
PRDM5	614161	PRDM5, BCS2 Brittle cornea syndrome 2, 614170 (3)	
PCK1	614168	PCK1 ?Phosphoenolpyruvate carboxykinase-1, cytosolic, deficiency, 261680 (1)	
NBEAL2	614169	NBEAL2, KIAA0540, GPS, BDPLT4 Gray platelet syndrome, 139090 (3)	
DIS3L2	614184	DIS3L2, PRLMNS Perlman syndrome, 267000 (3)	
DOCK6	614194	DOCK6, KIAA1395, AOS2 Adams-Oliver syndrome 2, 614219 (3)	
ASCC1	614215	ASCC1, p50 Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	
WDR81	614218	WDR81, CAMRQ2 Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2, 610185 (3)	
HSD11B2	614232	HSD11B2, HSD11K, AME Apparent mineralocorticoid excess, 218030 (3)	
OPLAH	614243	OPLAH, OPLAHD 5-oxoprolinase deficiency, 260005 (3)	
ACSF3	614245	ACSF3 Combined malonic and methylmalonic aciduria, 614265 (3)	
POLR3A	614258	POLR3A, RPC1, RPC155, ADDH, HLD7 Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, 607694 (3)	
WDR65	614259	WDR65, VWS2 van der Woude syndrome 2, 606713 (3)	
C9orf72	614260	C9orf72, FTDALS, ALSFTD Amyotrophic lateral sclerosis with frontotemporal dementia, 105550 (3)	
GLCCI1	614283	GLCCI1, TSSN1, GCTR {Glucocorticoid therapy, response to}, 614400 (3)	
BICC1	614295	BICC1, BICC, CYSRD {Renal dysplasia, cystic, susceptibility to}, 601331 (3)	
C19orf12	614297	C19orf12 Neurodegeneration with brain iron accumulation 4, 614298 (3)	
POLR3B	614366	POLR3B, RPC2, C128, HLD8 Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism, 614381 (3)	
PRRT2	614386	PRRT2, PKC, DYT10, EKD1 Episodic kinesigenic dyskinesia 1, 128200 (3)	
RHBDF2	614404	RHBDF2, IRHOM2, TOC Tylosis with esophageal cancer, 148500 (3)	
TMEM237	614423	TMEM237, ALS2CR4, JBTS14 Joubert syndrome 14, 614424 (3)	
TSHZ1	614427	TSHZ1, TSH1, CAA Aural atresia, congenital, 607842 (3)	
TMEM138	614459	TMEM138, JBTS16 Joubert syndrome 16, 614465 (3)	
C8orf37	614477	C8orf37, CORD16, RP64 Retinitis pigmentosa 64, 614500 (3); Cone-rod dystrophy 16, 614500 (3)	
COX14	614478	C12orf62 Mitochondrial complex IV deficiency, 220110 (3)	
FKBP14	614505	FKBP14, EDSKMH Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss, 614557 (3)	
BRAT1	614506	BRAT1, BAAT1, C7orf27, RMFSL Rigidity and multifocal seizure syndrome, lethal neonatal, 614498 (3)	
GPR179	614515	GPR179, GPR158L, GPR158L1, CSNB1E Night blindness, congenital stationary, type 1E, 614565 (3)	
GATAD1	614518	GATAD1, ODAG, CMD2B Cardiomyopathy, dilated, 2B, 614672 (3)	
NDUFA12	614530	NDUFA12 Leigh syndrome due to mitochondrial complex 1 deficiency, 256000 (3)	
ARID1B	614556	ARID1B, BAF250B, KIAA1235, MRD12 Mental retardation, autosomal dominant 12, 614562 (3)	
DNAAF3	614566	DNAAF3, PF22, DAB1, CILD2 Ciliary dyskinesia, primary, 2, 606763 (3)	
DIAPH3	614567	DIAPH3, DIA2, DRF3, AUNA1, NSDAN Auditory neuropathy, autosomal dominant, 1, 609129 (3)	
C5orf42	614571	C4orf42, JBTS17 Joubert syndrome 17, 614615 (3)	
ROGDI	614574	ROGDI, KTZS Kohlschutter-Tonz syndrome, 226750 (3)	
TTC37	614589	TTC37, KIAA0372 Trichohepatoenteric syndrome 1, 222470 (3)	
CEACAM16	614591	CEACAM16, CEAL2, DFNA4B Deafness, autosomal dominant 4B, 614614 (3)	
IFT140	614620	IFT140, KIAA0590, MZSDS Mainzer-Saldino syndrome, 266920 (3)	
ISPD	614631	ISPD, MDDGA7 Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7, 614643 (3)	
UVSSA	614632	UVSSA, KIAA1530, UVSS3 UV-sensitive syndrome 3, 614640 (3)	
COQ6	614647	COQ6, CGI10, COQ10D6 Coenzyme Q10 deficiency, primary, 6, 614650 (3)	
RNF170	614649	RNF170, SNAX1 Ataxia, sensory, 1, autosomal dominant, 608984 (3)	
CCDC103	614677	CCDC103, SMH, PR46B, CILD17 Ciliary dyskinesia, primary, 17, 614679 (3)	
